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Abstract 
Cell encapsulation systems, in which cells and/or biomaterials and molecules 
are physically isolated from the surrounding environment, are being 
increasingly applied as multifunctional strategies in Tissue Engineering and 
Regenerative Medicine. In the present thesis it is proposed a rather unique 
combination of functional biomaterials and different cell types for the 
groundbreaking advance of liquified cell encapsulation systems. The proposed 
system aims to transfigure the concept of conventional three-dimensional 
scaffolds, typically associated on the use of porous structures or hydrogels to 
support cells, by using an alternative and hierarchical methodology. Capsules 
are composed by different components: (i) a permselective multilayered 
membrane composed by various polyelectrolytes, namely alginate, chitosan, 
and poly(L-lysine), and also electrostatically bounded magnetic-nanoparticles 
which confer magnetic-responsive ability to the system; (ii) poly(L-lactic acid) 
microparticles surface functionalized by combining plasma treatment with 
different coating materials; and (iii) different cell types, namely L929, stem 
and endothelial cells. The membrane wraps the liquefied core of the capsules, 
ensuring permeability to essential molecules for cell survival, and enhancing 
direct contact between the encapsulated materials. The microparticles confer 
cell adhesion sites, and also influence biological processes of the encapsulated 
cells due to its chemically modified surface. Multilayered and liquified capsules 
encapsulating microparticles were first validated as successful cell 
encapsulation systems for tissue regeneration. Different parameters of the 
production process were optimized, such as the number, type and 
concentration of multilayers, and the required time de-crosslinker 
concentration to liquefy the alginate core. Capsules were further successfully 
proposed as bioencapsulation systems for the regeneration of specific tissues, 
namely cartilage and bone. Ultimately, the biological outcome of capsules was 
tested in vivo, demonstrating the biotolerability of the developed system. It is 
expected that the proposed capsules will have a strong impact and open new 
prospects in cell encapsulation systems for tissue regeneration. 
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Resumo 
 
Sistemas de encapsulamento celular, nos quais células e/ou biomateriais e 
moléculas estão fisicamente isolados do exterior, estão a ser cada vez mais 
propostos como estratégias multifuncionais para Engenharia de Tecidos e 
Medicina Regenerativa. Na presente tese é proposta a combinação de 
biomateriais funcionais e vários tipos de células para o progresso de sistemas 
liquefeitos de encapsulamento celular. O sistema proposto pretende transfigurar o 
conceito convencional de scaffolds tridimensionais, tipicamente associados a 
estruturas porosas ou hidrogéis para suporte celular, propondo uma metodologia 
hierárquica. As cápsulas são constituídas por diferentes componentes: (i) uma 
membrana com permeabilidade seletiva composta por vários polieletrólitos, 
nomeadamente alginato, quitosano e poli(L-lisina), e ainda nanopartículas 
magnéticas electrostaticamente acopladas à membrana que conferem ao sistema 
capacidade de resposta magnética; (ii) micropartículas de poli(L-ácido láctico) 
com a superfície funcionalizada por tratamento de plasma combinado com 
diferentes materiais de revestimento; (iii) diferentes tipos de células, 
nomeadamente L929, estaminais e endoteliais. A membrana envolve o núcleo 
liquefeito das cápsulas, assegurando a permeabilidade de moléculas essenciais 
para a viabilidade celular, e ainda maximiza o contacto direto entre os diferentes 
componentes encapsulados. As micropartículas oferecem locais de adesão 
celular, e ainda influenciam os processos biológicos das células encapsuladas 
devido à superfície quimicamente modificada. Cápsulas com multicamadas e 
liquefeitas com micropartículas encapsuladas foram primeiramente validadas com 
sucesso como sistemas de encapsulamento celular para regeneração de tecidos. 
Diferentes parâmetros do processo de produção foram optimizados, tais como o 
número, tipo e concentração das multicamadas, e o tempo necessário e 
concentração do des-reticulador para liquefazer o interior de alginato. As cápsulas 
foram ainda propostas com sucesso como sistemas de bio-encapsulamento para a 
regeneração de tecidos específicos, nomeadamente cartilagem e osso. Em última 
análise, a resposta biológica  das cápsulas foi testada in vivo, demonstrando a 
biotolerância do sistema desenvolvido. Espera-se que as cápsulas propostas 
tenham um impacto considerável e que abram novas perspectivas nos sistemas 
de encapsulamento celular para regeneração de tecidos. 
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Part 1 – General introduction 
 
Chapter I. Design principles and technologies in cell encapsulation 
systems towards tissue regeneration 
 
Figure I.1 – Schematic representation of the concept “open and closed” 
scaffolds for Tissue Engineering and Regenerative Medicine applications. In 
“open” strategies, cells are in direct contact with the host environment, while 
in “closed” systems the interaction is indirect due to the presence of the 
encapsulation matrix…………………………………………………………………..…….19 
 
Figure I.2 – Different types of beads and capsules as spherical cell 
encapsulation systems. (B1) Alginate microbeads encapsulating human 
umbilical cord mesenchymal stem cells. Scale bar is 200 µm. Reprinted from 
ref. [182] with permission from Elsevier. Copyright © 2016 Elsevier Ltd. (B2a) 
DEX-MA microbeads stained with safranin-O (red), alcian blue (light blue) and 
toluidine (dark blue) encapsulated within alginate beads. Scale bar is 1 mm. 
(B2b) Higher magnification of B2a to evidence the encapsulated microbeads. 
Scale bar is 200 µm. Reprinted from ref. [149] with permission from John 
Wiley & Sons. Copyright © 2015 WILEY-VHC Verlag GmbH & Co. KGaA, 
Weinheim. (MS1) Matrix-core/shell capsule encapsulating baby hamster kidney 
(BHK) cells. The encapsulated BHK that remained in the core of the capsule 
are viable as showed by green fluorescence, while BHK cells that migrated to 
the outer layer were effectively killed (red fluorescence). Reprinted from ref. 
[183] with permission from Nature Publishing Group. Copyright © 2016 
Macmillan Publishers Limited. (MS2a) Bi-layered DEX-MA matrix-core/shell 
capsule with the inner and outer layers stained with green and red fluorescent 
dyes, respectively. Scale bar is 500 µm. (MS2b) Localization of the 
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encapsulated L929 cells in the outer layer of the DEM-MA matrix-core/shell 
capsule. Cell nuclei were stained in blue (DAPI) and F-actin filaments in red 
(phalloidin). Scale bar is 200 µm. Reproduced from ref. [148] with permission 
from John Wiley & Sons. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim. (LS1) Liquid-core/shell capsule composed by a liquified 
alginate core encapsulating L929 cells and a layer-by-layer chitosan-alginate 
membrane. Scale bar is 500 µm. Reprinted from ref. [42] with permission from 
John Wiley & Sons. Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. (LS2a) Liquid-core/shell capsule composed by a liquified alginate 
core encapsulating L929 cells and solid poly(L-lactic acid) microparticles as 
cell adhesion sites. The liquified core is surrounded by a multilayered 
membrane composed by poly(L-lysine), alginate and chitosan. Scale bar is 500 
µm. (LS2b) Higher magnification of the liquified core of the capsules, showing 
the encapsulated microparticles. Scale bar is 100 µm. Reprinted with 
permission from [28]. Copyright © 2013, American Chemical Society. (CS1) 
Yeast cells coated with poly(N-vinyl pyrrolidone)/tannic acid multilayers, using 
a cationic poly(ethylene imine) as the first layer to facilitate the membrane 
adhesion. Scale bar is 4 µm. Reprinted with permission from ref. [184]. 
Copyright © 2010 Royal Society of Chemistry. (CS2) Cell-core/shell capsule 
composed by 6 layers of poly(allylamine hydrochloride) and poly(styrene 
sulfonate) stained in green surrounding a yeast cell. The resultant daughter cell 
was able to disrupt the membrane, resulting in a coating-free cell. Reprinted 
with permission from ref. [185]. Copyright © 2002 American Chemical 
Society…………………………………………………………………………………………...35  
 
Figure I.3 – Different types of fiber-shaped cell encapsulation systems. (M) 
Gelatin–hydroxyphenylpropionic acid (Gtn–HPA) matrix-core fibers 
encapsulating Madin-Darby canine kidney (MDCK) cells. (Ma) Optical 
micrograph (live-dead assay) and (Mb) cryosectional image (DAPI staining) of 
Gtn-HPA fibers. Scale bar in (Ma) is 400 µm and in (Mb) 50 µm. Reprinted 
from ref. [202] with permission from Elsevier. Copyright © 2009 Elsevier Ltd. 
(MSa) Matrix-core/shell fiber encapsulating rat mesenchymal stem cells in the 
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collagen core and bioactive glass nanoparticles (BGn) releasing silicon and 
calcium ions encapsulated in the alginate shell. Phalloidin (green) and DAPI 
(blue) staining after and 21 days of encapsulation in fibers (MSb) without or 
(MSc) with BGn. Scale bar is 100 µm. Reprinted from ref. [204] with 
permission from Elsevier. Copyright © 2015 Acta Materialia Inc. (LS1) Liquid-
core/shell fibers with 120 µm of diameter encapsulating HEK 293 cells 
transfected with GFP (293/GFP cells) in the liquid alginate core surrounded by 
a poly(L-lysine) (PLL) shell. Green fluorescence images were overlaid on bright-
field images. Scale bar is 400 µm. Reprinted with permission from ref. [126]. 
Copyright © 2008 Royal Society of Chemistry. (LS2a-c) Optical images of 
mouse embryonic cells encapsulated in alginate/PLL aqueous microstrands 
after 5 days of culture. The liquified environment allowed cells to self-assemble 
into tubular structures while promoting the formation of compact microtissues. 
Scale bar is 200 µm. Reprinted from ref. [129] with permission from Elsevier. 
Copyright © 2011 Elsevier Ltd. (H1) Schematic representation of alginate 
hollow fibers encapsulating HIVE-78 cells (red). Hollow fibers were then 
embedded in agar-gelatin-fibronectin matrix encapsulating HIVS-175 cells 
(green) to create a 3D vascularized co-culture system. Reprinted from ref. 
[125] with permission from John Wiley & Sons. Copyright © 2009 WILEY-VCH 
Verlag GmbH & Co. KGaA, Weinheim. (H2a) Hollow-core alginate fibers 
encapsulating L929 cells stained with red fluorescent dye. L929 cells stained 
in green were added to the hollow core to evidence the tubular structure of the 
fibers. (H2b) Hollow fibers were cut into pieces and slightly pressed, 
originating the release of the green cells in the hollow core, while the 
encapsulated red cells remained within the fiber matrix. Scale bar is 500 µm. 
Reprinted from ref. [206] with permission from Elsevier. Copyright © 2009 
Elsevier B.V……………………………………………………………………………………..42 
 
Figure I.4 – Examples of multifaceted and complex systems used for cell 
encapsulation in TERM applications. (I) Liquified capsules encapsulating L929 
cells. Hydrogels were assembled by a perfusion-based layer-by-layer technique. 
Reproduced from ref. [44] with permission from the Royal Society of 
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Chemistry. (II) Production of hydrogels by liquified air-interface-directed self-
assembly technique. (II.a) The pre-polymer solution (PEG and cells in 
suspension) is placed on top of an octadecyl-trimethoxysilane (OTS)-treated 
glass slide between the photomask and spacers. (II.b) UV light is selectively 
filtered through the photomask, leading the pre-polymer solution to polymerize 
in the desired pattern. (II.c) After PBS washing, PEG hydrogels encapsulating 
cells are obtained. (II.d) Microgels are randomly placed on the surface of 
perfluorodecalin (PFDC) or carbon tetrachloride, which due to the 
hydrophobicity of the solutions, microgels remain floating. (II.e) Due to surface 
tension, microgels self-assemble to minimize free energy. (II.f) Secondary UV 
polymerization to crosslink the microgels aggregation, originating macroscale 
engineered constructs. Scale bar is 2 cm. Reproduced from ref. [221] with 
permission from John Wiley & Sons. (III) Self-assembly of hydrogel cubes with 
uniform giant DNA glue modification. Hydrogel cubes display giant DNA on 
multiple designated faces, which allows constructing linear chain structures 
and net-like structures. To make chain structures, two cube species were 
made: a red cube that displays giant DNA a on two opposite faces, and a blue 
cube that displays giant DNA a* on two opposite faces. (III.a) Schematic 
representation of giant-DNA-directed hydrogel assembly. Giant DNA containing 
tandem repeats of complementary 48-nt sequences was uniformly amplified on 
the surface of red and blue hydrogel cubes. Hybridization between the 
complementary DNA sequences resulted in assembly of hydrogel cubes. (III.b) 
Hydrogel cubes were assembled in a 0.5 mL tube filled with assembly buffer 
under mild rotation, transferred to a Petri dish and imaged by microscopy. 
(III.c and III.d) Phase contrast and fluorescent microscopy images of the post-
assembly system, in which hydrogel cubes were modified with (III.c) short 56-
nt or (III.d) amplified giant DNA strands. Hydrogel cubes carrying 
complementary DNA a or a* were labeled with red or blue fluorescent 
microbeads, respectively, and stained with SYBR Gold. (III.e) Red and blue 
hydrogel cubes carrying complementary short (left) or giant (right) DNA 
strands failed (left) or succeeded (right) to assemble into aggregates, in the 
presence of competitive yellow hydrogel cubes that were not modified with 
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DNA. (III.f) Aggregates assembled from red and blue hydrogel cubes carrying 
complementary giant DNA fell apart after 1 h Baseline-ZERO DNase treatment 
(left: before DNase treatment; right: after DNase treatment). Scale bar is 500 
mm in III.c, III.d, III.e and III.f. (III.g–j) Aggregates were assembled from red 
and blue hydrogel cubes with various edge lengths: (III.g) 30 mm, (III.h) 200 
mm, (III.i) 500 mm and (III.j) 1 mm. Giant DNA glue was uniformly amplified 
on the hydrogel surface. Scale bar is 1 mm in the main panels and 50 mm in 
the inset of (III.g). Reproduced from ref. [213] with permission from Nature 
Publishing Group. (IV) Magnetic directed assembly of microgels produced by 
micromolding. Microgels were assembled to fabricate three-layer spheroids 
through the application of external magnetic fields. First layer gels were 
stained with rhodamine-B, second layer gels were stained with FITC-dextran, 
and third layer gels were stained with TPB (1,1,4,4-Tetraphenyl-1,3-butadiene). 
Scale bar is 500 µm. Reproduced from ref. [214] with permission from John 
Wiley & Sons. (V) Cell encapsulation in 3D gel objects (modules) in a variety of 
simple shapes (crosses, squares and cylinders). (V.a) Photolithography of SU-8 
photoresist on a silicon wafer to generate posts with diameters from 40 to 
1000 mm and heights from 100 to 1000 mm. (V.b) Spin-casting PDMS around 
the produced posts generates a membrane that bore an array of holes in a 
variety of shapes with precise dimensions. (V.c) The obtained holes penetrate 
the PDMS membrane, which allows the modules to be release easily after 
formation. (V.d) Emersion of the fabricated PDMS membrane in a collagen 
solution containing NIH 3T3 cells in suspension. (V.e) Incubation of the 
membrane containing holes filled with collagen and cells at 37ºC for 45 min. 
(V.f) After gelation of collagen, the membrane is immersed in cell culture 
medium and agitated for 10-15 min until the hydrogel modules are released. 
(V.g) Encapsulated cells proliferate and consequently the hydrogel shrinks 
without loosing its pre-defined shape. (V.h-k) Different shapes of modules. 
(V.h) Cross module fabricated from collagen. (V.i) Square cross-section module 
(40 mm wide) fabricated from collagen containing a single cell (bright spot). 
(V.j) Side view of square cross-section module (200 mm wide) fabricated from 
2 % w/v agarose gel without cells. (V.k) Cylindrical module (1 mm in diameter) 
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fabricated from Matrigel. Scale bar is 800 µm in (V.h, V.j and V.k) and 200 µm 
in (V.i). Reproduced with permission from ref. [222]. (VI) Polarity induction in 
individual EBs encapsulated in gelMA/PEG hybrid microgels with spatially 
patterned vasculogenic differentiation. (VI.a and VI.c) Phase contrast images of 
individual embryoid bodies (EBs) in hybrid microgel. (I.4VI.b and I.4VI.d) 
Microbead (green) laden PEG microgel and streptavidin conjugated rhodamine 
(red) laden gelMA microgel in hybrid microgel structure and EB morphology 
stained in blue by DAPI. Scale bar is 600 µm in (VI.a) and 300 µm in (VI.c). 
Reproduced from ref. [217] with permission from John Wiley & Sons. (VII) 
Bioprinting of aortic valve conduit. (VII.a) Aortic valve model reconstructed 
from micro-CT images. The root and leaflet regions were identified with 
intensity thresholds and rendered separately into 3D geometries into 
stereolithography format (green color indicates valve root and red color 
indicates valve leaflets). (VII.b and VII.c) Schematic illustration of the 
bioprinting process with dual cell types and dual syringes. (VII.b) Root region 
of first layer generated by hydrogel with human aortic root smooth muscle 
cells (SMC). (VII.c) Leaflet region of first layer generated by hydrogel with 
porcine aortic valve interstitial cells (VIC). (VII.d) Fluorescent image of first 
printed two layers of aortic valve conduit. Smooth muscle cells (SMC) for valve 
root were labeled by cell tracker green and aortic valve interstitial cells (VIC) 
for valve leaflet by cell tracker red. Scale bar is 3 mm. (VII.e) As-printed aortic 
valve conduit. Reproduced from ref. [219] with permission from John Wiley & 
Sons. (VIII) 3D printed rigid filament networks of carbohydrate glass as a 
cytocompatible sacrificial template in engineered tissues containing living cells 
to generate cylindrical networks, which could be lined with endothelial cells 
and perfused with blood under high-pressure pulsatile flow. Cells constitutively 
expressing EGFP (green) were encapsulated in a variety of ECM materials, then 
imaged with confocal microscopy to visualize the matrix (red beads), cells 
(10T1/2, green) and the perfusable vascular lumen (blue beads) shown 
schematically (bottom right). The materials have varied crosslinking 
mechanisms (annotated above images) but were all able to be patterned with 
vascular channels. Scale bars are 200 μm. Reproduced from ref. [218] with 
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permission from Nature Publishing Group. (IX) 3D printing of tough and 
biocompatible PEG–alginate–nanoclay hydrogels with various shapes: (from left 
to right) hollow cube, hemisphere, pyramid, twisted bundle, the shape of an 
ear, and a nose. Nontoxic red food dye was added postprint on some samples 
for enhanced visibility). Scale bars are 2 cm. Reproduced from ref. [55] with 
permission from John Wiley & Sons. (X) 3D bioprinting for fabricating 
engineered tissue constructs replete with vasculature, multiple types of cells, 
and ECM. (X.a) Schematic view and (X.b and X.c) fluorescence images of an 
engineered tissue construct cultured for 0 and 2 days, respectively, in which 
red and green filaments correspond to channels lined with red fluorescent 
protein-expressing HUVECs and green fluorescent protein-expressing human 
neonatal dermal fibroblast (HNDFs) cells-laden gelMA ink, respectively. The 
cross-sectional view shows that endothelial cells line the lumens within the 
embedded 3D microvascular network. Scale bar is 300 µm. Reproduced from 
ref. [173] with permission from John Wiley & Sons………………………………….49 
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Chapter II. Materials and methods 
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multilayered capsules encapsulating surface-modified microparticles and 
cells……………………….…………………….…………………….………………………..111 
 
 
 
 
 
MULTIFUNCTIONAL AND LIQUIFIED CAPSULES FOR TISSUE REGENERATION 	
 xxxviii 
Part 3 – Experimental results 
 
Chapter III. Liquified chitosan-alginate multilayer capsules 
incorporating poly(L-lactic acid) microparticles as cell carriers 
 
Scheme III.1 – A schematic representation of the organization of the proposed 
liquified multilayer capsules. (a) Cells are seeded at the surface of 
microparticles, originating the production of microcarriers. (b) After 
encapsulation of the obtained microcarriers in sacrificial hydrogel particles, 
oppositely charged polymers are deposited at their surface by layer-by-layer 
technique. (c) Upon core dissolution, liquified multilayer capsules are 
obtained. The permselective ability of the shell of the capsules allows the 
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Figure III.1 – (a) Build-up assembly assessment of chitosan (CHT) and alginate 
(ALG) up to 8 deposition layers. Results correspond to the quartz-crystal 
microbalance with dissipation monitoring (QCM-D) of normalized frequency 
(ΔFν/ν) and dissipation (ΔD) variations at the third overtone as a function of 
time. Arrows point to the end of polyelectrolytes adsorption. (b) Cumulative 
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Mechanical resistance of the liquefied capsules (n=15 in triplicate) after a 
rotational stress of 200 rpm for 60 min. Every 15 min, capsules where 
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Figure III.2 – Scanning electron microscopy (SEM) of cross-sections of 
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Figure III.3 – Calcium cumulative release as a function of time measured by 
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directly in EDTA solution (inset). Different concentrations of EDTA were used, 
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higher magnification images of days 1 and 7, respectively. Scale bar is 50 µm 
with 500x of magnification…….…….…….…….…….…….…….…….…….………..174 
 
Figure IV.5 – MTS viability assay at 1, 3 or 7 days of culture. Alginate particles 
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Structure of the thesis 
 
The present thesis is organized in four parts that include a total of eight 
chapters. Part 1-3 are based on scientific papers or book chapters published 
or submitted for publication in international peer-reviewed journals. The 
respective original publication is cited at the beginning of each chapter. Each 
thesis chapter based on published papers is presented in the original 
manuscript form: Abstract, Introduction, Materials and methods, Results, 
Discussion, Conclusion, Acknowledgements, Supplementary Information, and 
References. 
 
Part 1 is an introductory overview of cell encapsulation strategies applied in 
tissue regeneration strategies. The alternative path from cell encapsulation 
strategies to treat endocrine diseases to cell encapsulation strategies for tissue 
regeneration is discussed. The different designs and methodologies to produce 
such systems is also detailed discussed, as well as the multifunctionalities of 
cell encapsulation systems. 
 
Part 2 describes the techniques and materials used to the proposed cell 
encapsulation system comprising multilayered and liquified capsules 
encapsulating surface modified solid microparticles and different cell types. In 
vitro and in vivo characterization techniques are also presented. The aim of this 
chapter is to complement and summarize in a single section the Materials and 
Methods subsection of each chapter from Part 3. 
 
Part 3 comprises five experimental chapters related to the development of a 
novel cell encapsulation system for tissue regeneration. In Chapter III the 
different parameters to produce those capsules are optimized and in Chapter 
IV the applicability of capsules as bioencapsulation systems for tissue 
regeneration is successfully demonstrated. In Chapters V and VI capsules are 
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tested in a more specific tissue regeneration field, namely for cartilage and 
bone regeneration, respectively. Ultimately, in Chapter VII capsules are tested 
in vivo in a preliminary subcutaneous implantation. 
 
Part 4 summarizes the results achieved in this thesis. Additionally, recent 
progresses on the cell encapsulation towards tissue regeneration and future 
directions of the field are succinctly discussed. 
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Chapter I 
Design principles and technologies in cell encapsulation systems 
towards tissue regeneration 1 
 
Abstract 
Cell encapsulation systems are being increasingly applied as multifunctional 
strategies to regenerate damage tissues. Lessons afforded by efforts towards 
endocrine diseases treatment, the first impetus of primordial cell 
encapsulation systems, seemed to be highly valuable when the regeneration of 
tissues is aimed. Innumerous multifunctional systems for cell 
compartmentalization are being proposed to meet the specific needs required 
in the Tissue Engineering and Regenerative Medicine field. Here, we review the 
new methodologies that are being employed to fabricate the next generation of 
cell encapsulation strategies towards tissue regeneration. We also discuss the 
variable geometries of those systems, including spherical and fiber-shaped 
systems, as well as other complex shapes and arrangements that better mimic 
the highly hierarchical organization of native tissues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Based on the publication: C.R. Correia, R.L. Reis, J.F. Mano, Design principles and technologies in 
cell encapsulation systems towards tissue regeneration (2016) (submitted). 
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1. Introduction: From immunoisolation to multifunctional devices 
Cell encapsulation is the process in which cells and/or bioactive molecules are 
encapsulated within a semipermeable barrier, hence being physically isolated 
from the surrounding environment. The first impetus of cell encapsulation 
systems was to protect the encapsulated cells from potential hazardous 
processes of the surrounding host environment, such as the immunological 
system, while maintaining the normal physiological functions of the 
encapsulated cells. This immunopriviledge feature of cell encapsulation 
systems was first demonstrated in 1933 using amniotic membrane tissue as 
the immunoprotective barrier [1]. Results showed that after implantation in the 
abdominal cavity of pigs, a prolonged cell survival of encapsulated tumor cells 
could be observed. However, the therapeutic potential of the technology was 
not recognized in that time. Later, in 1954, the concept of “diffusion chamber” 
to graft therapeutic cells was introduced [2], while also emphasizing for the 
first time the importance of biocompatible polymers on the composition of the 
cell encapsulation matrix. The release of encapsulated bioactive molecules 
without encapsulating cells emerges in 1964 [3]. Microcapsules (1-100 µm 
diameter) encapsulating hemolysate isolated from erythrocytes were produced 
by the coacervation technique. The successful release of the enzyme, while 
maintaining its bioactivity, was assessed in vitro and in vivo. This was the first 
time that an “artificial cell” was created, by releasing functional bioactive 
molecules from engineered materials. The creation of an artificial 
immunopriviledge site with therapeutic potential had then prompted the 
scientific community into the development of bioartificial organs. In light, in 
1975 is developed for the first time an artificial endocrine pancreas [4]. Beta 
cells were isolated from neonatal rats and then cultured on bundles of artificial 
capillaries (Amicon XM-50 fibers). Results showed that cells continued to 
release insulin in similar levels of the flask cultures control, while remained 
responsive to changes in glucose concentration. The overarching principle of 
cell encapsulation was then to provide a long-lasting solution for treating 
secretory cell dysfunction [5-7]. By surrounding the transplanted cells within 
an immunological barrier opened new prospects in organ transplantation, 
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specially related with the culmination in the administration of 
immunosuppressant drugs, an important issue to be considered due to their 
adverse side effects. This was accomplished with the added benefits of 
reducing the burden of cell sourcing, since the immunoprotection feature 
allowed the use of allo- or even xenogeneic cells. Another remarkable study 
that influenced the pathway in the development of cell encapsulation 
strategies, is the work of Lim and Sun [8] with the encapsulation of islets in 
novel poly(L-lysine) (PLL) coated alginate beads. Since then, decades of 
extensive research have focused on the design and application of 
immunoisolation devices, which also facilitated the adequate transport of 
essential molecules for cell survival, namely oxygen and nutrients, as well as 
therapeutic molecules. Knowing the background of cell encapsulation it is 
understandable that the majority of works reported in the literature are related 
with the applicability of the technology in a wide range of endocrine diseases, 
including anemia [9], dwarfism [10], hemophilia B [11], kidney [12] and liver 
[13] failure, pituitary gland [14] and central nervous system [15] disorders, 
and, its major application field, diabetes mellitus [8]. In fact, the research on 
the encapsulation of pancreatic islets dominates the cell encapsulation field 
related with the immunoprotection feature. This is driven by the high number 
of diabetic patients and the recognized benefits of cell encapsulation 
strategies, which significantly improved their quality of life [16]. In parallel, 
with the discovery of new polymers and biomaterials, cell encapsulation 
strategies became more complex, and its use was extrapolated to respond to 
requirements of complex fields, such as Tissue Engineering and Regenerative 
Medicine (TERM). In TERM field, the concept of encapsulating cells is different 
from the immunoprotection required to treat endocrine diseases. In TERM 
applications, it is often desirable that the encapsulation matrix degrades while 
the encapsulated cells proliferate and create their own extracellular matrix. 
Additionally, different pro-healing components, such as growth factors and 
cytokines can be co-encapsulated with cells, while being released in a 
sustained fashion through the encapsulation matrix. Moreover, various 
encapsulation systems allow minimal invasive procedures through injection, 
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permitting the compartmentalization of cells and other desirable cargo in 
complex geometries. The large variety of cell encapsulation systems of 
different geometries proposed for TERM is almost exclusively produced from 
hydrogels due to a number of appealing features. Hydrogels provide a highly 
hydrated environment, while allowing the entrance of low-molecular mass 
nutrients and metabolites, for the encapsulated cells. Moreover, hydrogels can 
be easily functionalized to present biochemical, cellular, and physical stimuli 
that guide cellular processes such as migration, proliferation, and 
differentiation [17-20]. Additionally, the soft and pliable features of the 
hydrogel reduce the frictional or mechanical irritation to the surrounding tissue 
at the site of implantation. Some authors also claim that due to its hydrophilic 
properties, there is virtually no interfacial tension with surrounding tissues and 
fluids, which minimizes cell adhesion and protein adsorption, resulting in high 
biocompatibility [21]. 
In the present review, we intend to highlight the emergence of sophisticated, 
“smart” and multifunctional-engineered cell encapsulation systems that in 
common aim to successfully stimulate the regeneration of damaged tissues, 
while describing their relevant design criteria and the processing methods. In 
particular, a special focus will be given on the use of hydrogels as such class of 
materials has become the most effective used for cell encapsulation. We intend 
to highlight the state-of-the-art of the emerging techniques that are 
contributing to the development of the new generation of cell encapsulation 
systems. We critically describe challenges and achievements by giving 
examples of reported strategies. The new cell encapsulations systems are 
discussed in terms of its variable three-dimensional (3D) structures, 
comprising spherical, fiber-shaped and structures with increased 3D 
complexity, including multiscale devices obtained either from top-down or 
bottom-up approaches. Additionally, new features added to enhance the new 
multifunctional cell encapsulation systems are discussed, in which all of them 
have in common the same impetus: improve viability and functions of the 
encapsulated cells directing their activity in promoting the formation of new 
tissue. 
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2. Cell Encapsulation & Tissue Regeneration 
The application of cell encapsulation principles to be used in the regeneration 
of tissues brought several advantages to the TERM field as compared to 
conventional strategies. Knowing that the key element in TERM is to combine 
cells with instructive biomaterials to ultimately regenerate damaged tissues, it 
is easy to understand that the function of the engineered device is not limited 
to the protection of cells, as it is its main function when cell encapsulation is 
applied to treat endogenous diseases. Therefore, the development of cell 
encapsulation devices that aim to promote tissue regeneration should be 
carefully pondered before its conception, in order to meet all the complex 
requirements of the field. Those requirements are here critically discussed. 
Additionally, the limitations, advantages and practical considerations of cell 
encapsulation strategies (“closed scaffolds”) over the commonly used “open 
scaffolds” in TERM at which cells are in direct contact with the surrounding 
environment are discussed. 
 
2.1 Critical properties 
 
2.1.1 Mild and sterile conditions 
Concerning the multiple methods to produce cell encapsulation devices, which 
will not be discussed here (we suggest the reading of [17]), all of them have to 
take in consideration that for TERM applications cells are usually present in 
the to-be transformed biomaterial, so its transformation into the final structure 
must ensure the preservation of living components. Therefore, it is logical that 
all the production methods to produce cell encapsulation devices must ensure 
mild and sterile conditions. This limits the type of production techniques that 
can be employed, as well as the list of biomaterials that can be fabricated 
under those conditions. Allied to a number of appealing features, such as their 
structural resemblance to many natural biological tissues, viscoelasticity, and 
high water content, hydrogels have become the most favorable material used 
for cell encapsulation. Since the first hydrogel application in cell encapsulation 
when Lim and Sun developed calcium alginate microcapsules for islet 
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encapsulation [8], both synthetic and naturally derived cell encapsulation 
matrixes have been developed. Most of previous research has been focused on 
natural-derived hydrogels, such as alginate, chitosan, agarose, gelatin, 
collagen, fibrin, hyaluronic acid, among others [22]. The main advantages of 
natural-derived hydrogels are (i) its similar structure with the extracellular 
matrix (ECM) of many tissues, (ii) they are made of polymers similar to the 
biological macromolecules engineered by nature to perform specific functions 
in a demanding environment, (iii) various natural polymers may be found in 
large quantities from renewable sources, such as in the marine environment 
[23], and (iv) they can often be processed under mild conditions, thus not 
compromising the viability of the encapsulated cells [22]. Additionally, some 
natural polymers have cell-binding domains recognized by cells, thus 
promoting cell adhesion without requiring functionalization [24]; although this 
is not applicable for the most widely used natural polymer in cell 
encapsulation, namely alginate. Batch-to-batch variability and the presence of 
impurities are considered the main limitations in natural hydrogels. As an 
alternative, synthetic polymers have been employed, such as poly(ethylene 
glycol) (PEG), and poly(vinyl alcohol) (PVA), which are commonly used in 
combination with natural polymers to produce hydrogels. The different natural 
and synthetic polymers used in cell encapsulation systems and their 
characteristics are detailed discussed in different reviews [17, 18, 22, 25-27]. 
The incorporation of bioactive moieties is an increasingly trend being explored 
in cell encapsulation systems, as further discussed in section 5.2 Incorporation 
of bioactive molecules. The most widely used method to produce a viable cell 
encapsulation matrix is to incorporate cells in a water-based solution of a 
hydrogel precursor (sol flowing phase) followed by gelation, commonly 
triggered by thermal, ionic, or photo-crosslinking. Particularly, ionotropic 
gelation is the most common crosslinking method, since gelation via 
temperature change or ultraviolet (UV) exposure can influence the cell viability 
or physiology. In this method, the solutions can be easily sterilized by filtration 
or autoclaved, and then they can be processed in mild conditions without 
requiring harsher chemicals to obtain hydrogels with variable structures 
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encapsulating viable cells. The ionotropic gelation occurs via the interaction of 
the polymer chains with ions, typically cation-mediated gelation of negatively 
charged polysaccharides. The most commonly used is the ionotropic gelation 
of alginate in calcium chloride [28, 29], but also many other ionotropic 
gelation with different materials have been proposed, such as carrageenan in 
potassium chloride [30], and pectin in calcium carbonate/D-glucono-δ-lactone 
[31]. 
 
2.1.2 Permeability and mass transfer 
Once processed and formed, the cell encapsulation matrix will exhibit different 
transport properties depending on its structure, chemical composition and, in 
the particular case of hydrogels, the degree of crosslinking. This aspect will 
affect the permeability of essential molecules for cell survival, thus dictating 
the successful of cell encapsulation strategies. In the engineered matrix, either 
by the presence of a protective enveloping membrane or by the permeability 
properties of the cell encapsulation matrix itself, an immunobarrier can be 
created, avoiding the entrance of high molecular cells from the immune system 
or even deleterious molecules. In fact, even in the absence of a membrane, the 
hydrogel matrix can act as a mechanical and/or chemical barrier towards in- 
and out-flowing molecules. The efficiency of the barrier is application 
dependent, as well as being intrinsically connected with other parameters such 
as the stability of the cell encapsulation matrix, as further discussed. 
Nevertheless, in all the encapsulation strategies proposed for tissue 
regeneration, while the entrance of deleterious cells or molecules can be 
avoided, they all must ensure exchange of essential molecules for cell survival, 
such as nutrients, oxygen, metabolites, and waste products, as well as the 
exchange of important signaling biomolecules in the interaction of cells, either 
between the encapsulated cells or with the neighboring cells of the host 
environment. Additionally, in order to promote the integration of the implanted 
cell encapsulation device with the host tissue, it is desirable that the device 
should be permeable to the in-growth of blood vessels, except when 
regenerating avascular tissues such as cartilage. Therefore, either existing or 
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not the presence of an external membrane, the permeability of essential 
molecules ensuring cell survival across the entire 3D structure is of great 
importance in the design of the encapsulation matrix. It is important to 
highlight that the diffusion of essential molecules for cell survival will have a 
delay when comparing encapsulated cells localized in the core with the ones in 
the border of the matrix. This directly influences the size and/or geometry of 
cell encapsulation matrixes. Consequently, the majority of cell encapsulation 
systems are spherical and typically limited to a diameter of 400 µm, which is 
two times the maximum diffusion distance of oxygen and nutrients from blood 
vessels to cells [32]. With the increasing techniques to fabricate new TERM 
devices, other geometries have been progressively proposed as discussed in 
section 4. Engineered cell encapsulation systems with variable geometries.  
Considering the example of hydrogels as the engineered cell encapsulation 
matrix, its diffusion and permeability feature depends on at least three factors, 
namely (i) the obstruction effect caused by the presence of impenetrate slowly 
moving polymer chains that increase the path length for diffusion, (ii) the 
hydrodynamic drag at the polymer interface due to polymer-solvent and 
polymer-solute bonds during the solute diffusion, and (iii) the residual charges 
of the matrix, presence of counter ions, hydrogen bonds, polar and 
hydrophobic interactions, which will affect the transportation of solutes 
exhibiting similar interactive groups (especially essential in the transport of 
biological molecules) [33]. The solute transportation occurs by two main 
pathways, (i) convective, where transport is driven by a pressure gradient, and 
(ii) diffusive, where transport is driven by a concentration gradient [34]. In 
most cell encapsulation devices, including hydrogels, transport of solutes 
occurs by diffusion. In terms of solute diffusion depending on their pore size, 
hydrogels can be divided into three different classes, namely (i) macroporous, 
with pores >0.1 µm, which the transport occurs mainly by convection (ii) 
microporous, with pores ranging from 0.005 to 0.02 µm, which are in most 
cases smaller than the solute resulting in hindered diffusion, and (iii) 
nonporous hydrogels, the most commonly used in cell encapsulation, in which 
solute transport occurs only by diffusion through spaces between 
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macromolecular chains. The different parameters affecting the permeability of 
cell encapsulation systems using hydrogels have been detailed discussed [34]. 
Additionally, some cell encapsulation strategies are composed by membranes 
that surround the encapsulation matrix or directly the encapsulated cells 
(conformal coating). Although multilayered systems have been commonly used 
in cell encapsulation for the purpose of cell immunoisolation [35-38], they have 
been poorly explored in tissue regeneration. This is because in tissue 
regeneration the presence of a membrane for immunoisolation is not required, 
although it can confer other advantages to the system. For example, the 
properties of each membrane can be independently controlled, and the 
stability and permeability of the system can be easily customized the by 
varying the number of the multilayers. Multilayered cell encapsulation systems 
can be obtained by the sequential adsorption of oppositely charged 
polyelectrolytes using the mild conditions of layer-by-layer (LbL) technology 
[39, 40], as further discussed in section 3.1 Layer-by-layer methodology. Of 
note, the influence on permeability and diffusion properties by the presence of 
a membrane surrounding the cell encapsulation matrix must be considered, 
since the different extent of material heterogeneity between the encapsulation 
matrix and the membrane might create fluctuations of transport properties 
across the different structures [33].  
 
2.1.3 Stability  
The stability of the encapsulation matrix is related with its physical features, 
namely the mechanical resistance that it can support without disruption of its 
integrity, or chemical features related with their ability to maintain its structure 
without being dissolved by physiological chelator agents or degraded. Either 
physical or chemical instability would lead to the premature release of the 
encapsulated materials, releasing its content to other regions of the body 
rather than the implantation site. Increasing the stability of the encapsulation 
matrix can be performed by different approaches that could, however, 
influence other important parameters for cell survival. It is thus crucial to find 
a perfect balance between the semipermeability (i.e. preventing the entrance of 
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specific cells, while allowing the diffusion of essential molecules for cell 
survival) of the encapsulated system with an adequate mechanical stability. In 
fact, developing semipermeable systems with adequate mechanical stability 
balanced with good mass transport of oxygen and nutrients remains a key 
challenge in cell encapsulation technology, as they are often inversely related 
[34]. Since alginate is the most widely applied hydrogel in cell encapsulation 
systems, efforts have been made to increase its stability. The first approach 
was to coat alginate beads with the oppositely charged polyelectrolyte PLL [8]. 
Now, other polymers are being employed to construct improved biocompatible 
membranes, mainly using the LbL technology [28, 39, 41-44]. 
Another possibility is to increase the crosslinking density of the cell 
encapsulation matrix. The simplest example for the case of alginate systems is 
the use of barium instead of calcium as the gelling divalent agent or to use 
biopolymers richer in guluronic acid units. However, it may lead to 
encapsulation matrixes with lower swelling capabilities and decreased mesh 
sizes, thus influencing the permeability of the construct. Crosslinking control 
will also result in matrices with distinct stiffness that will play an important 
role in cell behavior, namely on the ability of stem cells to differentiate into 
specific lineages [45-50]. For example, different osteogenesis levels could be 
obtained by controlling the viscoelastic properties [51] and the stress-stiffening 
effect [52] of hydrogels. 
More recently, different groups are increasingly exploring the use of precise 
chemical routes to produce intrinsically robust hydrogels. A successful strategy 
was proposed [53] by incorporating 2,6,6-tetramethylpiperidine-1-oxyl 
(TEMPO)-mediated oxidized bacterial cellulose (TOBC) in alginate hydrogels. 
TOBC and alginate have similar chemical structures, and they both participate 
in the crosslinking process by gelling with calcium ions. The carboxyl groups 
available on the surface of TOBC provided the possibility of participating in the 
construction of an alginate-based composite and played crucial roles in the 
structural, mechanical and chemical stability of the formed hydrogel. The 
encapsulated NIH 3T3 cells in the composite hydrogel with enhanced 
mechanical properties remained viable and their proliferative ability was 
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preserved. Others, proposed robust hydrogels with adequate permeability 
inspired by the role of glycosaminoglycans in providing rigidity to the ECM due 
to their rigid sugar units and hydrophilic groups [54]. Inspired by that, a 
polysaccharide containing multivalent methacrylate groups and hydrophilic 
groups was incorporated into a hydrogel to control its stiffness over a broad 
range, while controlling the swelling ratio. This was achieved by the chemical 
crosslinking between methacrylic alginate and PEG-dimethacrylate (PEG-DMA). 
The increase of gel stiffness resulting from the incorporation of methacrylic 
alginate into a PEG-DMA hydrogel was related to the high chain rigidity of 
alginate as well as the multivalent methacrylate groups. In parallel, multiple 
hydroxyl groups of methacrylic alginate thermodynamically counterbalanced 
kinetic limits of osmotic water entry. Results showed that the chemical 
crosslinking of PEG-DMA allowed controlling the hydrogel stiffness without 
compromising its permeability, as demonstrated by the suitable viability of 
encapsulated neural cells (PC12 cells). In another study, alginate and PEG 
were also incorporated into interpenetrating network structures, improving 
significantly the toughness and elasticity of the final hybrid construct, without 
compromising the viability of encapsulated mesenchymal stem cells (MSCs) 
[55]. The resultant toughness relied on two mechanisms, namely the reversible 
calcium ions crosslinking of alginate that dissipated mechanical energy, while 
the covalent crosslinking of PEG maintained elasticity under large 
deformations. Besides alginate, other polymers have also been employed to 
produce ultra tough hydrogels allowing cell encapsulation by the use of precise 
chemical routes, as reviewed elsewhere [56]. For example, two chitosan 
derivatives, namely low molecular weight methacrylamide and medium 
molecular weight, were mixed with a photoinitiator (I2959) and the weak base 
β-glycerophosphate (β-GP) [57]. To produce double-network ultra tough 
hydrogels a sequential dual-crosslinking was performed, first by using UV-light 
exposure for the methacrylamide chitosan, and then by immersion in a 
solution containing negatively-charged tripolyphosphate (TPP) for the ionic 
crosslinking of medium molecular weight chitosan through their positively 
charged amine groups. This strategy allowed to create tough hydrogels that 
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were able to withstand an impressive compressive stress in the same order of 
magnitude as the ones found in native load-bearing soft tissues, with fast 
recover ability of their mechanical properties upon unloading, while allowing 
cell encapsulation. 
 
2.1.4 Degradation 
There are a number of factors influencing the degradation of cell encapsulation 
matrixes, which can occur by hydrolysis and enzymatic reactions or simply by 
dissolution/disruption of the matrix. In the case of the commonly used 
hydrogels, degradation can be mediated by (i) the chemistry of its matrix and 
the density of degradable groups, (ii) the presence and biological activity of 
cells, including the deposition of ECM and metabolite products, and (iii) 
environmental triggers in the in vivo physiological environment of the host. 
Considering the first referred circumstance, hydrogels produced by ionic or 
physical crosslinks may break down by processes that reverse the gelation 
mechanism, originating the dissolution of the encapsulation matrix. Using the 
example of ionotropic gelation of alginate in calcium chloride, the presence of 
electrolytes in the in vivo environment and/or the deposition of a newly formed 
ECM can lead to the exchange of divalent calcium ions for monovalent cations 
from the alginate matrix, leading to the dissolution of polymer chains or 
disruption of hydrogen bonds associated with physical crosslinks. In many 
cases, hydrogels are engineered to degrade by hydrolysis and/or enzymatically 
by adding specific degradable sequences within its chemical structure. This 
allows control both degradation rate and profile. Different to commonly used 
“open” scaffolds (see section 2.2 “Closed” and “open” scaffolds: Limitations, 
advantages and practical considerations) composed by pores in which cells can 
deposited ECM prior to the scaffold degradation, in the encapsulation matrix 
degradation has to occur to provide space for ECM deposition. Therefore, the 
formation of new tissue and hydrogel degradation are intrinsically linked in cell 
encapsulation strategies. If degradation of the hydrogel occurs too quickly, i.e. 
prior to an appropriate deposition of ECM, the encapsulate cells will be 
deprived from the physical support required for different cell anchorage 
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processes; if degradation occurs too slow the deposition of ECM will occur in 
the pericellular regions, since those are the regions at which the diffusion of 
essential molecules for cell survival is higher, leading to an heterogeneous 
distribution of ECM in the hydrogel as well as cell necrosis at the core of its 
structure, a very common drawback in 3D systems and particularly in 
encapsulation matrixes. It is thus highly desirable that degradation of the 
encapsulation matrix must match the formation of new tissue by ECM 
deposition by the encapsulated cells, in order to achieve a proper tissue 
regeneration and integration. One direction is the chemical degradation of 
hydrogen bonds, usually through hydrolysis, which degradation can be 
controlled through the chemistry of the degradable linker. For example, slowly 
degrading linkers such as ε-polycaprolactone are often mixed with rapidly 
degrading linkers like poly(L-lactic acid)  (PLLA) to achieve a proper 
degradation rate for a PEG hydrogel [58], or esters associated with lactic acid 
degrade significantly faster than ester linkages of caprolactone [59]. While 
these methods are frequently used in research today, alternative attractive 
possibilities involve the use of cell-mediated degradation of the matrix by 
enzymes activity [60, 61]. Through enzymatic cleavage or degradation, the 
cells can direct the time line of degradation and adjust their surrounding 
environment as needed for cellular growth, matrix deposition, and matrix re-
organization. Techniques to achieve cellular-mediated matrix degradation can 
be performed either by using hydrogels from natural biopolymers, such as 
hyaluronic acid which degrades by hyaluronidases activity [62, 63], or to 
program short amino acid sequences into the hydrogel network, which are 
susceptible to enzymatic cleavage [60]. Short peptide sequences have the 
advantage of being relatively stable for modification, tunable for cell binding, 
and easy to be synthetized on a large scale [64]. Examples of enzymatically 
degradable segments used in cell encapsulation strategies are polysaccharide-
based systems composed by ECM proteins, such as collagen, fibrin, fibronectin 
and laminin proteins, and peptide-based linkages that have specific cleavage 
sites for degradation by enzymes, such as elastase, plasmin or matrix 
metalloproteinases (MMPs) [64, 65]. Longer enzyme-cleavable chains can also 
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be used as connecting points for hydrogel formation, such as fibrinogen [66, 
67]. 
Although enzymatically degradable single-phase hydrogel materials offer 
elegant control over cellular invasion, cell confinement within these systems 
remains strongly coupled to matrix elasticity, and enzyme-mediated changes 
to local mechanical properties may be difficult to control in a pre-determined 
manner. Taking advantage of controlling hydrogel degradation, an interesting 
work was proposed using void-hydrogels [68]. Void-forming hydrogels were 
obtained by encapsulating sacrificial gel porogens composed by oxidized 
hydrolytically labile alginate within a bulk hydrogel composed by high 
molecular weight alginate, which has thus a slowly degradation rate. The rate 
of pore formation was controlled by the rate of porogen degradation and cell 
migration and proliferation within pores. Remarkably, this strategy allowed 
decoupling the pore formation from elasticity of hydrogels, while controlling 
MSCs osteogenesis in vitro. While maintaining the adequate porosity of the cell 
encapsulation matrix to the encapsulated stem cells, a wide range of elastic 
modulus of hydrogels could be tested, with optimal bone formation at 60 kPa. 
 
2.1.5 Biocompatibility/Biotolerability 
While some groups claim that biocompatible polymers for cell encapsulation 
are available [69, 70], others doubt whether such materials can ever be 
designed [71-73]. This paradox is explained by the “appropriate host 
response” of the original definition of biocompatibility. During the emerging of 
artificial organs field, the definition of biocompatibility emerged as “the ability 
of a biomaterial to perform with an appropriate host response in a specific 
application” [74]. The referred appropriate host response was characterized 
by, after implantation of these artificial organs, the formation of a dense layer 
of fibrotic tissue with further integration with the host tissue. However, for cell 
encapsulation systems, defining an appropriate host response is more complex 
because any inflammatory response against the implanted system is 
potentially harmful to the encapsulated cells, which can lead to the failure of 
the cell encapsulation system. This failure is mainly related to the overgrowth 
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of immune cells surrounding the encapsulation system, which compromise the 
diffusion of essential molecules for cells survival and the exchange of 
therapeutic molecules, consequently originating death of the encapsulated 
cells; we recommend the reading of [75] for a deep understand of the 
interaction between the physicochemical properties and the biological 
responses in cell encapsulation systems. Encapsulation systems developed for 
tissue regeneration applications, although its inherent immunoprotective 
feature, they are not meant to prevent immune responses, which will inevitably 
occur due to leakage of antigens, breakage of encapsulation matrixes, 
protrusion due to high proliferation rates of the commonly used anchorage-
dependent cells, and to responses associated with the surgery. Therefore, the 
current leading opinion is that cell encapsulation systems for tissue 
regeneration should preferably elicit a minimal immune response to avoid 
cellular overgrowth surrounding the capsules. With that, emerges the term 
biotolerability as “the ability of a material to reside in the body for long periods of 
time with only low degrees of inflammatory reactions” [76]. The current leading 
opinion is that, rather than “appropriate host response” of the term 
biocompatibility, the biotolerability concept of “low degrees of inflammatory 
reactions” is more appropriate in the cell encapsulation field (for further 
discussion details about this issue read [75]). Within the abroad spectrum of 
biomaterials available that induce different appropriate foreign body 
responses, other factors such as chemical modifications [77] and the 
dimension of the encapsulation matrix [78] also influence immune-mediated 
reactions. Combinatorial methods were proposed to study the immunological 
in vivo outcome of different biomaterials [79], or with a large library of the 
same biomaterial, namely alginate hydrogels, but with variable dimensions and 
chemical modifications [77]. Alginate has been the material of choice for 
encapsulation, but batches of this natural polymer need to be standardized to 
minimize endotoxin and protein content, both of which can affect 
biocompatibility of the encapsulated cells. In this regard, ultrapure alginate 
and other polymers are being commercialized. 
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Independently of the type of strategy used, all TERM strategies aim to 
regenerate living, healthy, and functional tissues, either partially by tissue 
grafts or even a total replacement of a severely damaged organ. In the 
perspective of using scaffolds for TERM, there are two main strategies: (i) 
scaffolds at which seeded cells adhere to a surface and are able to contact with 
the external milieu, here termed as “open” scaffolds, or (ii) scaffolds at which 
core cells are encapsulated, here termed as “closed” scaffolds that comprise 
cell encapsulation strategies (Figure I.1). The designation of “open” or “closed” 
scaffolds is thus respectively related to the direct contact or isolation between 
cells and the surrounding environment. In “open” scaffolds the production 
methods can comprise a wide range of precursors and harsh solvents and/or 
reactants as long as the final scaffold is cytocompatible, including its 
degradation products. On the other hand, in “closed” scaffolds mild production 
methods must be employed due to the presence of cells, which is also a 
significant limitation in terms of available technologies and suitable 
biomaterials that can be processed at those conditions. 
 
Figure I.1 – Schematic representation of the concept “open and closed” scaffolds for Tissue Engineering 
and Regenerative Medicine applications. In “open” strategies, cells are in direct contact with the host 
environment, while in “closed” systems the interaction is indirect due to the presence of the 
encapsulation matrix. 
 
Despite the current challenges, “closed” scaffolds can offer several advantages 
over “open” scaffolds in TERM. Overall, (i) allows to create an optimized 
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microenvironment for cells and protect them from an undesirable severe 
immunological response by avoiding the entrance of immune cells; (ii) it is 
compatible with in situ injectable strategies, in which cells are suspended in a 
liquid precursor solution and delivered in vivo to the site of interest. By curing 
the hydrogel directly at the lesion site, the precursor solution can diffuse into 
the entire volume of the defect, leading to an enhanced integration of the 
scaffolds without requiring glue or sutures [80], as the formed hydrogel can 
easily adapt o the defect geometry; (iii) multiple compartments or elements 
with distinct functions can be easily grouped in one single structure, conferring 
multifunctionality to the engineered system as well as facilitating in vitro 
handling and in vivo implantation procedures over dealing with various 
ungrouped materials; and (iv) if desirable, the implant can be easily removed 
after treatment. Ultimately, for a cell encapsulation strategy to be applied 
successfully in TERM, a number of practical factors must be considered in 
addition to the critical properties discussed above. The process must be easily 
scaled up for manufacturing, marketable, and accepted by surgeons, patients, 
and healthcare providers, and ultimately receive approval form the competent 
authorities, such as the US Food and Drug Administration (FDA) and equivalents. 
Additionally, the encapsulation process must also be fast, on the order of 
seconds to minutes, to be clinically accepted [81]. Incorporating these 
considerations into the early stages of the design will significantly enhance the 
translation of a cell encapsulation strategy from the bench to the clinic. 
 
3. New technologies for the next generation of cell encapsulation strategies 
To face the demanding requirement of cell encapsulation systems for TERM, 
different methodologies are being recently proposed. In the present section we 
discussed those methodologies, in our opinion with higher potential to 
contribute to the new generation of cell encapsulation devices. 
 
3.1 Protective coatings using the layer-by-layer technology 
Since the introduction of the LbL methodology [82], it has become one of the 
most prominent surface engineering strategies in biomaterials science, 
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capable of providing a reliable, easy, versatile, environment friendly, and cost-
effective way of tuning interfaces [39]. The principle of the technique is based 
on the sequential adsorption of a wide range of polyelectrolytes, which are 
selected and combined in function of their multipoint interactions [39, 40]. LbL 
methodology has been widely applied to produce polymeric multilayered 
capsules (PMCs), in which capsules are fabricated through LbL sequential 
deposition of polymers onto a sacrificial core template followed by the 
decomposition of this core yielding hollow capsules [83, 84]. The obtained 
nanometer thin membrane is permselective allowing diffusion of water and 
ions but excluding larger molecules. Additionally, the sequential fabrication 
procedure, combined with post-processing modifications (e.g. crosslinking or 
protein adsorption), allows a precise fine-tuning of the capsule’s 
physicochemical properties [85]. PMCs have been used in a wide range of 
applications, such as in medical imaging [86], drug delivery systems [87-89], 
biosensors [90, 91], synthetic vaccines [92], nanoreactors [93], catalysts [94], 
and many others. More recently, these properties have put PMCs under 
attention in the field of cell encapsulation. 
The most appealing features that the LbL technique could offer to cell 
encapsulation field are (i) the possibility to be performed at room temperature 
and in mild conditions, thus the viability of the encapsulated cells is not 
jeopardized, (ii) it is a aqueous-based procedure compatible with a broad 
range of natural and synthetic polyelectrolytes, thus requiring no exposure to 
organic and harmful solvents, which is highly desirable when aiming to 
incorporate biological active molecules due to its limited solubility in non-
aqueous solutions and susceptibility to denaturation, (iii) it is well suited to the 
deposition of membranes on 3D structures, including those with complex 
shapes and irregular topographies, (iv) it offers precision control over the 
composition and thickness of composite membranes through control over the 
number and nature of layers deposited, allowing to tune the semipermeability 
of the membrane, and (v) it allows increasing the complexity of the 
encapsulation system by adding new functionalities and capabilities, since the 
multilayered membrane can act as drug reservoirs or include biological 
Chapter I 
Design principles and technologies in cell encapsulation systems towards tissue regeneration 
 
	 	 	22 
functional components, such as proteins, enzymes, and peptides that elicit 
specific biological responses [95-97]. Therefore, LbL can be performed in cell 
encapsulation strategies by using the jellified hydrogel matrixes as templates 
to build an engineered membrane over its surface, which in tissue regeneration 
its presence is not compromised to the immunobarrier role. While being a very 
promising technique, with the possibility of open new prospects to the function 
of semipermeable membranes, LbL has been poorly explored in 3D cell 
encapsulation systems for tissue regeneration. The main exploited field of the 
LbL technique in cell encapsulation is within the single-cell encapsulation, 
which although being a promising instrument for engineering cells with 
enhanced properties is not on the scope of the present review (we recommend 
the reading of [98, 99]). We believe that this is mainly related to its inherent 
time-consuming aspect of LbL. Therefore, to the effort required to obtain an 
engineered cell encapsulation matrix, then adding the time-consuming task of 
the construction of a multilayered membrane has to be carefully pondered. 
This aspect is correlated to the viability of the encapsulated cells, limiting the 
number of layers composing the membrane. Clearly more efforts should be 
made to decrease the processing time by, for example, reduce the adsorption 
time of the layers (avoiding the adsorption until equilibrium or increasing the 
polyelectrolyte concentrations) or by using other assembly mechanisms 
between the layers, such as fast chemical reaction towards robust covalent 
bonds formation.  
In a recent study, LbL technology was combined with the ionotropic gelation of 
alginate to produce a liquified cell encapsulation strategy [42]. Alginate 
hydrogel spheres were used as cell encapsulation templates for the 
construction of the LbL membrane. Once the LbL membrane was built, the 
alginate core was liquified by chelation of the calcium ions through 
ethylenediaminetetraacetic acid (EDTA) treatment. The multilayered 
membrane was built due to the electrostatic bonds between chitosan and 
alginate polyelectrolytes. Results showed that the different number of layers 
influenced the mechanical strength of the capsules as well as the viability of 
the encapsulated cells. More recently, a liquified cell encapsulation strategy 
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was developed combining the ionotropic gelation of alginate, LbL assembly, 
and the co-encapsulation of cells with surface modified PLLA microparticles 
[28, 43]. In this concept, by providing to the encapsulated cells surface 
functionalized microparticles as solid cell adhesion sites, the viability of the 
encapsulated cells could be enhanced. Additionally, the number of layers was 
increased to 12 layers without compromising cell viability, and the mechanical 
strength of the capsules was improved by using a three-component 
polyelectrolytes assembly, namely PLL, chitosan, and alginate. Importantly, 
the LbL technique allowed creating an encapsulation strategy in which cells are 
encapsulated in a liquid environment. This allowed to confer freedom for the 
encapsulated cells to freely self-construct their three-dimensional organization, 
while providing an appropriate diffusion of essential molecules for cell survival, 
a major concern in cell encapsulation strategies. However, maximizing the core 
dissolution to achieve an excellent diffusion required the introduction of solid 
cell adhesion spots, provided by the PLLA microparticles. Consequently, this 
innovative cell encapsulation strategy allowed capsules to have a much higher 
diameter (~2 mm) rather than the established 200 µm for cell encapsulation 
matrixes. The proposed capsules were proposed as an “inverse” methodology 
to the commonly used “open” scaffolds, since here cells are also adhered at 
the surface of a subtract but then the system is wrapped by a membrane, 
being physically isolated from the environment but without being embedded in 
an elastic matrix as usually observed in “closed” scaffolds. The successful of 
this strategy boosted its application to the encapsulation of stem cells for bone 
[100] and cartilage [101] TERM applications. Recently, we successfully 
propose the liquified capsules as co-culture systems of stem and endothelial 
cells towards osteogenic differentiation [100]. Additionally, multilayers 
surrounding liquified capsules encapsulating cells also served as an assembly 
methodology to construct 3D macrostructures from a bottom-up approach [41, 
44]. 
Alternatively to the diffusion-driven kinetics of classical LbL assembly, which 
consists of dipping the subtract in the polymer solution, recent advances in 
LbL assembly technologies have explored other driving forces, namely 
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dewetting, roll-to-roll, centrifugation, creaming, calculated-saturation, 
immobilization, spinning, high gravity, spraying, atomization, 
electrodeposition, magnetic assembly, electrocoupling, filtration, microfluidics, 
and fluidized beds [98]. Among many other advantages, some of those 
different assembly technologies are also able to shorten the process. 
Additionally, there is now a growing realization that the assembly method not 
only determines the process properties (such as the time, scalability, and 
manual intervention) but also directly affects the physicochemical properties of 
the membrane (such as the thickness, homogeneity, and inter- and intra-layer 
organization). Process and physicochemical properties are both linked to 
application-specific performance [98]. However, the applicability of such LbL 
assemblies has not been tested yet in cell encapsulation devices. Nonetheless, 
we anticipate that its extrapolation and application will have a tremendous 
impact on the field. Besides the mechanical protection and mass transfer 
control, multilayers could also elicit specific functions that could have a direct 
impact on the performance of the device. For example, they could integrate 
inorganic elements to enhance bioactivity [102], magnetic- [101] and light-
responsiveness [103] or gold nanoparticles for light-activated disruption [104]; 
moreover, they could include or expose biochemical elements to exhibit 
specific bioinstructive characteristics [105], such as growth factors to 
stimulate stem cell differentiation [96, 106, 107]. 
Besides using the LbL methodology to surround cell encapsulation matrixes, 
conformal coating, in which cells are directly coated with ultrathin (2-100 nm) 
protective soft shells, are also an application example of LbL in cell 
encapsulation [108, 109]. The great advantage that conformal coating brought 
to the cell encapsulation field was the possibility to improve cell functionality 
and viability using a very simple technique rather than adding soluble factors 
to the culture medium, as commonly used in in vitro culture, or other complex 
techniques such as genetic manipulation. For example, the multilayers can 
improve their mechanical stability, to protect them against phagocytosis by 
masking the cells surface from immunological agents, provide chemical 
resistance to aggressive environments, and to supply cells with additional 
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instrumentation for their functionality, as similarly above discussed for cell 
encapsulation matrixes. The production of ultrathin protective shells directly 
surrounding cells by LbL technology can be performed through (i) synthetic 
polyelectrolyte shells, in which due to the cell surface negatively charge at 
physiological pH, the shell assembly begins with the deposition of a polycation, 
then a polyanion is deposited, and so on, until the planned shell architecture is 
realized, (ii) synthetic hydrogen-bonded shells, in which the assembly occurs 
via non-covalent hydrogen-bonding interactions and their micromechanical 
properties can be controlled by changing pH, ionic strength, light conditions, 
slat concentration, or temperature; additionally, the degradability of the shells 
can be tuned by adjusting conditions that result in a controllably 
disassembled, and (iii) natural proteins, including hemoglobin, bovine serum 
albumin, and human serum albumin (the different LbL protective shells have 
been detailed reviewed elsewhere [109]). The presence of protective shells has 
been poorly explored in the field of cell encapsulation towards tissue 
regeneration, since usually the living organisms coated are mainly bacterial 
and yeast cells. However, the application of conformal coatings on such living 
organisms has allowed improving one of the main drawbacks of the LbL 
technique in cell encapsulation, which is related with its extensive time-
consuming. In an innovative study, it was eliminated the adsorption step 
required between polyelectrolytes [110], thus significantly decreasing the 
required time to produce a thin membrane. For that, during the polycation 
adsorption, the surface potential of each layer was permanent monitoring. 
When the surface recharging process to positive is completed, the polycation 
solution is immediately replaced by the polyanion solution until negative 
surface charge saturation is reached, and so on. 
 
3.2 Microfluidic systems 
Microtechnologies in cell encapsulation allow a high degree of control over the 
morphological and dimensional (size and shape) properties of the 
encapsulation matrixes. It is also possible to encapsulate cells in different 
geometries, such as spherical hydrogels and in fibers, in a short time. The 
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microspheres and spheres can also be used to construct complex geometries 
through assembly into larger architectures mimicking the structure of tissues 
and organs, as discussed in section 4.3 Multifaceted and complex structures. In 
the case of microspheres, microfluidics is performed by two major approaches: 
flow-focusing and T-junction. In the first, microspheres are formed by 
intercepting the core solution with a sheath stream flowing, while in T-junction 
microspheres are formed by permitting the core fluid to be swept away by one 
sheath stream in one direction [111]. Typically, an aqueous alginate solution is 
emulsified in an oil phase and crosslinked ionically with divalent ions, 
immediately upon contact of the two solutions [112]. The fast reaction typically 
results in uncontrolled gelation within the microfluidic device that can cause 
clogging and nonuniform drop formation [113, 114]. To overcome these 
problems, different studies had propose the use of calcium carbonate (CaCO3) 
nanoparticles [115, 116], which allow to deliver calcium ions to the alginate 
solution without inducing unintended gelation prior to drop formation. The 
premature gelation of the alginate matrix is avoided by dispersing in the 
solution water-insoluble CaCO3 nanoparticles, which can dissolve under acidic 
conditions after drop formation. The main drawback is the heterogeneous 
distribution of calcium ions inside the microspheres, compromising the 
homogeneity of the resulting microspheres. Other similar techniques use 
calcium chloride or acetate particles dispersed in the oil phase to initiate the 
crosslinking process, which are subsequently dissolved in the emulsion droplet 
[117, 118]. However, the same drawbacks of inhomogeneous calcium 
distribution and clogging are observed. Therefore, the new generation of 
microfluidics system to develop microspheres as cell encapsulation systems 
are focused in controlling the crosslinking process to produce homogenous 
microspheres with reliable and precisely tunable properties, which is of great 
importance in TERM, stem cell research, and disease treatments [119-121]. 
Alternatively, the generation of alginate microspheres via coalescence of 
separate droplets containing alginate and calcium chloride has been tried 
[122]. However, mixing inside the coalesced droplets still results in 
heterogeneous microspheres since crosslinking occurs before a homogeneous 
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distribution of calcium ions can be achieved. Recently, the fabrication of 
monodisperse alginate microspheres with structural homogeneity via droplet-
based flow-focusing microfluidics was successfully developed [123]. The 
solution to overcome the above-mentioned drawbacks observed was to deliver 
calcium ions by a solution containing water-soluble calcium mixed with the 
chelator EDTA. By chelating the calcium ions with the EDTA, the ions remained 
in solution while being inaccessible to the alginate chains. After drop 
formation, acetic acid is added to the continuous phase to dissociate the 
calcium-EDTA complex, which results in the release of calcium ions. The free 
calcium ions react with the alginate chains in a highly controlled fashion, 
reticulating the alginate microspheres. Results demonstrated that the 
proposed gelation process was suitable for the encapsulation of living 
mesenchymal stem cells. 
Besides microspheres, microfluidics technique has been also recognized to be 
an efficient method to fabricate long hydrogel microfibers in a short time. 
These metre-long microfibers are generally prepared using microfluidic devices 
by embedding dispersed cells directly within a hydrogel precursor, such as 
alginate [29, 124-128], chemically modified gelatin [129, 130] and 
supramolecular hydrogels [131]. Fiber-based systems are an ideal platform for 
mimicking biological materials and tissue constructs, and current research has 
begun to exploit fiber matrices for these biomedical applications [29, 111, 
132]. It is important to highlight that the fiber fabrication process must be 
compatible with the next generation of biological soft materials, including 
proteins and other biomacromolecules that will not withstand the processing 
conditions of conventional spinning techniques to obtain fibers. As already 
mentioned, the processing of such biological materials in cell encapsulation 
systems requires aqueous conditions with precisely tuned temperature and pH 
in order to do not jeopardize the viability of the encapsulated cells and 
bioactive molecules. These processing limitations have exacerbated the sort-
comings of traditional fiber spinning processes and led to the advent of a new 
fiber spinning methodology by microfluidics technique. In this context, 
microfluidic-spinning methodology has been employed to produce fibers in a 
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microchannel using the coaxial flow of a pre-polymer and the crosslinking 
agent [111]. It is similar to the wet spinning [133] but here the crosslinking 
agent is supplied directly by the coaxial flow instead the bath. Microfluidics 
spinning is thus the most suitable fiber formation technique for cell 
encapsulation because it does not require high voltage or temperatures, fibers 
can be fabricated continuously, and allows a precise control over the diameter 
of the fibers only by regulating the flow rate, which can be tuned from a few 
microns to a few hundred microns, and a wide diversity of cells can be 
encapsulated without incurrent significant damage to cells. 
 
3.3 Superhydrophobic surfaces 
Superhydrophobic (SH) surfaces arises from a unique surface chemistry and 
nano/microstructure organization, and can be universally found in nature, such 
as in lotus leaf and cicada wing, the anisotropic dewetting behavior on a rice 
leaf, striking superhydrophobic force by legs of water striders among many 
other examples [134, 135]. Those unique surfaces have inspired biomimetic 
designs for controlling surface wettability for interesting applications in 
microfluidics, self-assembly, self-cleaning, anti-fouling, water/oil separation, 
and cell spheroids formation as discussed in different studies [136-141]. 
Inspired by the rolling of water drops on the lotus leaf, SH surfaces with water 
contact angles (WCA) higher than 150º have triggered increasing interest in the 
scientific community for their application in the biomedical field [134, 136, 
142], such as to produce cell spheroids in an innovative hanging drop 
methodology [143, 144]. Of particular interest to the present review, SH 
surfaces have been also used as an alternative methodology to produce 
spherical objects for cell encapsulation. The commonly used cell encapsulation 
methods imply the combination of two liquid environments, namely the 
solution containing the encapsulation materials and the 
precipitation/crosslinking bath. Cell encapsulation process using SH surfaces 
eliminates the crosslinking bath to harden the polymeric solution into a 
hydrogel. As first reported [145], the process involves the dispensing of a 
polymeric solution loaded with cells on its surface, which leads to spherically 
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shaped droplets due to the repellency properties of the surface, and, 
subsequently, the liquid droplets are crosslinked under mild conditions, 
originating cell encapsulated hydrogel spheres. SH polystyrene surfaces were 
further explored to produce alginate spheres encapsulating MSCs and 
fibronectin [146]. The developed cell encapsulation system was successfully 
tested in vivo by promoting bone healing in a calvarial bone defect. The alginate 
drops formed on the top of the SH polystyrene surfaces were crosslinked by 
adding a small amount of calcium chloride at the top of each spherical shaped 
droplet. Mild chitosan-based cell encapsulation system with two sequential 
gelation steps was also developed using similar SH polystyrene surfaces [147]. 
The acidic chitosan solution was first neutralized with βGP at room 
temperature to pH 6.2, an appropriate pH that did not jeopardized the viability 
of the encapsulated L929 cells. At the top of each droplet formed using SH 
surfaces, the ionic crosslinker sodium tripolyphosphate was added to induce 
the gelation process through electrostatic interactions. After incubation at 
37ºC, a second gelation step occurred due to the thermoresponsive ability 
conferred by adding βGP to chitosan, while the pH-responsive behavior of 
chitosan was maintained. Using the same type of SH surfaces, the authors also 
proposed a multicompartmentalized “onion-like” hydrogel [148]. 
Methacrylated dextran (DEX-MA) solution containing a photoinitiator and 
calcium chloride was dispensed on SH surfaces and then crosslinked under UV 
light. Then, a solution of sodium alginate containing L929 cells was dispensed 
on the top of the spherical DEX-MA hydrogels. Subsequently, the alginate outer 
layer was crosslinked by the release of calcium ions previously immobilized in 
the core of the DEX-MA hydrogels. This is an example of using the core of the 
particle as a source of the crosslinking agent, avoiding the need of any external 
action for activating the gelling process. 
Other types of SH surfaces were also explored to produce cell encapsulation 
systems. For example, glass SH surfaces produced by chemical vapor 
deposition were used to develop a hierarchical cell/drug encapsulation system 
[149]. For that, microdroplets of DEX-MA in phosphate-buffered saline 
containing the cytocompatible photoinitiator I2959 and L929 cells were 
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dispensed through a 350 µm diameter nozzle on the top of the glass SH 
surfaces. The formed droplets were crosslinked under UV-light exposure. Then, 
the obtained microspheres were added to an alginate solution and dispensed 
on the top of the SH surfaces, originating macrospheres encapsulating 
microspheres. 
Using patterned SH surfaces with wettable spots allows to obtain microgels 
with other geometries besides spheres, by controlling the geometry of such 
regions where the hydrogel precursors are dispensed. A rapid methodology 
using superhydrophilic-superhydrophobic patterned microarrays to dispense 
spatially separated pico- to microliter-sized droplets with defined geometry and 
volume was developed [150]. Based on discontinuous dewetting, which relies 
on the extreme wettability contrast between superhydrophilic and 
superhydrophobic patterns, arrays of droplets of the solution containing the 
encapsulation material are instantly formed as the liquid moves along the 
superhydrophilic-superhydrophobic patterned surface. Then, maleimide-
polyvinyl alcohol hydrogels encapsulating HeLa cells stably expressing green 
fluorescent protein (GFP) are created on the top of superhydrophilic spots, 
with no cells detected outside the hydrogel on the superhydrophobic regions. 
The major advantage of using SH surfaces in cell encapsulation is the high 
encapsulation efficiency of cells and bioactive molecules, which is of almost 
100% by eliminating the need of a crosslinking bath to form the hydrogels. 
 
3.4 Hydrogels 3D bioprinting 
One of the main disadvantages of processing hydrogels for cell encapsulation 
systems is the difficulty to shape them in predesigned geometries to mimic the 
complex microenvironments of natural tissues. To solve this specific drawback, 
different rapid prototyping (RP) techniques have emerged to produce cell 
encapsulation systems with complex 3D structures [151]. 3D computer models 
shape the external design that will dictate the final structure, and such models 
can either be designed by CAD software or by modeling imaging data (e.g., 
computer tomography (CT) and magnetic resonance imaging (MRI)). This 
directly indicates one of the greatest advantages of RP: direct fabrication of 
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scaffolds with a complex, patient specific external geometry in combination 
with a precise control over the internal architecture (limited by the resolution 
of the system) [152, 153]. In the context of TERM, RP techniques can be 
divided in two main strategies, namely (i) scaffold-based TERM systems, in 
which is assumed that cells require a 3D structure acting as a cell guide and 
supporting template that mimics the natural environment of the tissue to 
regenerate [154, 155] or (ii) scaffold-free TERM systems, in which cell-cell 
interactions and self-organization are the main key points of the system to 
regenerate the damaged tissue [156]. While scaffold-based TERM strategies 
emphasize the role of biomaterials as a supporting structure to guide cell 
function, minimizing the self-assembly and self-organization capability of the 
encapsulated cells, scaffold-free TERM reverses the importance of both 
contributions. A primary classification of the scaffold-based RP techniques 
supporting biomedical applications can be made hinged on the working 
principle, namely laser-based (photopolimerized hydrogels), nozzle-based (pre-
polymers by dint of extrusion/deposition), and printer-based (powder beds and 
deposition of a binder that fuses the particles or directly depositing material 
using inkjet technology) systems [151]. Although the wide diversity of scaffold-
based TERM systems produced by RP technologies for biomedical 
applications, only some of them are compatible for the processing of 
hydrogels. Additionally, among of them, the number of cell compatible RP 
technologies is still reduced when the hydrogels are formed in conditions that 
cannot allow cell encapsulation, due to the above-discussed mild conditions 
requirement (see section 2.2.1 Mild and sterile production techniques). Different 
studies using the referred scaffold-based RP techniques have been proposed, 
as very well reviewed elsewhere [151], including a detailed discussion of the 
advantages and limitations of each technique. On the other hand, scaffold-free 
RP techniques are based in the principle that cells and tissues do not require 
an engineered biomaterial, due to their ability of self-assembly (the 
autonomous organization of components without externally intervention) and 
self-organization. Based on the implementation of RP technology, a fascinated 
perspective on scaffold-free TERM systems emerged, commonly termed as 
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“bioprinting” (or “organ printing”) [157, 158]. Bioprinting principle is based on 
the controlled deposition of “bioink”, composed by cells with or without 
hydrogels, on “biopaper”, which is composed by a hydrogel matrix. With this 
technology 3D biomimetic tissues can be developed in a spatially controlled 
manner with high precision over the shape, size, and cell location across the 
hydrogel 3D structure, based on either laser [159, 160], inkjet [158, 161] or 
extrusion/deposition [162, 163] technology. Bioprinting thus enables the 
development of functional organs comprising multiple cell types by providing 
similar cellular microenvironments to those found in vivo. Using inkjet or 
extrusion-based technologies, the bioink objects, typically with spherical or 
cylindrical shape and composed by single or multiple cell types, are deposited 
in well-defined topological patterns into biopaper sheets. Then, the obtained 
construct is transferred to a bioreactor and the assembled bio-ink objects are 
fused. After that, the biopaper can be removed, if required. Bioprinters can be 
classified in (i) nozzle-based, which can be further divided into intermittent 
drop-wise printers, such as inkjet printers (both thermal and piezoelectric), 
and continuous robotic dispensing printers, and (ii) dropwise nozzle-free, 
which is based on laser-induced forward transfer printing techniques [164]. In 
the case of inkjet technology, individual or small cell clusters are printed. 
Despite the advantageous speed, versatility and cost, high cell densities are 
difficult to obtain and considerable cell damage is induced [165, 166]. On the 
other hand, extrusion-based bio-printers are more expensive but offer a more 
gentle approach towards cells [151]. Common hydrogels proposed for 3D 
bioprinting obtained from natural polymers, such as collagen [167], hyaluronic 
acid (HA) [168], chitosan [169], gelatin [170], and alginate [171]. To be 
suitable for 3D bioprinting, a hydrogel must be viscous enough to keep its 
shape during printing and must have crosslinking abilities allowing the 
maintenance of the 3D structure after printing. Crosslinking can occur by 
temperature change [167], UV photopolymerization [172-174] and ionic 
crosslinking [171]. A common challenge when 3D bioprinting hydrogels is that 
the printed shapes tend to collapse due to low viscosity. The viscosity of 
alginate, the most widely used polymer in cell encapsulation, can be increased 
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by varying the concentration and molecular weight [175]; however, it has not 
been sufficient for achieving shape fidelity while printing [171]. To increase the 
structural accuracy hydrogels are often printed in combination with other 
materials. In such cases the printability of alginate has been improved by the 
addition of gelatin [176], or by printing with a supporting sacrificial polymer 
[177]. Recently, to improve the mechanical resistance of alginate, it was 
combined with nanofibrillated cellulose and tested as a bioink to produce 
anatomically shaped cartilage structures [171]. Human ears and sheep 
meniscus were successfully bioprinted, encapsulating human chondrocytes. 
The complex cell encapsulation devices retained its shape during the 7 days of 
in vitro culture, while assuring the viability of the encapsulated cells. 
 
4. Engineering cell encapsulation systems with variable geometries 
One of the main drawbacks of using hydrogels in cell encapsulation strategies 
is the inherent difficulty to shape them in predesigned geometries. Therefore, 
due to the ease of process, the most widely used hydrogel geometry in cell 
encapsulation are spherical systems. Over the years, with the development of 
new technologies to process hydrogels, new conformities are increasingly being 
developed, including fibers-shaped systems. Additionally, more complex 
hydrogel structures, mainly resulting from the assembly of variable shaped 
building blocks are being developed. In the present section, different examples 
of cell encapsulation systems with spherical and fiber-shaped geometries will 
be discussed, processed at different sizes, from macro- (engineered structures 
with dimensions usually between 0.5-1.5 mm diameter and 1-10 mm in length 
[18]) down to the micro-scale level (usually smaller than 750 µm). 
 
4.1 Spherical systems 
Cell encapsulation strategies with spherical shape are the most widely use 
geometry. Spherical systems are considered advantageous from a mass-
transport perspective since they are able to provide an optimal surface-to-
volume ratio for the diffusion of essential molecules for cell survival [178]. In 
particular, microencapsulation strategies facilitate the implantation at different 
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sites through small diameter catheters, thus allowing minimal invasive 
procedures. Spherical cell encapsulation strategies comprise (i) beads, which 
is by far the most studied and simple spherical system, and consist of 
spherical hydrogels and (ii) capsules, when a membrane is surrounding the 
core environment. The terminology of capsules is variable in TERM, since 
systems that encapsulate other materials are also often called capsules. In the 
present review, the capsules terminology refers to systems surrounded by a 
membrane. In order to increase the complexity of beads in cell encapsulation, 
those systems have been combined with the incorporation of other materials, 
such as smaller beads [149] or solid microparticles [179], as discussed in 
section 4.3 Multifaceted and complex structures. Most of the capsules are 
derived from beads, which are used as templates to produce the membrane. 
Capsules can be further divided into subcategories depending on the core 
state, namely (i) matrix-core/shell, (ii) liquid-core/shell, and (iii) cells-
core/shell (or conformal coating). 
Matrix-core/shell capsules encapsulate cells within a jellified hydrogel matrix 
surrounded by a membrane. The most well-known system is the alginate 
capsules manufactured by gelling alginate droplets containing cells in a 
solution containing divalent ions, such as calcium or barium, followed by a 
surface treatment after immersion of the obtained beads in PLL, as first 
proposed by Lim and Sun [8]. On the other hand, liquid-core/shell capsules 
encapsulate cells within a liquified matrix surrounded by a membrane. Using 
again the alginate capsules as an example, the system can be obtained by 
inverting the solutions used in matrix-core/shell capsules, i.e. by dropping a 
cell suspension containing divalent ions into an alginate solution [180, 181]. 
Immediately a hydrogel membrane of alginate is formed surrounding the 
liquified core containing cells. An alternative methodology to obtain extremely 
thin membranes in the order of nanometers is to combine cell encapsulation 
techniques with the LbL methodology as discussed in section 3.1 Protective 
coatings using the layer-by-layer technology. Many refinements of the techniques 
to produce spherical cell encapsulation systems have been attempted over the 
years, giving raise to the emerging of new production methods and new coating 
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techniques, mainly produced using principles of microfluidics technology, SH 
surfaces, and rapid prototyping of hydrogels (see section 3. New technologies 
for the next generation of cell encapsulation strategies). The cells-core/shell (or 
conformal coating) is a more recently technique compared with the referred 
two types of subcategories of capsules, and comprises the direct coating of a 
cell mass using LbL technique, as briefly discussed in section 3.1 Protective 
coatings using the layer-by-layer technology. 
 
Examples of beads and capsules as spherical systems used for cell 
encapsulation in TERM applications are illustrated in Figure I.2. 
 
 
Figure I.2. Different types of beads and capsules as spherical cell encapsulation systems. (B1) Alginate 
microbeads encapsulating human umbilical cord mesenchymal stem cells. Scale bar is 200 µm. 
Reprinted from ref. [182] with permission from Elsevier. Copyright © 2016 Elsevier Ltd. (B2a) DEX-MA 
microbeads stained with safranin-O (red), alcian blue (light blue) and toluidine (dark blue) encapsulated 
within alginate beads. Scale bar is 1 mm. (B2b) Higher magnification of B2a to evidence the 
encapsulated microbeads. Scale bar is 200 µm. Reprinted from ref. [149] with permission from John 
Wiley & Sons. Copyright © 2015 WILEY-VHC Verlag GmbH & Co. KGaA, Weinheim. (MS1) Matrix-
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core/shell capsule encapsulating baby hamster kidney (BHK) cells. The encapsulated BHK that remained 
in the core of the capsule are viable as showed by green fluorescence, while BHK cells that migrated to 
the outer layer were effectively killed (red fluorescence). Reprinted from ref. [183] with permission from 
Nature Publishing Group. Copyright © 2016 Macmillan Publishers Limited. (MS2a) Bi-layered DEX-MA 
matrix-core/shell capsule with the inner and outer layers stained with green and red fluorescent dyes, 
respectively. Scale bar is 500 µm. (MS2b) Localization of the encapsulated L929 cells in the outer layer 
of the DEM-MA matrix-core/shell capsule. Cell nuclei were stained in blue (DAPI) and F-actin filaments in 
red (phalloidin). Scale bar is 200 µm. Reproduced from ref. [148] with permission from John Wiley & 
Sons. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (LS1) Liquid-core/shell 
capsule composed by a liquified alginate core encapsulating L929 cells and a layer-by-layer chitosan-
alginate membrane. Scale bar is 500 µm. Reprinted from ref. [42] with permission from John Wiley & 
Sons. Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (LS2a) Liquid-core/shell 
capsule composed by a liquified alginate core encapsulating L929 cells and solid poly(L-lactic acid) 
microparticles as cell adhesion sites. The liquified core is surrounded by a multilayered membrane 
composed by poly(L-lysine), alginate and chitosan. Scale bar is 500 µm. (LS2b) Higher magnification of 
the liquified core of the capsules, showing the encapsulated microparticles. Scale bar is 100 µm. 
Reprinted with permission from [28]. Copyright © 2013, American Chemical Society. (CS1) Yeast cells 
coated with poly(N-vinyl pyrrolidone)/tannic acid multilayers, using a cationic poly(ethylene imine) as the 
first layer to facilitate the membrane adhesion. Scale bar is 4 µm. Reprinted with permission from ref. 
[184]. Copyright © 2010 Royal Society of Chemistry. (CS2) Cell-core/shell capsule composed by 6 layers 
of poly(allylamine hydrochloride) and poly(styrene sulfonate) stained in green surrounding a yeast cell. 
The resultant daughter cell was able to disrupt the membrane, resulting in a coating-free cell. Reprinted 
with permission from ref. [185]. Copyright © 2002 American Chemical Society.  
 
Additionally, Table I.1 summarizes the biomaterial, production technique, type 
of encapsulated cells, and the TERM application of examples of cell 
encapsulation systems with spherical structure. 
 
Table I.1 – Examples of spherical cell encapsulation systems for Tissue Engineering and Regenerative 
Medicine (TERM). The examples cover the type of biomaterial used to produce the different cell 
encapsulation systems, the production technique, the type of encapsulated cells, and the TERM 
application. 
Abbreviations: hCSCs: Human Cardiac stem cells; rMSCs: Rat mesenchymal stem cells; hMSCs: Human 
mesenchymal stem cells; IMR-90: Human fetal lung fibroblasts; hCSP: Human progenitor stem cells from 
the subchondral bone marrow; hPCs: Human placental microvascular pericytes; EDTA: 
Ethylenediaminetetraacetic acid; HUVECs: Human umbilical vein endothelial cells; hUCMSCs: Human 
umbilical cord mesenchymal stem cells; RGD: arginine-glycine-aspartic acid peptide sequence; TOBC: 
2,6,6-tetramethylpiperidine-1-oxyl radical oxidized bacterial cellulose; PLL: Poly(L-lysine); ES: Murine 
embryonic stem cells; hASCs: Human adipose-derived stem cells; hAMECs: Human adipose-derived 
microvascular endothelial cells; MNPs: Magnetic nanoparticles; CHO-K1: Chinese hamster ovary cells. 
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Spherical 
Systems 
Biomaterial 
Production 
Technique 
Encapsulated 
Cells 
TERM App. Ref. 
B
E
A
D
S
 
Agarose with fibronectin 
or fibrinogen 
Thermal gelation hCSCs Cardiovascular [186] 
Agarose, collagen I, 
fibrin and dextran-
sulfate 
Water/oil emulsion 
rMSCs or hMSCs 
and IMR-90 
Cardiovascular [187] 
Alginate Calcium gelation hCSP Cartilage [188] 
Alginate Calcium gelation hPCs Vascular [189] 
Alginate 
Calcium gelation with disodium 
EDTA 
D1 MSCs General [123] 
Alginate (macrobeads) 
Dextran-methacrylate 
(microbeads) 
Calcium gelation (macrobeads) 
Photocrosslinking 
(microbeads) 
L929 General [149] 
Alginate and fibronectin Calcium gelation rMSCs Bone [146] 
Alginate and keratine Calcium gelation HUVECs Vascular [190] 
Chitosan 
Sodium tripolyphosphate 
gelation 
L929 General [147] 
Collagen I Thermal gelation hMSCs Bone [191] 
Collagen I Thermal gelation hMSCs Cartilage [192] 
Oxidized alginate and 
fibrin 
Calcium gelation hUCMSCs Bone [182] 
RGD-alginate Calcium gelation hMSCs Bone [193] 
TOBC-alginate Calcium gelation with nitrogen NIH/3T3 General [53] 
C
A
P
S
U
LE
S
 
Matrix-
core/shell 
Alginate (core) 
PLL (shell) 
Calcium gelation (core) 
Polyelectrolyte complexation 
(shell) 
ES Neural [194] 
Alginate and collagen I 
(core) 
Collagen I (shell) 
Calcium gelation (core) 
Polyelectrolyte complexation 
(shell) 
hASCs Adipose [195] 
Dextran-methacrylate 
(core) 
Alginate (shell) 
Photocrosslinking (core) 
Calcium gelation (shell) 
L929 General [148] 
Liquid-
core/shell 
Alginate (core) 
Chitosan and alginate 
(shell) 
Calcium gelation followed by 
EDTA decrosslinking (core) 
Layer-by-layer (shell) 
Saos-2 General [42] 
Alginate (core) 
Chitosan and alginate 
(shell) 
Calcium gelation followed by 
EDTA decrosslinking (core) 
Layer-by-layer (shell) 
L929 General [43] 
Alginate (core) 
Chitosan, alginate and 
PLL (shell) 
Calcium gelation followed by 
EDTA decrosslinking (core) 
Layer-by-layer (shell) 
L929 General [28] 
Alginate (core) 
Chitosan, alginate and 
PLL (shell) 
Calcium gelation followed by 
EDTA decrosslinking (core) 
Layer-by-layer (shell) 
hASCs and hAMECs Bone [100] 
Alginate (core) 
Chitosan, alginate, PLL 
and MNPs (shell) 
Calcium gelation followed by 
EDTA decrosslinking (core) 
Layer-by-layer (shell) 
hASCs Cartilage [101] 
Dextran (core) 
Tetronic (T1107) 
derivatives (shell)  
Pluronic F127 CHO-K1 General [196] 
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4.2 Fiber-shaped systems 
Fibers are long, thin and flexible structures that facilitate high-order 
assemblies such as nanoscale materials [197, 198] and textiles [199] by 
folding, bundling, reeling and weaving of fibers. In contrast with spherical cell 
encapsulation systems, fiber-shaped systems were not popularly employed 
until more recently. This is because the conventional mass-produced fibers 
widely use industrialized spinning techniques, namely wet, dry, melt, gel, and 
electrospinning, that after require process parameters (e.g. high shear, melt 
temperatures, harsh chemical solvents, or high voltages, rapid 
evaporation/solidification) [132] incompatible with the required mild 
conditions for cell encapsulation. Nonetheless, fiber-based systems are an 
ideal platform for mimicking biological materials and tissue structures, and 
current research has begun to exploit fiber matrices for biomedical 
applications [111, 132, 151]. Fiber-shaped systems can easily create 3D 
complex and hierarchical constructs in vitro mimicking the interconnected 
networks of native tissues, such as the immense tubular network of the 
cardiovascular systems, neural pathways, and even the direct fibrous 
constructs of the musculoskeletal system [200, 201]. The processing of such 
biological materials requires aqueous conditions with precisely controlled 
temperature and pH. The processing limitations coupled with the TERM 
biomimetic solutions mimicking the complexity and hierarchical organization 
of native tissues led to the advent of microfluidic fiber fabrication. In 
comparison to standard fiber-manufacturing technologies, microfluidics offers 
a combination of improved properties for biomaterials fabrication, including 
speed, reproducibility, yield, purity, and conservation of the biological 
component’s functionality and viability in part due to the benign reaction 
conditions [132]. Various fiber-shaped cell encapsulations systems have been 
proposed to encapsulate different cell types by microfluidic spinning technique 
[29, 111, 124-131]. Microfibers are continuously formed in a microchannel 
using a coaxial flow of a fiber precursor solution sheathed by a second fluid 
that contains the crosslinking agent. The inner phase undergoes either a 
physical or chemical transformation, inside the microchannel or after ejection, 
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to produce the solid fiber. This method is similar to the wet spinning [133], 
although here the crosslinking agent is supplied directly by the coaxial flow 
instead of by the bath. This technique does not require high voltages or 
temperatures, thus ensuring mild conditions and, consequently, the viability of 
the encapsulated cells. Additionally, the diameter of the fibers can be easily 
tuned from a few to a few hundred microns only by regulating the flow rate 
[111]. Similarly to spheres, the most common biomaterial used to produce 
microfluidic-spun fibers is alginate [18, 124-128], but other polymers have 
been also employed, such as chemically modified gelatin [130, 202], chitosan 
[203], collagen [204] and supramolecular hydrogels [131]. Among the 
different polymers employed, also different types of cells have been 
encapsulated alone or in co-cultures. For example, matrix-core fibers were 
proposed to encapsulate hepatocytes or fibroblasts using spinning 
microfluidics [127]. Additionally, those fibers were also tested to encapsulate 
hepatocytes and fibroblasts by spatiotemporal control of the localization of 
cells in fibers with multiple parallel layers. Overall, the production methods to 
produce fibers by microfluidics remain similar between the different strategies 
with only slight modifications of the technique, such as by exploring different 
laminar flows. For example, a fiber-shaped cell encapsulation system was 
proposed using a double-coaxial laminar flow microfluidic device. The 
advantage of the system is the ability to include within the fibers structural 
ECM proteins, namely collagen I (both pepsin- and acid-solubilized collagen) 
and fibrin, which require longer gelation time compared to the polymers used 
in microfluidic (less than 1s). The double-coaxial laminar flow allowed creating 
a microfiber-shaped inner core of ECM proteins covered by a thin and tubular 
outer layer of mechanically stable and rapidly gelating alginate hydrogel [29]. 
The alginate shell prevented the ECM proteins in the liquified core from 
diffusing out the core, until finally the structure is solidified into a hydrogel. 
Different cell types were encapsulated, namely fibroblasts, myocytes, 
endothelial, nerve or epithelial cells. In a final step, the alginate shell is 
removed, resulting in a fiber-shaped cell encapsulation system only composed 
by cells and ECM proteins. 
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Besides matrix-core fibers, the simplest and commonly used system, fiber-
shaped cell encapsulation systems can present other geometries. Therefore, 
depending on the core state and the presence of a membrane, fibers can be 
divided into (i) matrix-core fibers (ii) hollow-core fibers, (iii) matrix-core/shell 
fibers, and (iv) liquid-core/shell fibers. In particular, hollow-core and liquid-
core/shell fibers have been poorly described in the literature. In the case of 
hollow-core fibers, the majority of reports are related with the encapsulation of 
therapeutic cells within the lumen of hollow fibers, which are then sealed with 
adhesive at both ends [205]. This strategy is mainly employed to produce 
immunoisolation membranes, thus is not within the scope of the present 
review. In tissue regeneration, since the immunoisolation feature is not 
compulsory, hollow-core fibers are widely used as tubular structures usually to 
mimic the vascular network [199]. Consequently, few studies have employed 
hollow-core fibers encapsulating cells within its matrix for TERM, although its 
production have been recently increase with the emerging of new techniques to 
produce cell encapsulation systems [125, 202, 206, 207]. Hollow fibers 
encapsulating cells within its matrix were first reported only 7 years ago with 
alginate fibers encapsulating endothelial cells (HIVE-78) using a three-layer 
coaxial flow [125]. Calcium chloride solution was used as the core and out-
layer fluids to crosslink the middle layer alginate solution. The fabricated 
hollow fibers were then embedded into agar-gelatin-fibronectin hydrogels 
encapsulating smooth muscle cells (HIVS-125). However, this method lacked 
control over the lumen diameter of the microfiber. In fact, the lack of reports 
might be resultant from the difficulty in controlling the hollow core (lumen) 
during the fibers processing as well as after by preventing lumen collapse or, 
especially in the case of hydrogels, obstruction due to its inherent swelling. To 
control the lumen diameter of hollow microfibers, a coaxial triple cylinder was 
then suggested [206]. For that, aqueous solutions of dextran (core cylinder), 
alginate (intermediate cylinder) and calcium chloride (outer cylinder) were 
simultaneously extruded. The lumen diameter could be controlled only by the 
ratio of flow volume of dextran solution to total flow volume of dextran and 
alginate solutions (core volume ratio). Additionally, the outer diameter of the 
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fiber could also be controlled. Currently, since hollow-fibers are challenge to 
obtain, cell encapsulation tubular structures for TERM applications are mainly 
obtained by wrapping a tubular structure with matrix-core fibers using complex 
microfluidic technologies, such as combined with weaving machines [29] or 
multilayered structures [208]. On the other hand, liquid-core/shell fibers were 
barely reported in the literature [126, 129, 209]. Alginate fibers were proposed 
to encapsulate human embryonic kidney (HEK) 293 cells transfected with GFP 
and coated with PLL [126]. The alginate core was then liquified by using 
sodium citrate. Cells remained viable within the liquified core and cells formed 
a cylindrical multicellular aggregate after two weeks of culture. Others, used 
alginate fibers to encapsulate L929 cells, which were then coated with 
multilayers of alginate and chitosan using a LbL perfusion technique [209]. 
The core was then liquified by using the divalent ions chelator EDTA. The 
multilayered shell also allowed assembling the liquid-fibers into a spiral 
structure. 
The recent methods to produce fiber-shaped systems allow a fine control of the 
diameter, composition and radial organization. However, usually the surface of 
the produced fibers is smooth and thus do not replicate the micro- and nano-
features of natural tissues, which guide and regulate cell behavior. In an 
attempt to re-create such conditions, fibers with microstructured surfaces have 
successfully proposed encapsulating murine C2C12 myoblast cells and human 
osteoblasts encapsulation [210]. 
Examples of different fiber-shaped systems used for cell encapsulation in 
TERM applications are illustrated in Figure I.3.  
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Figure I.3 – Different types of fiber-shaped cell encapsulation systems. (M) Gelatin–
hydroxyphenylpropionic acid (Gtn–HPA) matrix-core fibers encapsulating Madin-Darby canine kidney 
(MDCK) cells. (Ma) Optical micrograph (live-dead assay) and (Mb) cryosectional image (DAPI staining) of 
Gtn-HPA fibers. Scale bar in (Ma) is 400 µm and in (Mb) 50 µm. Reprinted from ref. [202] with 
permission from Elsevier. Copyright © 2009 Elsevier Ltd. (MSa) Matrix-core/shell fiber encapsulating rat 
mesenchymal stem cells in the collagen core and bioactive glass nanoparticles (BGn) releasing silicon 
and calcium ions encapsulated in the alginate shell. Phalloidin (green) and DAPI (blue) staining after and 
21 days of encapsulation in fibers (MSb) without or (MSc) with BGn. Scale bar is 100 µm. Reprinted from 
ref. [204] with permission from Elsevier. Copyright © 2015 Acta Materialia Inc. (LS1) Liquid-core/shell 
fibers with 120 µm of diameter encapsulating HEK 293 cells transfected with GFP (293/GFP cells) in the 
liquid alginate core surrounded by a poly(L-lysine) (PLL) shell. Green fluorescence images were overlaid 
on bright-field images. Scale bar is 400 µm. Reprinted with permission from ref. [126]. Copyright © 2008 
Royal Society of Chemistry. (LS2a-c) Optical images of mouse embryonic cells encapsulated in 
alginate/PLL aqueous microstrands after 5 days of culture. The liquified environment allowed cells to 
self-assemble into tubular structures while promoting the formation of compact microtissues. Scale bar is 
200 µm. Reprinted from ref. [129] with permission from Elsevier. Copyright © 2011 Elsevier Ltd. (H1) 
Schematic representation of alginate hollow fibers encapsulating HIVE-78 cells (red). Hollow fibers were 
then embedded in agar-gelatin-fibronectin matrix encapsulating HIVS-175 cells (green) to create a 3D 
vascularized co-culture system. Reprinted from ref. [125] with permission from John Wiley & Sons. 
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. (H2a) Hollow-core alginate fibers 
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encapsulating L929 cells stained with red fluorescent dye. L929 cells stained in green were added to the 
hollow core to evidence the tubular structure of the fibers. (H2b) Hollow fibers were cut into pieces and 
slightly pressed, originating the release of the green cells in the hollow core, while the encapsulated red 
cells remained within the fiber matrix. Scale bar is 500 µm. Reprinted from ref. [206] with permission 
from Elsevier. Copyright © 2009 Elsevier B.V. 
 
Additionally, Table I.2 summarizes the biomaterial, production technique, type 
of encapsulated cells, and the TERM application of examples of cell 
encapsulation systems with fiber-shaped structure.		
Table I.2 - Examples of fiber-shaped cell encapsulation systems for Tissue Engineering and Regenerative 
Medicine (TERM). The examples cover the type of biomaterial used to produce the different cell 
encapsulation systems, the production technique, the type of encapsulated cells, and the TERM 
application. 
Abbreviations: HepG2: Human hepatocellular carcinoma cells; Gtn-HPA: Gelatin-hydroxyphenylpropionic 
acid; HRP: Horseradish peroxidase enzyme; H2O2: Hydrogen peroxide; MDCK: Madin-Darby canine kidney 
cells; PEG-DA: Poly(ethylene glycol) diacrylate; hMSCs: Human mesenchymal stem cells; Alg-Ph: Alginate 
with Ph moieties; hPTCs: Human proximal tube cells; PGA: Propylene glycol alginate; PLL: Poly(L-lysine); 
BGn: Bioactive glass nanoparticles; rMSCs: Rat mesenchymal stem cells; hME: Human microvascular 
endothelial cells; EDTA: Ethylenediaminetetraacetic acid; ES: Embryonic stem cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter I 
Design principles and technologies in cell encapsulation systems towards tissue regeneration 
 
	 	 	44 
Fiber-
shaped 
Systems 
Biomaterial 
Production 
Technique 
Encapsulated 
Cells 
TERM 
App. 
Ref. 
M
at
ri
x-
co
re
 
Alginate Calcium gelation L929 General [124] 
Alginate and chitosan Polyelectrolyte 
complexation 
Primary rat hepatocytes 
and L929 
General [127] 
Alginate and chitosan Calcium gelation HepG2 General [203] 
Gtn-HPA HRP and H2O2 
crosslinking 
MDCK General [202] 
PEG-DA Photocrosslinking NIH/3T3 Vascular  [208] 
Peptide amphiphile 
solution 
Ionic (calcium) self-
assembly 
hMSCs or HL-1 Cardiovascular, 
neural and nerve 
[131] 
H
ol
lo
w
-c
or
e 
Alginate Calcium gelation HIVE-78 Vascular  [125] 
Alginate Calcium gelation L929 General [206] 
Alg-Ph HRP and H2O2 
crosslinking 
HeLa General [207] 
Gtn-HPA HRP crosslinking MDCK General [202] 
Gtn-HPA (inner layer) 
Polysulfone (outer layer) 
HRP and H2O2 
crosslinking 
hPTCs General [130] 
M
at
ri
x-
co
re
/s
h
el
l 
Alginate and PGA (core) 
Alginate and PLL (shell) 
Calcium gelation (core) 
Polyelectrolyte 
complexation (shell) 
NIH/3T3, HeLa or PC12 Hepatic, vascular, 
and 
musculoskeletal 
 
[128] 
Collagen I (core) 
Alginate and BGn (shell) 
Calcium gelation rMSCs Bone [204] 
Collagen I (pepsin- or 
acid-solubilized) or 
fibrinogen (core) 
Alginate (shell) 
Thermal gelation 
(collagen I-core fibers) 
or ionic crosslinking 
with thrombin and 
calcium chloride 
(fibrinogen-core fibers) 
Fibroblasts (NIH/3T3), 
myocytes (C2C12 or rat 
primary), endothelial 
(HUVECs or MS1), nerve 
(rat primary cortical cells 
or mouse primary neural 
stem cells) or epithelial 
(HepG2, MIN6m9 or 
HeLa) cells 
Vascular, 
musculoskeletal 
or neural 
[29] 
Gtn-HPA (core and shell) HRP and H2O2 
crosslinking 
MDCK General [130] 
Gtn-HPA (core and shell) HRP and H2O2 
crosslinking 
MDCK and hME General [202] 
Li
q
u
id
-c
or
e/
sh
el
l 
Alginate (core) 
Alginate and PLL (shell) 
Calcium gelation 
followed by sodium 
citrate decrosslinking 
(core) 
Layer-by-layer (shell) 
Human kidney 293 cells Vascular [126] 
Alginate (core) 
Alginate and chitosan 
(shell) 
Calcium gelation 
followed by EDTA 
decrosslinking (core) 
Layer-by-layer (shell) 
L929 General [209] 
Alginate (core) 
PLL (shell) 
Calcium gelation 
followed by sodium 
citrate decrosslinking 
(core) 
Polyelectrolyte 
complexation (shell) 
Mouse ES General [129] 
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4.3 Multifaceted and complex structures 
Native tissues are hierarchical assemblies of heterogeneous types of cells and 
ECM across multiple length scales. Inspired by that, different cell 
encapsulation strategies with complex structures have been increasingly 
proposed. A commonly used strategy is the assembly of hydrogels as building 
blocks by bottom-up approach (Figure I.4I-IV). Bottom-up approaches have the 
potential to construct tissues with defined properties including spatial and 
temporal control at cellular level [211]. An example of spherical building 
blocks composed by alginate beads encapsulating a cell line (L929) assembled 
by perfusion-based LbL technology was proposed [44]. Due to the spherical 
shape of the beads, molds with variable shapes could be easily filled, and thus 
cell encapsulation systems with distinct final 3D macrophages were obtained. 
After the construction of the membrane, the core was liquified. The system 
maintained its structural integrity, showing the feasibility of using LbL 
technology to assemble cell-laden building blocks. Other interesting bottom-up 
approaches to construct 3D structures of hydrogels are being explored using 
different assembly techniques. For example, self-assembly of hydrogel modules 
with different geometries with micro-scale range (i.e., cubes of ca. 1000 µm3) 
was demonstrated by placing cubes of methacrylated gelatin (gelMA) into the 
surface of a higher density hydrophobic liquid (carbon tetrachloride or 
perfluorodecalin) [212]. Due to surface tension complex aggregates of the 
hydrogels was observed. A second crosslinking step by UV light radiation was 
employed to consolidate the complex 3D structure. The hydrogel blocks were 
proposed to encapsulate different cell types, which could then be combined in 
one single structure to design multi-cellular structures. Precise control over the 
assembly process can be achieved by functionalization of the surface of the 
hydrogel blocks encapsulating cells. For that, cube-shaped hydrogel blocks 
functionalized with single-stranded DNA segments were proposed as a 
molecular recognition-assisted self-assembly strategy [213]. Results showed 
that cubes loaded with long complementary DNA strains could preferentially 
bind to each other and create complex microarchitectures. Others, produced 
multifaceted hydrogels co-encapsulating NIH 3T3 mouse embryo fibroblast cell 
Chapter I 
Design principles and technologies in cell encapsulation systems towards tissue regeneration 
 
	 	 	46 
line and magnetic nanoparticles, which conferred magnetic-response ability to 
the hydrogels [214]. By spatially controlling the magnetic field, different 
geometries of the 3D constructs could be obtained, including dome, sphere, 
tube, and hexagon. These geometries were chosen as examples to mimic 
structures observed in vivo, e.g. dome for diaphragm (dome-shaped muscle) 
beneath the lungs, tube for vascular structure, spheres for islets, and hexagon 
for the lobules in pancreas. The different assembly methods of hydrogels 
encapsulating cells in order to fabricate complex structures by bottom-up 
approaches were recently reviewed in detail [215]. 
A different approach is to use micromolding to fabricate complex templated 
hydrogels on a massive scale (Figure I.4V and I.4VI). Generally, the molds can 
be made from different materials, such as metal and plastics, through soft 
photolithography and rapid prototyping [111]. Polydimethylsiloxane (PDMS) 
elastomers are also widely used to fabricate the molding replica due to their 
tunable mechanical strength, optical transparency, and biocompatibility [216]. 
The process involves the filling of molds with a pre-polymer solution that, 
usually by photocrosslinking, is crosslinked and ultimately originates hydrogels 
with multifaceted shapes. Micromolding was combined with photopatterning 
techniques to spatially organize 3D hybrid hydrogel arrays based on gelMA and 
PEG derivatives. Mouse embryoid bodies (EBs) were encapsulated within the 
engineered constructs to study their interactions with different hydrogel 
compositions [217]. For that, cells were first seeded into the microwells on a 
PDMS substrate, followed by the sequential loadings of the two pre-polymer 
solutions and UV crosslinking through a photomask. The photomask was 
specifically designed so that the EBs were embedded at the interfaces of the 
two different hydrogels and therefore were exposed to an asymmetric 
microenvironment. The EBs were found to preferentially sprout into the gelMA 
hydrogel part and thus led to induced polarity in the embryonic development, 
suggesting possible approaches to regulate the behaviors of the stem cell 
niche for TERM applications. 
A more automated strategy to construct cell encapsulation strategies with 
complex shapes, are those fabricated using hydrogel rapid prototyping (Figure 
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I.4VII-X), as already discussed in section 3.4 Hydrogels 3D bioprinting. The 
main advantages are its speed and versatility, although with some strategies 
cell damage might occur, thus limiting the technique in terms of fabrication 
processes and also the range of biomaterials than can be employed. Of 
relevance, the methodology allows to construct anatomically complex cell 
encapsulation systems, such as vascular networks [173, 218]. The 3D printing 
of vascular networks is a highly scalable platform that allows fabricating 
engineered tissue constructs in which vasculature and multiple cell types are 
precisely placed within a hydrogel matrix. This methodology allows increasing 
the diffusion of essential molecules by creating an extending network within the 
3D structure of the engineered hydrogel, and thus avoids cell necrosis, one of 
the main issues in cell encapsulation systems. Other example of an 
anatomically complex cell encapsulation system using hydrogel rapid 
prototyping was the production aortic valves using hydrogels composed by 
natural polymers such as alginate/gelatin hydrogels [219] or combined with 
synthetic polymers such as alginate with PEG diacrylate (PEG-DA) [220]. One 
of the main disadvantages of having complex 3D structures by hydrogels rapid 
prototyping is the lack of mechanical resistance. In order to solve this problem, 
an interpenetrating network of ionically crosslinked alginate and covalently 
crosslinked PEG was proposed to fabricate a hydrogel possessing high fracture 
toughness, while allowing the encapsulation of human mesenchymal stem cells 
[55]. The unique tough and robust properties o the proposed hydrogel relied 
on the combination of two mechanisms, namely the reversible calcium 
crosslinking of alginate that dissipates mechanical energy under deformation, 
while the covalent crosslinked long-chain PEG maintains high elasticity of the 
hydrogel. The capability of printing PEG-alginate hydrogels into various 
complicated 3D structures, including hollow cube, hemisphere, pyramid, 
twisted bundle, and physiologically relevant shapes such as human nose and 
ear models, was tested. For that, it was include within the hydrogel matrix a 
biocompatible nanoclay in order to increase the viscosity of the prepolymer 
solution, required to produce complex shapes. HEK cells were encapsulated 
into a collagen I solution, which then gelled throughout the interconnected 
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pores of the printed PEG-alginate-nanoclay mesh to form a composite 
hydrogel. The encapsulated HEK cells maintained high viability of ca. 95% over 
the course of 7 days of in vitro culture. The printed hydrogel structures are 
also highly deformable and tough, demonstrating that the added nanoclay 
does not significantly affect the superior mechanical qualities of the hydrogel.  
Examples of multifaceted and complex systems used for cell encapsulation in 
TERM applications are illustrated in Figure I.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter I 
Design principles and technologies in cell encapsulation systems towards tissue regeneration 	
	 49 
Figure I.4 – Examples of multifaceted and complex systems used for cell encapsulation in TERM 
applications. (I) Liquified capsules encapsulating L929 cells. Hydrogels were assembled by a perfusion-
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based layer-by-layer technique. Reproduced from ref. [44] with permission from the Royal Society of 
Chemistry. (II) Production of hydrogels by liquified air-interface-directed self-assembly technique. (II.a) 
The pre-polymer solution (PEG and cells in suspension) is placed on top of an octadecyl-trimethoxysilane 
(OTS)-treated glass slide between the photomask and spacers. (II.b) UV light is selectively filtered 
through the photomask, leading the pre-polymer solution to polymerize in the desired pattern. (II.c) After 
PBS washing, PEG hydrogels encapsulating cells are obtained. (II.d) Microgels are randomly placed on 
the surface of perfluorodecalin (PFDC) or carbon tetrachloride, which due to the hydrophobicity of the 
solutions, microgels remain floating. (II.e) Due to surface tension, microgels self-assemble to minimize 
free energy. (II.f) Secondary UV polymerization to crosslink the microgels aggregation, originating 
macroscale engineered constructs. Scale bar is 2 cm. Reproduced from ref. [221] with permission from 
John Wiley & Sons. (III) Self-assembly of hydrogel cubes with uniform giant DNA glue modification. 
Hydrogel cubes display giant DNA on multiple designated faces, which allows constructing linear chain 
structures and net-like structures. To make chain structures, two cube species were made: a red cube 
that displays giant DNA a on two opposite faces, and a blue cube that displays giant DNA a* on two 
opposite faces. (III.a) Schematic representation of giant-DNA-directed hydrogel assembly. Giant DNA 
containing tandem repeats of complementary 48-nt sequences was uniformly amplified on the surface of 
red and blue hydrogel cubes. Hybridization between the complementary DNA sequences resulted in 
assembly of hydrogel cubes. (III.b) Hydrogel cubes were assembled in a 0.5 mL tube filled with assembly 
buffer under mild rotation, transferred to a Petri dish and imaged by microscopy. (III.c and III.d) Phase 
contrast and fluorescent microscopy images of the post-assembly system, in which hydrogel cubes were 
modified with (III.c) short 56-nt or (III.d) amplified giant DNA strands. Hydrogel cubes carrying 
complementary DNA a or a* were labeled with red or blue fluorescent microbeads, respectively, and 
stained with SYBR Gold. (III.e) Red and blue hydrogel cubes carrying complementary short (left) or giant 
(right) DNA strands failed (left) or succeeded (right) to assemble into aggregates, in the presence of 
competitive yellow hydrogel cubes that were not modified with DNA. (III.f) Aggregates assembled from 
red and blue hydrogel cubes carrying complementary giant DNA fell apart after 1 h Baseline-ZERO DNase 
treatment (left: before DNase treatment; right: after DNase treatment). Scale bar is 500 mm in III.c, III.d, 
III.e and III.f. (III.g–j) Aggregates were assembled from red and blue hydrogel cubes with various edge 
lengths: (III.g) 30 mm, (III.h) 200 mm, (III.i) 500 mm and (III.j) 1 mm. Giant DNA glue was uniformly 
amplified on the hydrogel surface. Scale bar is 1 mm in the main panels and 50 mm in the inset of (III.g). 
Reproduced from ref. [213] with permission from Nature Publishing Group. (IV) Magnetic directed 
assembly of microgels produced by micromolding. Microgels were assembled to fabricate three-layer 
spheroids through the application of external magnetic fields. First layer gels were stained with 
rhodamine-B, second layer gels were stained with FITC-dextran, and third layer gels were stained with 
TPB (1,1,4,4-Tetraphenyl-1,3-butadiene). Scale bar is 500 µm. Reproduced from ref. [214] with 
permission from John Wiley & Sons. (V) Cell encapsulation in 3D gel objects (modules) in a variety of 
simple shapes (crosses, squares and cylinders). (V.a) Photolithography of SU-8 photoresist on a silicon 
wafer to generate posts with diameters from 40 to 1000 mm and heights from 100 to 1000 mm. (V.b) 
Spin-casting PDMS around the produced posts generates a membrane that bore an array of holes in a 
variety of shapes with precise dimensions. (V.c) The obtained holes penetrate the PDMS membrane, 
which allows the modules to be release easily after formation. (V.d) Emersion of the fabricated PDMS 
membrane in a collagen solution containing NIH 3T3 cells in suspension. (V.e) Incubation of the 
membrane containing holes filled with collagen and cells at 37ºC for 45 min. (V.f) After gelation of 
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collagen, the membrane is immersed in cell culture medium and agitated for 10-15 min until the 
hydrogel modules are released. (V.g) Encapsulated cells proliferate and consequently the hydrogel 
shrinks without loosing its pre-defined shape. (V.h-k) Different shapes of modules. (V.h) Cross module 
fabricated from collagen. (V.i) Square cross-section module (40 mm wide) fabricated from collagen 
containing a single cell (bright spot). (V.j) Side view of square cross-section module (200 mm wide) 
fabricated from 2% w/v agarose gel without cells. (V.k) Cylindrical module (1 mm in diameter) fabricated 
from Matrigel. Scale bar is 800 µm in (V.h, V.j and V.k) and 200 µm in (V.i). Reproduced with permission 
from ref. [222]. (VI) Polarity induction in individual EBs encapsulated in gelMA/PEG hybrid microgels 
with spatially patterned vasculogenic differentiation. (VI.a and VI.c) Phase contrast images of individual 
embryoid bodies (EBs) in hybrid microgel. (I.4VI.b and I.4VI.d) Microbead (green) laden PEG microgel 
and streptavidin conjugated rhodamine (red) laden gelMA microgel in hybrid microgel structure and EB 
morphology stained in blue by DAPI. Scale bar is 600 µm in (VI.a) and 300 µm in (VI.c). Reproduced from 
ref. [217] with permission from John Wiley & Sons. (VII) Bioprinting of aortic valve conduit. (VII.a) Aortic 
valve model reconstructed from micro-CT images. The root and leaflet regions were identified with 
intensity thresholds and rendered separately into 3D geometries into stereolithography format (green 
color indicates valve root and red color indicates valve leaflets). (VII.b and VII.c) Schematic illustration of 
the bioprinting process with dual cell types and dual syringes. (VII.b) Root region of first layer generated 
by hydrogel with human aortic root smooth muscle cells (SMC). (VII.c) Leaflet region of first layer 
generated by hydrogel with porcine aortic valve interstitial cells (VIC). (VII.d) Fluorescent image of first 
printed two layers of aortic valve conduit. Smooth muscle cells (SMC) for valve root were labeled by cell 
tracker green and aortic valve interstitial cells (VIC) for valve leaflet by cell tracker red. Scale bar is 3 
mm. (VII.e) As-printed aortic valve conduit. Reproduced from ref. [219] with permission from John Wiley 
& Sons. (VIII) 3D printed rigid filament networks of carbohydrate glass as a cytocompatible sacrificial 
template in engineered tissues containing living cells to generate cylindrical networks, which could be 
lined with endothelial cells and perfused with blood under high-pressure pulsatile flow. Cells constitutively 
expressing EGFP (green) were encapsulated in a variety of ECM materials, then imaged with confocal 
microscopy to visualize the matrix (red beads), cells (10T1/2, green) and the perfusable vascular lumen 
(blue beads) shown schematically (bottom right). The materials have varied crosslinking mechanisms 
(annotated above images) but were all able to be patterned with vascular channels. Scale bars are 200 
μm. Reproduced from ref. [218] with permission from Nature Publishing Group. (IX) 3D printing of tough 
and biocompatible PEG–alginate–nanoclay hydrogels with various shapes: (from left to right) hollow cube, 
hemisphere, pyramid, twisted bundle, the shape of an ear, and a nose. Nontoxic red food dye was added 
postprint on some samples for enhanced visibility). Scale bars are 2 cm. Reproduced from ref. [55] with 
permission from John Wiley & Sons. (X) 3D bioprinting for fabricating engineered tissue constructs 
replete with vasculature, multiple types of cells, and ECM. (X.a) Schematic view and (X.b and X.c) 
fluorescence images of an engineered tissue construct cultured for 0 and 2 days, respectively, in which 
red and green filaments correspond to channels lined with red fluorescent protein-expressing HUVECs 
and green fluorescent protein-expressing human neonatal dermal fibroblast (HNDFs) cells-laden gelMA 
ink, respectively. The cross-sectional view shows that endothelial cells line the lumens within the 
embedded 3D microvascular network. Scale bar is 300 µm. Reproduced from ref. [173] with permission 
from John Wiley & Sons. 
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5. Bringing multifunctionality to cell encapsulation systems 
 
5.1 Stimuli-responsive strategies  
To sustain life and maintain biological function, nature requires selectively 
tailored and adaptive molecular assemblies and interfaces that provide a 
specific chemical function and structure [223]. Based on that, different stimuli-
responsive and “adaptative” systems that are capable of conformational and 
chemical changes on receiving an external signal are being developed. These 
changes are accompanied by variations in the physical properties of the 
polymers employed within the hydrogel matrix or within components added to 
its matrix, such as embedded materials, or by functionalizing coatings that 
surround the hydrogel matrix. The signal is derived from changes in the matrix 
environment, such as a change in temperature, pH, chemical composition (e.g. 
redox stimulus) or applied mechanical force, or that can be triggered 
exogenously by irradiation with light (UV, laser, visible) or exposure to an 
electrical and magnetic field. All the referred stimuli are widely used in drug 
delivery systems, in which pH and redox stimuli are the most common since 
they exist naturally in certain pathological sites as well as in all cancer cells 
[224, 225]. However, being the focus of the present review cell encapsulation 
strategies for tissue regeneration, only temperature-, light-, and magnetic-
responsive stimuli will be discussed in the following section, since those are 
the most common. 
 
5.1.1 Temperature-responsive cell encapsulation systems 
The most widely used temperature-responsive systems are related with the 
crosslinking process to fabricate in situ forming hydrogels. Those hydrogels are 
composed by thermoresponsive polymers that exhibit a lower critical solution 
temperature (LCST) and form a gel upon temperature increase [226]. The 
process is reversible, and the polymers return into solution when the 
temperature is lowered below the LCST. Thermally responsive hydrogel 
systems based on natural polymers (such as alginate, chitosan, cellulose 
derivatives, gelatin, hyaluronic acid) and synthetic polymers (e.g., N-
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isopropylacrylamide (NiPAAm), poly(ethylene oxide)–b-poly(propylene oxide)–b-
poly(ethylene oxide) (PEO–PPO–PEO) triblock copolymers, PEG-biodegradable 
polyester copolymers, poly(organophosphazenes) and 2-(dimethylamino) ethyl 
methacrylate) have been proposed for biomedical applications [227, 228]. The 
theories and mechanisms behind thermogelation have already been very well 
summarized in previous articles [227]. Thermally responsive systems are 
particularly appealing in biomedical applications, mainly because their gelation 
can be triggered by temperature change from ambient to physiological 
conditions. Therefore, it allows the implantation of hydrogels by minimally 
invasive procedures, since before implantation the hydrogel is in a liquid state. 
Additionally, after injection of the pre-hydrogels, the solution can easily achieve 
different complex and matched conformations to the lesion site. Some of the 
challenges with this type of hydrogels involved precise control over the LCST 
and gelation kinetics, stability and mechanical properties as well as 
degradation profiles. A major problem observed in some thermally responsive 
systems is syneresis, especially in NiPAAm hydrogels. Syneresis is 
characterized by high amounts of water expel from the hydrogel matrix after 
gelation. This fact may prove problematic for various biomedical applications, 
for example in the case of an injectable hydrogel not conforming to the shape 
of a defect after shrinkage, or reduced water contents impairing diffusion of 
essential molecules to encapsulated cells compromising its viability [229]. To 
stabilize hydrogel matrixes and mitigate syneresis biodegradable 
methacrylated thermogelling macromers (MA-TGMs) have been proposed 
[230]. These macromers are made from a statistical copolymer of NiPAAm, 
acrylamide, and mono-acryloxyethyl phosphate (MAEP) that are esterified with 
glycidyl methacrylate after polymerization to yield dual-gelling macromers. 
These macromers are particularly promising for cell encapsulation 
applications, as they facilitate biointegration of the hydrogels and degradation 
via hydrolysis of phosphate ester bonds of MAEP. Hydrolysis of phosphate 
ester bonds of MAEP is accelerated in the presence of the naturally occurring 
enzyme alkaline phosphatase, which is upregulated in areas of regenerating 
bone tissue. Hydrogels that readily undergo enzymatic degradation have 
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demonstrated improved bone growth and infiltration into hydrogels [60]. Two 
formulations (high and low MAEP content) of these dual gelling macromers 
were selected for in vitro and in vivo characterization to evaluate their potential 
to encapsulate MSCs and regenerate bone tissue [231]. Results showed that 
functionalized hydrogels from macromer solutions and encapsulating MSCs 
were able to induce bone growth into and across a critical-size rat cranial 
defect, as well as accelerated mineralization and helped facilitating bony 
integration. Furthermore, phosphate groups incorporated in MAEP improved 
bony integration and bone regeneration, while the degradation of phosphate 
ester bonds helped facilitating infiltration of bone tissue. 
In another approach towards tissue regeneration, induced pluripotent stem 
cells (iPSCs) were encapsulated within thermogelling hydrogels that were 
implanted by injection based on amphiphatic carboxymethylhexanoyl chitosan 
[232] and adipose-derived stem cells (ASCs) within aminated hyaluronic acid-
g-poly(N-isopropylacrylamide) hydrogels [233]. In both temperature-responsive 
cell encapsulation strategies, encapsulated cells remained viable and 
expressed stem cell markers within the hydrogels. The former hydrogel 
promoted corneal wound repair and reconstruction in an animal model with 
severe cornea damage, while the later was proposed for adipose TERM. The 
potential of the proposed strategies as in situ forming biomaterials has 
rendered these hydrogels very attractive for TERM applications as they can be 
implanted by injection, thus allowing minimal invasive procedures.  
In a different approach, the thermal behavior of polymers employed in cell 
encapsulation systems can be also applied as porogens to induce porosity in 
the hydrogel matrix. The principle of the process is the opposite on in situ 
gelation of hydrogels, i.e. the polymers employed are in gel state at low 
temperatures and become liquid when the temperature increases to a certain 
value, depending on the nature of the polymer used. Gelatin is a frequently 
employed polymer to fabricate those types of cell encapsulation systems. At 
4ºC gelatin forms a hydrogel matrix and at physiological temperature it 
becomes a liquid. Based on that, alginate hydrogels incorporating gelatin 
microbeads as porogens were proposed. The creation of pores inside the 
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alginate hydrogel matrix was mediated by the dissolution of gelatin 
microparticles after incubation at 37ºC. This thermo-responsive hydrogel 
architecture resulted in increased cell proliferation compared to alginate 
hydrogels without the gelatin microbeads [234]. In a similar approach, gelatin 
microbeads were used both as chondrocytes carriers and porogens in alginate 
hydrogels [235]. The gelatin microbeads were completely dissolved after two 
days of incubation at 37ºC. Subsequently, the encapsulated chondrocytes 
occupied the created empty spaces within the alginate matrix and formed 
viable aggregates. Other shapes of such sacrificial elements could be explored, 
including fibers or branched structures to allow culture medium or blood 
perfusion in the hydrogel. 
Temperature-responsive polymers can also be used to functionalize the 
hydrogel matrix and improve specific features important for the success of cell 
encapsulation strategies. For example, the triblock copolymer PEO-PPO-PEO, a 
class of synthetic materials with thermally responsive properties, was 
conjugated with transforming growth factor (TGF)-β1 to induce the 
chondrogenic differentiation of encapsulated ASCs [236] or with the arginine-
glycine-aspartic acid (RGD) peptide sequence, a ubiquitous cell-binding 
domain found in many ECM molecules, well-known to mediate and enhance 
cell attachment to the hydrogel matrix [237]. The incorporation of 
biomolecules within the matrix of hydrogels to modulate the behavior of the 
encapsulated cells, not necessarily composed by temperature-responsive 
polymers, will be detailed addressed in section 5.2 Incorporation of bioactive 
molecules. Another example of the contribution of a temperature-responsive 
polymer to enhance specific properties of the hydrogel matrix uses 
thermosensitive microparticles composed by poly(lactic-co-glycolic acid) 
(PLGA) and PEG within PEO-PPO-PEO hydrogels  [238]. When the temperature 
increased to physiological levels, the microparticles became cohesive and 
adhered to each other. Then, the hydrophilic environment provided by the 
temperature-responsive PEO–PPO–PEO hydrogel caused leaching of PEG 
microparticles. Consequently, with the release of PEG to the hydrogel matrix, 
its mechanical properties were significantly enhanced. No assay with 
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encapsulated cells was performed, but the authors suggest its applicability for 
growth factors incorporation and/or cell encapsulation due to the mild 
conditions of the process. Due to the observed high mechanical strength, 
future studies with this hydrogel should focus on its osteogenic potential for 
bone TERM. 
 
5.1.2 Light-activated cell encapsulation systems 
Similar to temperature-responsive strategies for in situ crosslinking, light-
responsive hydrogels are also of particular interest in biomedical applications 
requiring in situ non-toxic gelation, such as cell encapsulation strategies. The 
principle in light-responsive hydrogel crosslinking is based on the presence of 
free radicals that lead to the fast formation of covalent bonds between 
macromolecular precursor molecules, resulting in the formation of a polymer 
network with uniform and replicable physical properties [25, 239]. Long-wave 
UV light-activated polymerization is on of the most common methods of 
forming cell encapsulation strategies because of the advantages of temporal 
and spatial control of the reaction, low energy requirements, and clinically 
acceptable curing times [240]. Photopolymerization can thus be easily 
performed at physiological temperature and pH, while enabling the 
implantation of photopolymerized hydrogels encapsulating cells by minimally 
invasive procedures. The critical aspects to consider in photopolymerized 
hydrogel in cell encapsulation are the required non-toxicity of the photoinitiator 
(PI) and the irradiation with an appropriate wavelength and time. As the PI 
incorporated within the hydrogel matrix is irradiated with light, free radicals 
dissociate from the PI and attack with high efficiency vinyl groups on precursor 
macromolecules, creating covalent bonds that rapidly promote the crosslink 
within seconds to minutes of UV light exposure. However, photoinitiator 
solutions associated with free-radical generation can lead to cell toxicity [241]. 
Therefore, some critical shortcomings related with the use of PIs in cell 
encapsulation strategies, including its limited water solubility, sub-optimal 
crosslinking efficiency when applied with safe light spectra (i.e. ≥ 350 nm), and 
the toxic reaction conditions of the free radicals must be considered before 
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designing cell encapsulation strategies [242]. Consequently, among the many 
initiator systems available for photopolymerization, only a few have been 
identified as suitable for cell encapsulation systems. Studies providing a better 
understanding of the interplay between the radical crosslinking efficiency, 
hydrogel network formation, and cytotoxicity using photopolymerized 
hydrogels for cell encapsulating are thus of extreme importance. Hydrogels 
were photopolymerized from PEG-DA or PEG-fibrinogen precursors using 
different Irgacure PIs (I2959, I184 and I651), together with the chemical 
initiator/accelerator ammonium persulfate/tetramethylethylenediamine [239]. 
The study evaluated the influence of PI type, concentration and UV light 
intensity, and how these affected the mechanical properties of the hydrogel, 
the crosslinking reaction time and the viability of encapsulated cells. For this 
purpose, a biosynthetic hybrid hydrogel synthesized from functionalized PEG 
conjugated to fibrinogen and encapsulating bovine aortic smooth muscle cells 
(SMCs) was used. The photoinitiators I2959 and I184 were identified as 
suitable for achieving both cell viability and efficient crosslinking, contrary to 
the results obtained with I651. Optimization of PI concentration or irradiation 
intensity was particularly important for achieving maximum mechanical 
properties; a sub-optimal choice of PI concentration or irradiation intensity 
resulted in a substantial reduction in the elastic modulus. The viability of the 
encapsulated SMCs may be compromised by unnecessarily prolonging 
exposure to cytotoxic free radicals or inadvertently enhancing the 
instantaneous dose of radicals in solution, both of which are dependent on the 
PI type/concentration and irradiation intensity. In the absence of a radical 
initiator, the short exposures to long-wave UV light irradiation did not prove to 
be cytotoxic. 
I2959 photoinitiator was used to yield the crosslinking of DEX-MA hydrogels 
[149]. L929 cells were suspended in the DEX-MA solution and dispensed on 
the surface of the SH surfaces. Due to surface repellency, spherical drops were 
obtained, which were then crosslinked using UV-light. Subsequently, the 
microbeads were encapsulated in alginate hydrogels using again the SH 
surfaces. This type of photo-responsive strategy allowed creating a 
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multicompartmentalized cell encapsulation strategy. These types of cell 
encapsulation systems will be discussed in detail in section 5.3 
Multicompartmentalization. 
In a different perspective, photo-responsive cell encapsulation systems can be 
used to control specific properties of the hydrogel matrix, such as its 
degradation. This strategy emerges as an alternative to hydrolysis and 
enzymolysis, the two most commonly used mechanisms to control hydrogel 
degradation. Although both mechanisms are effective, the rate of degradation 
cannot be adjusted or arrested after the hydrogel is fabricated. Additionally, 
the degradation of hydrogels occurring by hydrolysis and enzymolysis cannot 
be spatially controlled. In contrast, photodegradation allows external real-time 
spatial and temporal control over hydrogel properties. This represents a great 
advantage for cell encapsulation strategies aiming tissue regeneration, 
because the properties of the encapsulation matrix can be tailored to match 
the time required for the natural regeneration process of the damaged tissue. 
For example, different macromers were synthesized incorporating 
photodegradable ortho-nitrobenzyl (o-NB) groups in the macromer backbone 
[243]. To show the applicability of the synthetized hydrogels to encapsulated 
cells, human mesenchymal stem cells were used. Results showed high viability 
rates. By exploiting the differences in reactivity of different o-NB linkers, the 
degradation rate of the hydrogels could be precisely controlled. 
Others have proposed controlling the material properties of hydrogels both 
dynamically and in a user defined fashion using cleavable chemistries whose 
degradation can be triggered exogenously. Toward this end, different groups 
have presented a class of photodegradable hydrogels whose physical and 
chemical properties can be modified by light post-fabrication with full spatial 
and temporal control [244-246]. Within the TERM field, those hydrogels are 
particularly interesting since they allow controlling the extracellular 
microenvironment in the presence of cells in 3D, while providing insights of the 
microenvironment in real time [247-250]. 
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5.1.3 Magnetic-responsive cell encapsulation systems 
While the majority of temperature- and light-responsive cell encapsulation 
systems emerged as in situ crosslinking strategies, magnetic-responsive cell 
encapsulation systems have emerged as a new strategy to manipulate and/or 
stimulate cell encapsulation systems. This strategy exploits interactions 
between encapsulation devices and magnetic fields that can be either static 
[251] or alternating fields established by a magnet [252] or electromagnet  
[253]. Magnetic assembly of cell encapsulating systems into 3D structures has 
been recently reported for TERM [214, 215, 253-255]. Specifically, magnetic 
nanoparticles (MNPs) have been loaded in cell-encapsulating microscale 
hydrogels (M-gels) to create composite smart materials responsive to magnetic 
fields. As an example, gelMA hydrogels were produced co-encapsulating 3T3 
cells and MNPs [214]. By spatially controlling the magnetic field, these 
composite hydrogel building blocks could be manipulated to construct 3D 
structures with variable geometries, as well as to control the composition of 
the hydrogel matrix by creating multilayers. MNPs have also been used to 
stimulate encapsulated stem cells into a specific differentiation lineage. This 
can be achieved by manipulation or mechanical activation of cellular pathways, 
such as the mechano-gated potassium channel TREK-1, and integrin signaling 
such as the RGD transmembrane protein, which have been showed to enhance 
the osteogenic and chondrogenic potential of magnetic labeled bone marrow 
MSCs encapsulated in alginate/chitosan spherical hydrogels [256]. Others, 
have showed to enhance the chondrogenic potential of ASCs encapsulated in κ-
carrageenan hydrogels containing within its matrix MNPs [257]. 
In order to physically isolate the co-encapsulated cells and MNPs, different 
multicompartmentalized strategies were proposed [86, 258], which will be 
further discussed in detail (section 5.3 Multicompartmentalization). A major 
concern of incorporating MNPs in the cell encapsulation matrix is their release 
as the hydrogel degrades, although it was demonstrated that the released 
MNPs from gelMA hydrogels had no adverse effect on the viability of NIH 3T3 
cells [259]. However, because of the risk of heavy metal poisoning from iron 
oxide, the use of such MNPs in clinical applications has to be proven. 
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Additionally, the distribution of MNPs in M-gels may differ due to aggregation 
of the MNPs in the pre-polymeric solutions, which may reduce the affinity of M-
gels to the magnetic field (MF) [260, 261]. Another potential drawback with 
this method is that a certain amount of heat generated by MNPs exposure to 
an alternating current-based MF (magnetic hyperthermia) may compromise the 
viability of the encapsulated cells [254]. 
Alternatives without integrating hydrogels with other magnetic components, 
such as MNPs, were successfully proposed using their paramagnetic free 
radicals when placed in a magnetic field [214, 262, 263]. Radicals can be 
utilized to change the magnetic susceptibility of liquids on each the levitation 
of structures is performed (suspension liquids) or they can be directly 
incorporated in the encapsulation matrix for guided levitational self-assembly 
[263]. Magnetization of the TE systems via free radicals is a versatile and 
robust strategy, and cell encapsulation can be performed before radical 
exposure for magnetization. 
The magnetic manipulation of fibers was also reported to control and align 
fibers into specific patterns [264, 265]. This hierarchical organization allows 
the hydrogel matrix to take a variety of forms in different tissues and at 
different stages of development in the same tissue. Moreover, the biological 
assemblies, disassembly and re-assembly are dynamic during the transition to 
accomplish local and global conformational changes. Additionally, with this 
strategy it is possible to guide the cell growth at specific directions by 
regulating the magnetic fibers. 
 
5.2 Incorporation of bioactive molecules  
Interactions of cells and ECM initiate signaling cascades involved in critical cell 
functions, such as regeneration [266-268]. An important goal of cell 
encapsulation systems aiming tissue regeneration is to mimic critical aspects 
of the extracellular environment in order to ensure the viability of the 
encapsulated cells while controlling different cellular functions through cell-
material interactions. This prompted the encapsulation of cells with 
biomolecules, which encompass nowadays a major area of investigation in 
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TERM and regenerative medicine field. Challenges of this strategy include all 
the critical properties above discussed to fabricate cell encapsulation systems  
(section 2.1 Critical properties) with the addition of critical properties to develop 
systems incorporating biomolecules, such as the bioactivity preservation and a 
sustained release. Additionally, when designing these types of combined 
systems, the incorporation of biomolecules at the right concentration in the 
right context and, when aimed, release with the right profile must be carefully 
pondered. The incorporation of different biomolecules can be directly within 
the biomaterials employed or indirectly by first encapsulating the biomolecule 
in micro- or nano-sized spheres (particles or beads) or fibers, which are then 
embedded in the system. 
Encapsulation of biomolecules directly in the core of the cell encapsulation 
system is easily achieved during gelation and provides a simple way to entrap 
molecules of interest. For example, TGF-β1 was co-encapsulated with Sca-
1+/CD45- cardiac progenitor cells (CPCs) in high molecular weight heparin-
containing hyaluronic acid-based hydrogels [269]. Results showed that TGF-β1 
was able to induce the differentiation of CPCs into endothelial cells, which 
formed vascular-like networks within the hydrogel. Due to the electrostatic 
association between heparin and TGF-β1, which was enhanced due to the high 
molecular weight of heparin, a portion of the initially encapsulated growth 
factor remains immobile. Therefore, TGF-β1 could be provided to the 
encapsulated cells since it did not diffuse out from the hydrogel. In fact, the 
rapid loss of the entrapped biomolecule from the system is a major concern 
when direct encapsulation methodology is employed. Consequently, this 
method is more appropriate for molecules in a limited molecular weight range 
(i.e., similar to the network mesh size), and those that are relatively stable and 
have a long half-life. Therefore, indirect entrapment of biomolecules is more 
often used in TERM strategies. For example, TGF-β3 was encapsulated in 
gelatin beads, which were subsequently incorporated in a collagen-low 
molecular weight hyaluronic acid semi-interpenetrating network encapsulating 
MSCs. This injectable system supported in vitro and in vivo the growth of nasal 
chondrocytes and chondrogenic differentiation and MSCs, and was proposed 
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for nucleus pulposus regeneration [270]. In a similar strategy, but using fibers 
as drug carriers, electrospun polycaprolactone (PCL) nanofibers were used as 
drug carriers of bovine serum albumin [271]. The nanofibers were then 
embedded in PEG hydrogel encapsulating fibroblasts. In the case of indirect 
methods, a complex coacervation methodology was recently proposed in order 
to eliminate the step of encapsulating the biomolecule within drug carriers 
previous to its addition to the cell encapsulating system [272]. Complex 
coacervation is defined as liquid-liquid phase separation in an aqueous 
solution by spontaneous aggregation associated with electrostatic matching 
between two oppositely charged polyelectrolytes [273]. Based on that, 
coacervate-laden photo-crosslinked hydrogels were produced from the simple 
mixing of oxidized methacrylated alginate (OMA) and gelMA in aqueous 
solution. Bone morphogenic protein (BMP)-2 was incorporated in the gelMA 
solution, which mainly comprised the resulting coacervate microdroplets, and 
MSCs in OMA. Within the resultant compartments, MSCs differentiated into the 
osteogenic lineage due to the internal sustained release of BMP-2. Combined 
direct and indirect encapsulation of biomolecules was achieved by embedding 
PLGA microparticles within the matrix of alginate hydrogels through a coaxial 
electro-dropping method [179]. Two different osteogenic biomolecules, namely 
BMP-2 and dexamethasone (Dex), were co-encapsulated with bone marrow 
MSCs. Consequently, two different co-encapsulation systems were produced by 
switching the position of BMP-2 and Dex, either in the PLGA microparticles or 
in the alginate matrix. Based on the localization of BMP-2 and Dex, their 
release profiles were very unique on a temporal basis. An initial burst of 
biomolecules was highly suppressed when either biomolecule was loaded in 
the PLGA core. Therefore, the release profiles of each biomolecule could be 
easily manipulated alternately positioning biomolecules in the embedded 
microparticles or in the hydrogel matrix domain. Alternatively to large 
biomolecules and growth factors encapsulation, biochemical signals can also 
be integrated by incorporating smaller molecules, such as peptides, in cell 
encapsulation systems, targeting a desired cellular response. MSCs were 
induced to differentiate towards osteogenic or adipogenic pathways by 
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introducing in PEG hydrogels tethered small-molecule chemical functional 
groups, namely 2-aminoethyl methacrylate, t-butyl methacrylate, ethylene 
glycol methacrylate phosphate, 2,2,3,3-tetrafluoropropyl methacrylate and 
methacrylic acid [274]. In response to the small-molecule incorporated, 
encapsulated MSCs changed its morphology and differentiated in the absence 
of soluble signals, thus highlighting the crucial role that cell-material 
interactions have in cell fate. 
Another study developed an agarose hydrogel with a concentration gradient of 
immobilized vascular endothelial growth factor (VEGF)-165 [275]. By 
mimicking the cues that guide endothelial cells (ECs) during vascular 
development, ECs were shown to follow the concentration gradient of VEGF-
165 in the 3D hydrogel, with the identification of tip and stalk cells and the 
formation of tubular-like structures. Furthermore, the stem cell differentiation 
could be controlled in the developed 3D hydrogels by taking advantage of 
orthogonal physical binding pairs, such as barnase, an extracellular RNase of 
Bacillus amyloliquefaciens, with its intracellular inhibitor barstar, and 
streptavidin-biotin [276]. This allowed the simultaneous immobilization of 
multiple growth factors. 
In a different perspective, the encapsulated cells can also release different 
biotherapeutics itself, which in fact constitute the first impetus when cell 
encapsulation systems were proposed. However, in the present review, the 
biotherapeutics release ability of encapsulated cells will not be addressed (for 
that subject we advise the reading of [277]), as here we intend to review the 
multifunctionality of cell encapsulation systems on a material engineering 
basis. 
 
5.3 Multicompartmentalization 
Inspired by the natural multicompartmentalized complex system of cells, in 
which a wide range of isolated components with specific functions are grouped 
together in a single compartment, different miniaturized compartmental 
engineered systems have been proposed in fields such as catalysis, sensors, 
drug delivery, microreators, and theoretical models of cellular events and 
Chapter I 
Design principles and technologies in cell encapsulation systems towards tissue regeneration 
 
	 	 	64 
diseases [158, 168, 278-280]. The idea is “to borrow Nature’s design strategies 
to achieve novel functional materials, with highly useful properties exceeding by far 
those available by current methods” [281], but “not to copy Biology: learning in 
modesty from her principles and to transfer it to materials space and conditions 
previously not accessible to biology” [282]. Inspired by that, and particularly for 
cell encapsulation systems, the idea is not to mimic intracellular reactions, but 
rather construct a customizable system by assembling subcompartments to 
ultimately giving raise to a complex system with improved cell viability and 
functionality. Different groups have recently begun to explore the field and its 
application in TERM. For example, Janus particles, i.e. anisotropic particles 
that contain distinct compositions in each hemisphere, were proposed to 
physically isolate encapsulated cells from MNPs [258]. Alginate Janus 
particles, produced in a microfluidic chip, were composed by one magnetic 
hemisphere with MNPs, and one hemisphere with HeLa cells. The strategy was 
proposed as an alternative to magnetic labeling of cells via uptake of surface 
functionalized magnetic beads, which can lead to undesirable effects on cells 
[283]. Also aiming to physically isolate cells from MNPs, a capsule-in-capsule 
system was proposed for the treatment of diabetes [86]. The idea was to 
confer to the cell encapsulation system the ability to be detectable by clinically 
applicable non-invasive imaging modalities, such as magnetic resonance, 
computed tomography, and ultrasound imaging, in order to monitor over time 
and assess the efficacy of islets transplantation and engraftment. However, a 
high concentration of iron and gold nanoparticles is required to achieve a 
sufficient amount of contrast signal to be detectable by the referred methods, 
which could be harmful to the encapsulated cells. Therefore, nanoparticles 
were encapsulated in a primary inner capsule of alginate, and then added to a 
secondary outer capsule containing the therapeutic isles cells. Also using 
MNPs, three-layer spheroids composed by magnetic gelMA M-gels 
encapsulating NIH 3T3 cells were fabricated onto the tip of a magnetic rod 
[214]. Three fluorochromes, namely rhodamine-B (red) in the first layer, FITC-
dextran (green) in the second layer, and 1,1,4,4-tetraphenyl-1,3-butadiene 
(blue) in the third layer, were used as a proof-of-concept to show that three 
Chapter I 
Design principles and technologies in cell encapsulation systems towards tissue regeneration 	
	 65 
different compartments could be easily created (in seconds) by magnetic 
manipulation. Each layer was stabilized via a second crosslinking procedure 
using filling layers of PEG. A filling layer between multiple M-gels permitted to 
increase cell-cell distances and thus isolate the different layer compartments. 
A similar multicompartmentalized cell encapsulation strategy resembling 
“onion-like” structure using alginate and L929 cells was achieved without 
magnetic manipulation but using the unique repellency properties of SH 
surfaces [148]. A remarkable advantage of this technique, especially when 
combining cell encapsulation with drug loading, is that high encapsulation 
efficiencies (of ca. 100%) of non-volatile molecules can be achieved under mild 
conditions. This is possible because each compartmentalized layer solidifies in 
air rather than in contact with a liquid solvent. Hence, one avoids the 
possibility of molecules migration, and thus any loss during the preparation of 
the particles. Others explored different spatial organization of 
compartmentalized layers inside a single cell encapsulation system by 
microfluidic electrostatic spraying technique [284]. For that, cell encapsulation 
systems were produced using double layer, side-by-side or triple-layer 
conformities. In each compartment, different cells were encapsulated, each 
one fluorescently stained with different dyes. The system was tested for 
different potential applications, such as size-controlled tumor micro tissues 
and its implications in cancer diagnostics, and a scalable platform for 3D co-
culture. Similarly to multilayered spherical systems, also multilayered fiber-
shaped systems have been reported for cell encapsulation [127, 204]. 
Recently, core-shell hydrogel fibers were successfully generated using the dual 
concentric nozzle by the simultaneous injection of collagen and alginate 
solutions in the core and shell, respectively [204]. By encapsulating MCs, 
osteoblasts, and bioactive glass nanoparticles (BGn) were also incorporated 
within the multilayered fibers. By varying the position and presence of the 
encapsulated cells and BGn within the fibers compartments, different 
formulations could be obtained. In a higher scale level, such fibers could be 
organized into more complex 3D shapes using established rapid prototyping 
methods. 
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In a different perspective, compartmentalization was used to avoid protrusion 
of the encapsulated cells [183]. In the proposed system, alginate with different 
mechanical stabilities was used to facilitate growth of the cells in the core of 
the capsules, but to kill cells that might escape from the capsule and invade 
the host. For that, 3.4% intermediate-G alginate was employed to fabricate the 
core encapsulating cells, while 2% high-G alginate was employed in the outer 
layer, since it was showed to jeopardize cell survival. 
It is expected that advances in bottom-up and top-down technologies will 
originate the development of new hierarchical and complex structures with 
sophisticated geometries [285], as well as production on a massive scale and a 
wider clinical application of those systems.  
 
6. Conclusion 
Since the early pioneering period, the technology of mammalian cell 
encapsulation has developed significantly in such a way that nowadays cell 
encapsulation is an evolving branch of TERM. The application of cell 
encapsulation principles in the TERM field brought new possibilities for the 
development of highly complex cell culture systems. The use of such systems 
for tissue regeneration holds tremendous promise, also because this 
technology attempts to keep pace with recent molecular biology 
breakthroughs. This allows increasing the complexity of the systems by 
recreating adequate environmental signals found in native tissue (in particular 
during the regenerative process) to control the cellular outcome, and 
conferring multifunctional properties, namely the incorporation of bioactive 
molecules and the ability to create smart and adaptive systems in response to 
different stimuli. In parallel, advances in the production methods and 
characterization techniques have contributed for the improved performance of 
these systems. Yet many difficulties remain, some of which will certainly 
challenge our scientific creativity. The stepwise analysis of the essential 
obstacles, coupled with increased international collaboration, should move the 
technology forward in a careful and controlled way, and bring it much closer to 
clinical reality [114]. This ambitious goal requires the interdisciplinary and 
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integrated effort of scientists with different areas of expertise such as genetics, 
materials science, physicochemistry and chemical engineering, pharmaceutical 
technology, cell biology and medicine [178]. Issues on long term viability, risk 
of immune response, together with the development of high biocompatible 
materials, with sufficient durability and appropriate permeability, should be 
addressed to further explore their possible clinical applications.  
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Abstract 
In this chapter are described the different materials and methodologies to 
produce liquified and multilayered capsules. Capsules are composed by an 
external multilayered membrane produced by the layer-by-layer adsorption of 
poly(L-lysine), alginate, and chitosan. Additionally, magnetic-nanoparticles 
were electrostatically bounded to the multilayered shell, conferring magnetic-
responsive ability. Within the liquified core different types of cells were 
encapsulated, namely (i) L929 cells, (ii) stem cells, and (iii) endothelial cells, 
as well as different surface modified poly(L-lactic acid) microparticles, namely 
microparticles coated with (i) collagen I and (ii) collagen II combined with TGF-
β3. The different capsules were tested in vitro and in vivo as bioencapsulation 
devices for tissue regeneration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 Partially based on the publication: C.R. Correia, R.L. Reis, J.F. Mano, Nanostructured 
capsules for cartilage tissue engineering, in: P.M. Doran (Ed.), Cartilage Tissue Engineering – 
Methods and Protocols, Springer, New York, 2015, pp. 181-189.  
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1. Introduction 
Since the pioneering study of Decher [1], the layer-by-layer technique (LbL) has 
been used in a wide range of biomedical applications, including the production 
of polymeric multilayered capsules (PMCs). Particularly, PMCs have found 
great applicability in bioencapsulation systems for tissue engineering and 
regenerative medicine purposes [2-8]. The production of PMCs is based on the 
LbL setwise adsorption of polyelectrolytes with oppositely charged 
macromolecules. Polyelectrolytes are assembly on the surface of spherical 
particles used as sacrificial templates, and, ultimately, the core is dissolved or 
eliminated, originating PMCs [9-13]. Due to the high versatility of the LbL 
technique, different properties of the capsules can be easily tailored; for 
example, the permeability of the shell can be controlled by varying the number 
of layers deposited and the surface of the capsules can be customized by 
endowing nanoparticles, lipids, viruses, among others [14]. While the liquified 
core ensures the viability of the encapsulated cells by allowing a rapid diffusion 
of nutrients, oxygen, waste products, and metabolites, the LbL membrane 
provides an immune privilege environment by blocking the entrance of high 
molecular weight immune system compounds, such as immunoglobulins and 
immune cells [15]. 
The main drawback of capsules in cell encapsulation approaches is related 
with the fact that most cells are anchorage dependent and, thus, deprived of a 
physical support cells are not able to adhere and proliferate [16]. Therefore, 
the liquefaction of the core to achieve an excellent diffusion of essential 
molecules will, on the other hand, compromise the biological outcome of the 
encapsulated cells. To ensure an efficient diffusion provided by the liquified 
environment of PMCs, and simultaneously provide cell adhesion sites to the 
encapsulated cells, we propose liquified and multilayered capsules 
encapsulating microparticles as cell supports. 
The aim of this chapter is to present in a more comprehensive manner the 
details concerning both the materials and techniques to produce multilayered 
and liquified capsules encapsulating surface modified microparticles and 
different types of cells. The in vitro and in vivo procedures used to characterize 
 Chapter II 
Materials and methods 
 
	102 
the developed system are also described. Moreover, the specific processing 
techniques, namely (i) the layer-by-layer technique to produce the multilayered 
membrane, (ii) the plasma treatment for the surface modification of 
microparticles, and (iii) the isolation of cells from adipose tissue are here 
described. The detailed specifications of the different materials and equipment 
suppliers can be found in the experimental subsection of each chapter of Part 
3. 
 
2. Materials 
 
2.1 Membrane materials 
 
2.1.1 Alginate 
Alginate is a naturally occurring anionic polymer typically extracted from brown 
algae, such as Laminaria hyperborea and lessonia, by treatment with aqueous 
alkali solutions. Briefly, after filtration, sodium or calcium chloride is added 
and an alginate salt is obtained. This alginate salt can be transformed into 
alginic acid by treatment with diluted hydrochloric acid. Ultimately, upon 
purification and conversion, a water-soluble sodium alginate powder is 
obtained [17]. Structurally, alginate embraces a whole family of linear 
unbranched copolymers composed by homopolymeric blocks of consecutive or 
alternating (1,4)-linked-β-D-mannuronate (M) and α-L-guluronate (G) residues. 
D-Mannuronic acid is 4C1 with diequatorial links, while L-guluronic acid is 1C4 
with diaxial links. The blocks are similar (MMMMM or GGGGGG) or strictly 
alternating (GMGMGM), and the relative amount is dependent on the origin of 
the alginate [18]. Due to its biocompatibility, low toxicity, low cost, and mild 
gelation conditions, alginate has been extensively used to produce hydrogels 
for biomedical applications. Disadvantages of this material include that it is 
not naturally broken down enzymatically in mammals and hence has poorly 
regulated degradation in vivo. In addition, cells do not naturally adhere to 
alginate. Over the past decade there has been significant research to overcome 
these drawbacks and to broaden the utility of alginate hydrogels. 
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The most common method to produce alginate hydrogels is to crosslink with 
divalent cations, usually calcium chloride. The divalent cations bind exclusively 
to the G blocks of the adjacent alginate chains through interactions with the 
carboxylic groups, since the structure of the L-guluronate offers a greater 
flexibility than the D-mannuronate chains. By creating ionic inter-chain bridges, 
divalent ions replace the hydrogen bonds between the carboxyl group of D-
mannuronate (pKa 3.38) and the 2-OH and 3-OH groups of the subsequent L-
guluronate (pKa 3.65), originating the gelation of aqueous alginate solutions by 
the egg-box conformation [19]. 
 
2.1.2 Chitosan 
Chitosan is a cationic polymer resulting from the deacetylation of chitin under 
alkaline conditions or by enzymatic hydrolysis in the presence of a chitin 
deacetylase [20]. Due to the semi-crystalline morphology of chitin, when 
chitosan is obtained from a solid-state reaction, it has a heterogeneous 
distribution of acetyl groups along the chains. Depending on the origin of the 
polymer and on the distribution of acetyl groups, when the degree of 
deacetylation (DD) of chitin is c.a. 50%, it becomes soluble in aqueous acidic 
solutions and is called chitosan [21]. The solubilization occurs by protonation 
of the –NH2 function on the C2 position of the D-glucosamine repeat unit [20]. 
Therefore, the polysaccharide is converted to a polyelectrolyte in acidic 
solutions, which favors its solubility due to electrostatic repulsions. Owing to 
its well-established biocompatibility and a number of other appealing 
properties, chitosan has been widely used in biomedical applications to 
produce different biomaterials, such as hydrogels [22], films [23], fibers [24] 
or, sponges [25]. 
The solubility of chitosan is influenced by different parameters, namely the DD, 
ionic concentration, pH, nature of the acid used for protonation, and the 
distribution of the acetyl groups along the polymer chain [20, 21]. The 
isolation of chlorohydrate or acetate salt forms in chitosan results in direct 
water solubility, giving an acidic solution with pKa of c.a. 6.5 [26, 27]. Along 
the different chitosan derivatives described in literature [20] it is important to 
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highlight the specific reactions involving the –NH2 group at the C2 position or 
non-specific reactions of –OH groups at the C3 and C6 positions, especially 
esterification and etherification [28]. The –NH2 in the C2 positions is the main 
key difference between chitosan and cellulose, where three –OH groups of 
nearly equal reactivity are available. The main reactions easily performed 
involving the C2 position are the quaternization of the amino group or the 
reductive amination between an aldehydic function with –NH2. Particularly, the 
reductive amination has the advantage of being performed in aqueous 
solutions at mild conditions. Therefore, this method has been proposed to 
produce a wide range of chitosan derivatives by the introduction of different 
functional groups. In order to obtain more regular and reproducible chitosan 
derivatives, especially when biological applications are aimed, the modification 
reactions should be performed in highly deacetylated chitin, assuring quality 
control of the initial material that originates chitosan. Many companies, such 
as NovaMatrix with Protasan UP CL 213 used in our experiments, 
commercialize purified water-soluble chitosan with ultra low levels of 
endotoxins and proteins and with a DD between 75% to more than 90%. Those 
purified chitosans has been used in wide range of biomedical applications, 
including tissue repair, wound healing, local delivery of cells, drugs, proteins, 
genes and other therapeutics, orthopedics, rheumatology, and reconstructive 
surgery [21]. 
 
2.1.3 Poly(L-lysine) 
Poly(L-lysine) (PLL) is the most widely used polycation to coat alginate 
hydrogels for cell encapsulation. In fact, it has been reported that more then 
85% of the articles about cell encapsulation technology published since the 
original manuscript of Lim and Sun [29] have involved modifications of the 
alginate-PLL system [30]. Since charged PLL is known to be immunogenic 
[31], the PLL-alginate hydrogels usually undergo a final incubation with 
alginate, known as APA capsules. However, several studies have reported that 
APA capsules are not fully biocompatible since induced the production of 
cytokines involved in the systemic inflammation, such as tumor necrosis factor 
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(TNF)-α and interleukin (IL)-1 [32-34], suggesting that the external alginate 
coating is not effectively masking and/or neutralizing the immunogenic PLL. 
Consequently, different attempts have been made to improve knowledge about 
all the variables that might affect the biocompatibility of the encapsulation 
devices. Efforts should be focused on either properly balancing any net positive 
charge that is created at the capsule surface due to excessive exposure of NH3+ 
residues, or finding a way to physically mask all the PLL [35]. Therefore, in the 
present thesis, to produce the multilayered membrane of liquified capsules, 
PLL was combined with alginate and chitosan by layer-by-layer technique. The 
objective was to take advantage of the high biocompatibility of the two natural 
polymers alginate and chitosan, while PLL was expected to enhance the 
mechanical stability of the system. This assembly of three-component 
polyelectrolytes via alternate deposition has fuelled much interest due to its 
demonstrated superior tunability and versatility to the traditional two-
component method [36, 37]. 
 
2.1.4 Magnetic-nanoparticles 
As a proof-of-concept, magnetic-nanoparticles (MNPs) of iron oxide (Fe3O4) were 
electrostatically bond to the multilayered membrane to confer magnetic-
response ability to the capsules. Fe3O4 nanoparticles have received enormous 
interests and attracted the most attention due to its unique magnetic 
properties and biocompatibility. Therefore, capsules and MNPs have been 
combined in several biomedical applications, including targeted drug delivery, 
tissue engineering, magnetic thermotherapy (hyperthermia), magnetic 
resonance imaging, among others [38-40]. By employing magnetic 
manipulation we envisage that magnetic-responsive capsules can aggregate 
and form moldable and complex macrostructures, in which each liquified 
capsules could work as compartmentalized building blocks. Capsules can be 
fixated in situ, and their motion can be controlled and guided into a specific 
spot. These features might be useful for the handling of the capsules during in 
vitro studies but also to guide and fixate the injectable capsules into a lesion 
site during implantation procedures. Besides movement control, the high 
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surface area to volume ratio of MNPs provides abundant chemically active 
sites for functionalization and biomolecule conjugation, which may allow the 
implementation of other features to increase the complexity of the capsules. 
 
2.2 Encapsulated core materials 
 
2.2.1 Microparticles bulk and coating materials 
In order to provide cell adhesion sites to the encapsulated cells within the 
liquified core of capsules, poly(L-lactic acid) (PLLA) was used as a bulk 
material to produce microparticles. PLLA is a biodegradable thermoplastic 
aliphatic polyester derived from the polymerization of L-lactide in lactic acid 
[41]. Polyesters have been well documented for their excellent 
biodegradability, biocompatibility, nontoxicity and their biocompatible 
degradation products. Therefore, PLLA has gained the approval of US Food 
and Drug Administration (FDA) [42]. However, poor hydrophilicity and the lack 
of natural recognition sites on polyester surfaces for covalent cell-recognition 
signal molecules to promote cell attachment have limited the utility of PLLA as 
tissue engineering biomaterials [43, 44]. Different techniques to modify the 
surface of those biomaterials have been proposed to enhance cell-material 
interaction. In the present thesis, the modification of PLLA surface was 
achieved by combining plasma treatment with different types of collagen, 
namely (i) collagen type I as a control material to allow the adhesion of L929 
cells to PLLA microparticles (Chapters III and IV) as a proof-of-concept of the 
multilayered and liquified capsules as bioencapsulation systems for tissue 
regeneration, or to apply the developed multilayered and liquified capsules 
encapsulating adipose-derived stem cells (ASCs) and endothelial cells towards 
bone regeneration (Chapters VI and VII); and (ii) collagen type II (Chapter V) to 
apply the developed multilayered and liquified capsules encapsulating ASCs 
towards cartilage regeneration. Collagen type I is the most abundant type of 
collagen in bone, providing to the tissue the ductility and ability to absorb 
energy (toughness) [45]. Collagen II is the major component of the collagen 
fibrillar network, being also essential for the mechanical stability and the 
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proper function of the tissue [46]. Additionally, TGF-β3 was also immobilized 
at the surface of collagen II coated PLLA microparticles (Chapter V). TGF-β3 
was selected since it has the highest and rapid chondrogenic potential among 
the different isoforms [47-49]. The immobilization of TGF-β3 was performed by 
the enzyme transglutaminase-2 (TG2). TG2 is a ubiquitously expressed 
member of an enzyme family catalyzing Ca2+ dependent transamidation of 
proteins via ε(γ-glutamyl)lysine bonds, being its ability to crosslink proteins, 
including collagen II, well described in the literature [50-52]. 
 
2.2.2 Encapsulated cells 
To test the ability of the multilayered and liquified capsules as 
bioencapsulation systems, different cells were encapsulated within the liquified 
core, namely (i) L929 cells (Chapters III and IV), (ii) human ASCs (Chapter V) 
and (iii) ASCs co-cultured with human adipose-derived microvascular 
endothelial cells (ECs, Chapters VI and VII). 
L929 is an immortalized cell line able to proliferate indefinitely, being thus very 
useful to study different cell-materials interactions in vitro. Such cell source 
offers the advantage of being more homogeneous and standardized than 
primary cultures. Therefore, L929 cells were encapsulated within the capsules 
to prove the concept in Chapter III and IV. 
Directing the application of the capsules towards specific tissue regeneration 
fields, namely of bone and cartilage, stem and endothelial cells were used as 
the biological encapsulating material, namely (i) ASCs (Chapters V, VI and VII) 
and (ii) ECs (Chapters VI and VII). Due to a number of appealing features such 
as multipotent character [53], being available in large quantities, and easy 
accessibility, both cell types were isolated from human adipose-tissue. 
 
3. Specific techniques 
 
3.1 Production of micro and nanoparticles 
PLLA microparticles were produced by oil/water emulsion technique. For that, 
5% w/v of PLLA was dissolved in methylene chloride (CH2Cl2). Under agitation, 
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this solution was added to 0.5% w/v polyvinyl alcohol. After 2 days at room 
temperature (RT) to evaporate the organic solvent, the produced 
microparticles were subsequently collected, washed with distilled water, and 
lyophilized for 3 days. 
Iron oxide (Fe3O4) nanoparticles were synthesized by the co-precipitation 
reaction of ferrous (FeCl2.4H2O) and ferric (FeCl3.6H2O) salts in the presence of 
ammonium hydroxide (NH4OH) under a nitrogen atmosphere at 60ºC. The 
obtained MNPs were washed with deionized water and ethanol for several 
times, and ultimately dried in a vacuum oven. 
 
3.2 Layer-by-layer technique to produce the multilayered membrane 
Layer-by-layer (LbL) is one of the most prominent surface engineering 
strategies in biomaterials science, capable of providing a reliable, easy, 
versatile, environment friendly, and cost-effective way of tuning interfaces [8]. 
The principle of the technique is based on the sequential adsorption of a wide 
range of polyelectrolytes, which are selected and combined in function of their 
multipoint interactions [8, 54]. LbL methodology has been widely applied to 
produce PMCs, in which capsules are fabricated through LbL sequential 
deposition of polymers onto a sacrificial core template followed by the 
decomposition of this core yielding hollow capsules [55, 56]. The obtained 
nanometer thin membrane is permselective allowing diffusion of water and 
ions but excluding larger molecules. 
Using the LbL principle, different polyelectrolytes at 0.5 mg.mL-1 and 
previously sterilized by filtration were used to coat the surface of alginate 
hydrogels. For that, alginate hydrogel particles were first immersed in chitosan 
(Chapter III) or in PLL (Chapters IV, V, VI, and VII) solutions, and subsequently 
in alginate solution. The polyelectrolyte solutions were dissolved in 0.15 M 
sodium chloride (NaCl) containing 25 mM MES hydrate buffer. Following a 10 
min period for each polymer adsorption, the excess of macromolecules was 
removed by immersion in NaCl for 5 min. This process was repeated until the 
desired number of layers is achieved. Additionally, to confer magnetic-
response properties to capsules, in the last adsorption of chitosan solution 1 
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mg.mL-1 of magnetic-nanoparticles (MNPs) (Chapter V) were added. MNPs 
could be incorporated within the multilayered membrane due to the 
electrostatic attraction between the negatively charged MNPs and the 
positively charged chitosan polyelectrolyte solution. 
 
3.3 Plasma treatment combined with collagen coating 
Plasma treatment is an effective and widely used method for modifying the 
surface of biomaterials to improve cell-material interaction. The principle is 
based on the presence free electrons in the air, which are accelerated by a high 
voltage discharge and ionize the gas. As a result, chemical and physical 
modifications occur on the treated surfaces, creating reactive sites such as 
amine group and carboxyl [41].  
In the present thesis, plasma treatment was used to modify the surface of 
PLLA microparticles. Microparticles were placed in a plasma reactor chamber 
fitted with a radio frequency generator. Air was used as the working 
atmosphere. A glow discharge plasma of 0.2 mbar at 30 V was created for 15 
min. Subsequently, 500 mg of microparticles were sterilized by 30 min of UV 
radiation and immediately immersed in 1200 μg of collagen I 4 h at RT 
(Chapters III, IV, VI and VII) or 1700 μg collagen II overnight at 37ºC (Chapter 
V). Additionally, after washing with phosphate-buffered saline (PBS), collagen 
II-microparticles were then immersed in a solution containing TGF-β3 (10 ng 
per 50 mg of microparticles) and TGs (0.01 U per 50 mg of microparticles) 
overnight at 4ºC (Chapter V). 
 
3.4 Isolation of stem and endothelial cells from human adipose tissue 
Subcutaneous adipose tissue from liposuction procedures was used to isolate 
both ASCs [39] and ECs [57]. The collected tissues were obtained under a 
cooperation agreement between the 3B’s Research Group and Hospital da 
Prelada (Porto, Portugal), after approval of the Competent Ethics Committee 
(CEC). The human tissues received were handled in accordance with the 
guidelines approved by the CEC. Informed consent was obtained from all 
subjects. Tissue samples were transported in PBS supplemented with 
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penicillin-streptomycin (10%, pen-strep) and kept at 4°C. The lipoaspirates 
were washed with PBS and incubated with collagenase type II A (0.05% w/v) 
for 45 min at 37°C in a shaking water bath. The digested samples were filtered 
(200 μm) and centrifuged at 800 g for 10 min at 4 °C. The obtained stromal 
vascular fraction (SVF) was resuspended in erythrocyte lysis buffer at pH 7.4 
containing ammonium chloride (155 mM), potassium bicarbonate (5.7 mM), 
and ethylenediaminetetraaceticacid (0.1 M, EDTA) in distilled water. After 10 
min of incubation at RT, the mixture was centrifuged at 300 g for 5 min. 
To isolate the ASCs the red blood cell-free SVF was resuspended in α-MEM 
medium supplemented with fetal bovine serum (10%, FBS) and pen-strep (1% 
v/v). To isolate the ECs the red blood cell-free SFV was resuspended in 
EndoGroTM-MV-VEGF complete media kit. The ECs were plated in cell culture 
flasks, previously coated with gelatin (0.7% w/v, porcine skin type A) for 30 
min at 37°C. Culture medium was changed 48 h after initial plating and then 
every 3-4 days for both cell phenotypes. 
 
3.5 Bioencapsulation set-up 
At 90% confluence, cells grown in tissue culture flasks were washed with PBS 
and subsequently detached using TrypLETM Express solution at 37°C for 5 min. 
PBS was added and the cell suspensions were centrifuged for 5 min at 300 g. 
Low viscosity sodium alginate from brown algae (1.5% w/v) was dissolved in 
0.15 M NaCl containing  25 mM MES hydrate at pH 7. The solution was 
sterilized by 0.22 μm filtration. Different cells were then ancapsulated, namely 
(i) 1x106 L929 cells (Chapters III and IV), (ii) 5x106 ASCs alone (Chapters V, VI 
and VII) or mixed with 5x106 ECs (Chapters VI and VII) were added to the 
different microparticles (50 mg.mL−1 of alginate). The alginate solutions were 
then used to produce liquified and multilayered capsules. 
The alginate solutions containing cells and microparticles were added drop 
wise using 18 G (Chapters III and IV) or 21 G needles (Chapters V, VI and VII) 
to 0.1 M calcium chloride (CaCl2) buffered with 25 mM MES hydrate at pH 7. 
After 20 min at RT, alginate hydrogels were collected and rinsed in a washing 
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solution of 0.15 M NaCl. The external membrane was processed by subsequent 
adsorption of oppositely charged polyelectrolytes by layer-by-layer deposition 
as referred at 3.1 Layer-by-layer technique to produce the multilayered membrane. 
The coated hydrogels were ultimately immersed in 20 mM EDTA at pH 7 for 5 
min to liquefy the alginate core. The scheme for the production of liquified and 
multilayered capsules encapsulating surface modified microparticles and cells 
is shown in Figure II.1. 
 
Figure II.1 - Schematic representation of the production steps of liquefied and multilayered capsules encapsulating 
surface-modified microparticles and cells. 
 
The different capsules were ultimately cultured in different cell culture media 
according to the type of cells encapsulated and the application propose of the 
developed bioencapsulation system. Therefore, capsules encapsulating (i) 
L929 cells were cultured in low glucose DMEM supplemented with 3.7 g·L−1 
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sodium bicarbonate, 10% FBS, and 1% pen-strep at pH 7.4 (Chapters III and 
IV); (ii) ASCs for cartilage regeneration (Chapter V) in DMEM High glucose, FBS 
(10% v/v) and pen/step (1:100) with or without supplementation with ITS + 
premix (1:100), MEM sodium pyruvate (1:100), proline (0.4x10−4 M), 
dexamethasone (100x10−9 M) and TGF-β3 (10 ng.mL−1); (iii) ASCs co-cultured 
with ECs for bone regeneration (Chapters VI and VII)  in EndoGroTM-MV-VEGF 
complete kit media without ascorbic acid. To this endothelial medium, β-
glycerophosphate (10 mM) was added. Additionally, capsules were also 
cultured in endothelia medium supplemented with osteogenic differentiation 
factors, namely, dexamethasone (10 nM), ascorbic acid (50 μg.mL−1), and β-
glycerophosphate (10 mM). 
All the capsules were transferred to non-adhesive plates and incubated at 37°C 
in a humidified 5% CO2 air atmosphere. The entire procedure was performed 
under sterile conditions in appropriate flow chambers. All the solutions used at 
this step were sterilized by filtration through a 0.22 μm filter. 
 
4. Methods 
 
4.1 Physicochemical characterization 
 
4.1.1 Quartz-crystal microbalance with dissipation monitoring 
The build-up process of the multilayered membrane growth was monitored by 
a quartz-crystal microbalance with dissipation monitoring (QCM-D) in a liquid 
environment (Chapters III and IV).  An equivalent circuit model was fitted to 
the impedance curve, and the obtained parameters were used to calculate the 
thickness of the multilayers. For that, PLL, alginate and chitosan 
polyelectrolytes were deposited on gold-coated quartz crystals. Before 
adsorption, the quartz crystals were cleaned with 0.15 M sodium chloride 
solution at 25ºC until a baseline was obtained. Polymeric and washing 
solutions were alternatively introduced into the measuring chamber at a flow 
rate of 100 mL.min-1. Variations in frequency (ΔF) and in dissipation (ΔD) were 
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monitored in real time up to a deposition of 8 cycles. The frequency of each 
overtone was normalized to the fundamental resonant frequency of the quartz-
crystal (ΔFν/ν, in which ν stands for the overtone). Thickness assessment was 
estimated using the Voigt viscoelastic model. 
 
4.1.2 Ion coupled plasma 
Ion coupled plasma (ICP) was performed to quantify the release of calcium 
during and after the liquefying process (Chapter III). Capsules were placed in 
EDTA solution with different concentrations, namely 0.02 M, 0.05 M or 0.1 M. 
After each 5 min, 3 mL of EDTA solution were withdrawn and replaced by fresh 
solution. The concentration of calcium in solution was then automatically 
measured by ICP. Additionally, capsules were placed in EDTA solutions for 5 
min and then transferred to a 0.15 M NaCl. Similarly, after each 5 min, 3 mL 
of NaCl were withdrawn and replaced by fresh solution. For both experiments, 
after 30 min, capsules were destroyed ensuring the total release of the 
remaining calcium in the core. Data analysis was performed as a cumulative 
release assay. 
 
4.1.3 Scanning electron microscopy and energy dispersive X-ray 
spectroscopy 
The membrane morphology of capsules (i) composed by different number of 
layers (Chapter III) or (ii) with MNPs adhered at the surface (Chapter V) was 
visualized by scanning electron microscopy (SEM). Additionally, SEM was also 
used to visualize the surface morphology of microparticles before and after 
plasma treatment (Chapter IV). Due to the magnetite composition of the 
MNPs, their spatial dispersion could be also assessed by iron detection 
through energy dispersive X-ray spectroscopy (EDS) analysis (Chapter V). 
Capsules were dehydrated using sequential ethanol series, namely 45%, 50%, 
60%, 70%, 80%, 90%, 96% and 100% v/v, 10 min each. Prior to SEM 
visualization EDS analysis was performed. Then, samples were gold-coated 
using a sputter coater. 
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4.1.4 Membrane mechanical stability 
The influence of depositing different number of layers on the mechanical 
stability of capsules was evaluated using a rotational stress test. Different 
types of membrane were tested, namely (i) to assess the influence of the 
number of layers in the mechanical resistance of the membrane (Chapter III) 
4-, 6- or 8- bilayered capsules composed by an alginate and chitosan 
membrane (n = 15 in triplicates) were tested; and (ii) to assess the 
contribution of the PLL presence into the stability of the multilayered 
membrane 12-layered capsules with PLL and 12-layered capsules without PLL 
(n = 10 in triplicates) were tested (Chapter IV). Capsules were placed in 
centrifuge tubes containing 5mL of PBS. The tubes were rotated at a speed of 
200 rpm for 60 min at RT. After every 15 min of rotation, the number of 
damage capsules was observed and counted under a light microscope. The 
intact capsules were placed again inside the centrifuge tubes to continue the 
rotational test. 
 
4.2 In vitro biological performance analysis 
 
4.2.1 MTS 
Capsules were tested for cytotoxicity and suitability for living cell encapsulation 
using a MTS colorimetric assay. This metabolic activity assay is based on the 
bioreduction ability of mitochondrial dehydrogenase enzymes present in viable 
cells to convert the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulphofenyl)-2H-tetrazolium (MTS) compound into a cell culture soluble 
brown formazan product. 
The different bioencapsulation systems, namely (i) alginate particles and 
capsules encapsulating L929 cells (Chapters III and IV), (ii) capsules 
encapsulating ASCs (Chapter V), and (iii) capsules encapsulating ASCs co-
cultured with ECs (Chapter VI) were placed in cell culture plate and incubated 
at 37°C and 5% CO2. At different pre-determined periods, MTS assay was 
performed protected from light. Briefly, culture medium was removed and 1 
mL of serum-free DMEM containing MTS solution with a dilution ratio of 1:5 
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was added to each well. Samples were then incubated in the dark at 37°C and 
5% CO2. After 3 h, 100 μL of each well (in triplicate) was transferred to a 96-
well plate. The amount of formazan product was measured by absorbance at a 
wavelength of 490 nm using a multiwall spectrophotometer. 
 
4.2.2 DNA 
Capsules ability to support the proliferation of encapsulated cells was tested 
by DNA quantification assay. The different bioencapsulation systems, namely 
(i) alginate particles and capsules encapsulating L929 cells (Chapters III and 
IV), (ii) capsules encapsulating ASCs (Chapter V), and (iii) capsules 
encapsulating ASCs co-cultured with ECs (Chapter VI) were placed in cell 
culture plate and incubated at 37°C and 5% CO2. At different pre-determined 
periods each well was washed with PBS and 1 mL of ultrapure sterile water 
was added. Upon mixing, contents were transferred to eppendorf tubes, which 
were then placed in a shaking water bath at 37°C for 1 h. Ultimately, the tubes 
were immediately stored at -80°C until use. Quantification of total DNA was 
determined after cell lysis, according to the manufacturer’s description. After 
transferring each solution to a 96-well white opaque plate (in triplicate), the 
plate was incubated at RT protected from light for 10 min. The standard curve 
for DNA analysis was generated with provided DNA from the assay kit. 
Fluorescence was read at excitation of 485/20 nm and emission of 528/20 nm 
using a multiwall spectrophotometer. 
 
4.2.3 Flow cytometry 
The phenotypic profile of ASCs and ECs before and after encapsulation within 
capsules for bone regeneration (Chapter VI) was assessed regarding 
mesenchymal (CD105-FITC, CD90-APC, and CD73-PE) and endothelial (CD31-
APC) markers. Isolated and encapsulated cells were harvested by TrypLETM 
Express solution at 37ºC for 5 min, and centrifuged. Samples were 
resuspended in PBS solution containing bovine serum albumin (3% w/v, BSA) 
and the specified antibodies at the dilutions defined by the manufacture’s 
specifications. After 20 min at RT, samples were subsequently washed with 
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PBS, centrifuged, fixed in PBS with formaldehyde (1% v/v), and analyzed in a 
flow cytometer. 
 
4.2.4 Alkaline phosphatase activity and calcium quantification 
Alkaline phosphatase (ALP) is an enzyme secreted by active osteoblasts, and is 
responsible for the cleavage of pyrophosphate ions, which are inhibitors of the 
formation of hydroxyapatite crystals. The hydrolysis reaction results in the 
saturation of the extracellular fluid with orthophosphates that induce 
mineralization [58, 59]. Increased levels of ALP activity are thus correlated 
with enhanced osteogenic differentiation [60]. Therefore, capsules 
encapsulating ASCs and ECs for bone regeneration (Chapters VI and VII) were 
tested for ALP quantification. The activity of ALP was determined by the 
amount of p-nitrophenol. A substrate solution at pH 9.8 was prepared by 
dissolving 4-nitrophenylphosphate disodium salt hexahydrate (0.2% w/v) in 
diethanolamine (1 M). Each sample (20 μL, in triplicate) was mixed with the 
prepared substrate solution (60 μL). After 45 min at 37ºC protected from light, 
the reaction was stopped (80 μL) with sodium hydroxide (NaOH, 2 M) and 
EDTA (0.2 mM). A standard curve with a range of concentrations was prepared 
by diluting 4-nitrophenol solution (10 mM) in the stop solution. Absorbance 
was read at 405 nm in a microplate reader. Results were normalized with 
dsDNA quantification data. 
The amount of calcium in the extracellular matrix (ECM) of capsules 
encapsulating ASCs and ECs for bone regeneration (Chapter VI) was also 
quantified. Samples were washed with PBS and resuspended in 100 μL of HCl 
(6 M). A standard curve was prepared with a CaCl2 solution (5 mM). 10 μL of 
each sample and standard (in triplicate) were transferred to a 96-well plate. 
Upon mixing the calcium kit components according to manufacture’s 
specifications, absorbance was read at 570 nm in a microplate reader. 
 
4.2.5 TGF-β3, BMP-2 and VEGF cytokines quantification 
The amount of TGF-β3 in the supernatant coating solution after immersion of 
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surface modified PLLA microparticles (Chapter V) was quantified by a 
commercially available human TGF-β3 ELISA kit. Absorbance was read at 450 
nm with correction wavelength set to 570 nm in a microplate reader. The 
amount of TGF-β3 coating the microparticles was calculated by subtracting the 
ELISA quantification results to the initial amount of the prepared TGF-β3 
solution (10 ng). Then, the PLLA microparticles immobilized with TGF-β3 were 
immersed in PBS for 7 days. The PBS solution was also quantified by ELISA to 
assess if TGF-β3 was released from the surface of microparticles. 
The profile of BMP-2 and VEGF cytokines release into the supernatants of 
capsules encapsulating ASCs co-cultured with ECs for bone regeneration 
(Chapter VI) was assessed by ELISA quantification assay. The supernatants 
(500 μL) were stored at -80ºC with a diluted protease inhibitor cocktail (1:100) 
until analysis. Commercially available human BMP-2 and VEGF ELISA 
development kits were used according to manufacture’s specifications. 
Absorbance was read at 405-650 nm in a microplate reader. 
 
4.2.6 Glycosaminoglycans quantification 
The quantification of sulfated glycosaminoglycans (GAGs) was performed by 
the dimethylmethylene blue (DMB) assay [61]. Briefly, a digestion buffer at pH 
6.8 composed by phosphate buffer (200x10−9 M) and EDTA (1x10−4 M) was 
prepared. To the digestion buffer (50 mL), papain (25 mg) and L-cysteine 
hydrochloride anhydrous were added. The prepared papain solution was added 
to each well containing capsules encapsulating ASCs for cartilage regeneration 
(Chapter V) (1 mL, n = 4 capsules, in triplicate). Samples were incubated at 
65ºC for 18 h. To perform the DMB assay, a standard curve with chondroitin 4-
sulfate was prepared. Additionally, the DMB dye (16 mg) was dissolved in 
absolute ethanol (5 mL), and then NaCl (2.37 g) and glycine (3.04 g) dissolved 
in distilled water (900 mL) were added. The pH was set to 3 and distilled water 
was added to make up 1 L. Samples or chondroitin sulfate standards (20 μL) 
were mixed with the prepared DMB dye (250 μL) in a transparent 96-well plate. 
Absorbance was read at 595 nm using a microplate reader. Total DNA 
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quantification was used to normalize the DMB content. 
 
4.2.7 RNA extraction, cDNA production and quantitative real-time 
polymerase chain reaction (qPCR) 
The extraction of mRNA was performed using TRIzol reagent. Capsules (n = 5 
per well in triplicate) were stored in TRIzol (800 μL) at -80ºC until analysis. 
Samples were slowly defrosted on ice and chloroform (160 μL) was added. 
After 15 min at 4ºC, samples were centrifuged at 13000 rpm for 15 min. The 
aqueous part of each sample was collected and isopropanol (400 μL) was 
added. Following an overnight incubation at -20ºC, samples were centrifuged at 
13000 rpm for 10 min at 4ºC. The supernatant was discarded and the 
resulting pellets were washed with ethanol (70% v/v) in RNase/DNase free 
distilled water. The pellets were let to partially dry on air, and dissolved in 
RNase/DNase free distilled water (10 μL). RNA quantity and purity was 
determined in nanodrop spectrophotometer. Samples with a 260/280 purity 
ratio higher than ~1.8 were used for cDNA synthesis. The cDNA synthesis was 
performed using a qScript cDNA SuperMix kit and a MiniOpticon Real-time 
PCR Detection System. All samples were normalized (1 μg of RNA in 20 μL of 
RNase/DNase free distilled water). 
The expression of different genes were quantified in the cDNA samples using a 
real-time PCR reaction. Different genes were analyzed, namely (i) chondrogenic 
gene, specifically collagen I, II, and X, aggrecan and SOX9 (Chapter V), (ii) 
osteogenic genes, specifically bone morphogenic protein-2 (BMP-2), 
transcription factor RUNX2, and bone sialoprotein (BSP) (Chapter VI), (iii) 
angiogenic genes, specifically von Willebrand factor (vWF), CD31, and vascular 
endothelial growth factor A (VEGF-A) (Chapter VI). The target genes were 
normalized with 18S rRNA as the housekeeping. The primers (200 nM) were 
designed to span exon-exon junctions using the primer-BLAST tool. The 
primers sequences are showed in Table II.1. 
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Table II.1 – Primer sequences used for real-time polymerase chain reaction, with the respective purpose of selection. 
Type Name Forward/reverse sequence Purpose 
Housekeeping 18S 5’-GAAACCTTCCGACCCCTCTC-3’ 
5’-TACGAGGTCGATTTGGCGAG-3’ 
 18S ribosomal RNA is a widely used control for 
qPCR analyses because of its invariant expression 
across tissues, cells, and experimental treatments.  
C
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Collagen 
l 
5’-AAGAACCCCAAGGACAAGAG-3’ 
5’-GTAGGTGATGTTCTGGGAGG-3’ 
 Type I collagen is highly expressed in ASCs. 
Monitoring this marker transcript reveals the degree 
to which fibrous tissue may develop. 
Collagen 
II 
5’-CGGTGAGAAGGGAGAAGTTG-3’ 
5’-GACCGGTCACTCCAGTAGGA-3’ 
 Type II collagen is the primary protein in the 
extracellular matrix of articular cartilage and 
provides a critical mechanical function. Thus, high 
expression of 
This marker is desirable. 
Collagen 
X 
5’-CAGGCATAAAAGGCCCACTA-3’ 
5’-AGGACTTCCGTAGCCTGGTT-3’ 
 Type X collagen is the hallmark hypertrophic 
chondrocyte marker. Type X collagen is found in the 
transition from articular cartilage to bone. Hence, 
some expression of this marker is desirable. 
Excessive expression may indicate tissues tending 
toward an ossification pathway. 
Aggrecan 5’-TGAGTCCTCAAGCCTCCTGT-3’ 
5’-TGGTCTGCAGCAGTTGATTC-3’ 
 Aggrecan is a large aggregating proteoglycan found 
in articular cartilage. High levels of this marker 
transcription are desirable in chondrogenesis. 
SOX9 5’-TTCATGAAGATGACCGACGC-3’ 
5’-GTCCAGTCGTAGCCCTTGAG-3’ 
 SOX9 encodes a potent chondrogenic transcription 
factor and is closely correlated with the transcription 
of collagen II marker. 
O
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BMP-2 5’-TGAATCAGAATGCAAGCAGG-3’ 
5’-TCTTTTGTGGAGAGGATGCC-3’ 
 BMP2 induces DLX3, a homeodomain protein that 
activates RUNX2 gene transcription. 
RUNX2 5’-TTCCAGACCAGCAGCACTC-3’ 
5’-CAGCGTCAACACCATCATTC-3’ 
 RUNX2 is the master switch (earliest transcription) 
for osteogenic differentiation. It is crucial for the 
generation of a mineralized tissue. 
BSP 5’- ACTGAGCCTGTGTCTTGAAA-3’ 
5’-CTTCCAACAGCCAATCACTG-3’ 
 BSP is a significant component of the bone 
extracellular matrix. High levels of this marker 
transcription are related to the mineralizing 
potential of the cells. 
A
n
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vWF 5’-CCCTGGGTACAAGGAAGAAAAT-3’ 
5’-AGTGTCATGATCTGTCTCCTCTTAG-3’ 
 vWF is a glycoprotein produced uniquely by 
endothelial cells, and is responsible to regulate 
angiogenesis. 
CD31 5’-AAGGCCAGATGCACATCC-3’ 
5’-TTCTACCCAACATTAACTTAGCAGG-3’ 
 CD31 is expressed by endothelial cells. The encoded 
protein is a member of the immunoglobulin 
superfamily, and transcription of this marker is 
correlated to angiogenesis. 
VEGF-A 5’- GATCCGCAGACGTGTAAATG-3’ 
5’-TACGAGGTCGATTTGGCGAG-3’ 
 VEGF is a very potent angiogenic agent that has a 
central role in normal physiological angiogenesis. 
 
The real-time PCR reaction was done using the PerfeCTa SYBR Green FastMix 
Reaction Mixes, according to manufacturer’s specifications. The reactions were 
monitored in a Mastercycler using the software Realplex (version 2.2). The 
relative quantification of the markers expression was performed using the 2-
ΔΔCT method (Perkin-Elmer). Results in Chapter V are expressed relatively to 
capsules without TGF-β3 supplementation at day 1, and in Chapter VI 
relatively to gene expression levels of each formulation of capsules at day 3. 
 
4.2.8 Scanning electron microscopy visualization 
The morphology of the different encapsulated cells, namely (i) L929 cells 
(Chapters III and IV), (ii) ASCs (Chapters V, VI and VII), and (iii) ECs (Chapter 
VI) was visualized by SEM. After pre-determined periods, capsules (n = 4 per 
well in triplicate) were washed with PBS and fixed at RT in formalin (10% v/v). 
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After 1 h at RT, samples were dehydrated in an increasing gradient series of 
ethanol for 10 min each. The membrane of capsules was destroyed to expose 
the core contents. After gold sputtering, samples were visualized by SEM. 
 
4.3 In vivo implantation: animal’s surgery, euthanasia, and implants 
retrieval 
The animal experimentation project (Chapter VII) was approved by the 
institutional Animal Welfare Body (SECVS 032/2015) and the National Authority 
Direção Geral de Alimentação e Veterinária. Five week-old male nude mice 
(average weight of 25 g) were used to subcutaneously implant the different 
developed capsules. Four mice were used for each formulation and at each 
timepoint (1, 3, and 6 weeks). Under surgical sterile conditions, animals were 
anaesthetized with an intraperitoneal injection of a mixture of ketamine (75 
mg.kg-1) and metedomidine (1 mg.kg-1). One medial incision of approximately 
0.7 cm was performed in the dorsum of the mice and two craniolateral-
oriented pockets were subcutaneously created by blunt dissection. Three 
capsules were inserted into each pocket. Pockets without capsules were also 
used as control. Subsequently, the panniculus carnosus and the skin were 
carefully sutured with non-resorbable 4/0 sutures. After the surgical 
procedure, the animals were induced to recover from anaesthesia with an 
intraperitoneal injection of Atipazemol (1 mg.kg-1). The animals were kept 
housed together (different conditions in each cage) with standard diet and 
water ad libitum during all the time of the experiment. After 1, 3, and 6 weeks 
of implantation, the animals were sacrificed by carbon dioxide inhalation. The 
implanted capsules and the respective surrounding tissue were explanted from 
each animal. The collected explants were subjected to macroscopic 
observation and fixed in 10% formalin for 24 h at RT. Samples were then 
processed for standard histological evaluation. 
 
4.4 Histological procedures and stainings 
At predetermined periods, the different capsules cultured in vitro (Chapters V 
and VI) or the respective tissue explants with the implanted capsules (Chapter 
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VII) were collected and processed in an automatic ethanol-xylene spin tissue 
processor for histological analysis. Afterward, samples were embedded in 
paraffin and cut into sections of 5 μm thickness using a microtome. Sections 
were subsequently deparaffinized, rehydrated, and stained. 
 
4.4.1 Safranin-O and alcian blue  
Sections were automatically stained for safranin-O (0.1% w/v) and alcian blue 
(1% w/v) stainings. Samples were then dehydrated and immersed in xylene, 
before being mounted. The stained sections were analyzed by microscopy.   
 
4.4.2 Alizarin red  
To assess the presence of a mineralized matrix within the capsules, alizarin 
red staining was performed. This staining was performed on capsules 
(Chapters VI and VII) collected after 21 days in order to visualize calcium-rich 
deposits. Deparaffinized sections were immersed in alizarin red staining 
solution for 5 min at RT. Samples were then mounted and analyzed by 
microscopy. 
 
 4.4.3 Hematoxylin and eosin  
The explants collected after pre-determined periods of subcutaneously 
implanted capsules (Chapter VII) were automatically processed for 
hematoxylin and eosin (H&E) staining. Briefly, histological sections were 
subsequently immersed in hematoxylin and after bluing in an ammonia 
solution (1% v/v) in eosin y. Samples were then mounted and analyzed by 
microscopy. 
 
4.4.4 CD31 
The explants collected after pre-determined periods of subcutaneously 
implanted capsules (Chapter VII) were processed for CD31 staining. Antigen 
retrieval was performed in heat-mediated (95-100ºC) sodium citrate buffer (10 
mM) for 20 min. After cool down for 20 min, endogenous peroxidases were 
inactivated with hydrogen peroxide (3% v/v) and non-specific binding blocked 
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with normal horse serum incubation (2.5% v/v, NHS) for 30 min at RT. The 
sections were incubated with the primary antibody rabbit polyclonal anti-
human to CD31 (1:50 diluted in PBS with NHS) in a humidified chamber at 
4ºC overnight. The second antibody (kit) was added for 1 h at RT, and the 
stained revealed with a DAB solution prepared according to manufacturer’s 
specifications. Sections were counterstained with hematoxylin before 
microscopic analysis. 
 
4.4.5 Masson’s trichrome 
The explants collected after pre-determined periods of subcutaneously 
implanted capsules (Chapter VII) were processed for Masson’s trichrome 
staining. Sections were stained for 5 min in a solution containing azure B (0.5 
g), ammonium iron (5 g, ammonium iron sulfate (III) dodecahydrate) and 
distilled water (100 mL). Sections were then subsequently stained with 
hematoxylin and picric ethanol (1% w/v) for 5 min each. After 10 min washing 
in running tap water, sections were stained with the solutions from the 
Trichrome Stain Masson kit according to the manufacturer’s specifications. 
 
4.5 Fluorescence stainings 
 
4.5.1 Live-dead assay 
To assess the ability of capsules to support living cell encapsulation, calcein-
AM and propidium iodide dyes were used to perform live-dead assays 
(Chapters III and IV). Calcein-AM is a membrane-permeant dye, which is 
hydrolyzed by endogenous esterase into the highly negatively charged green 
fluorescent cell marker calcein retained in the cytoplasm. Propidum iodide is a 
membrane impermeant and, thus, binds to DNA of dead cells. Briefly, at each 
time point, culture medium was removed and 1 mL of PBS containing 2 μL of 
calcein-AM and 1 μL of propidium iodide was added to each well. Samples 
were then incubated at 37°C for 10 min protected from light. Afterward, 
samples were washed three times with PBS and immediately visualized in the 
dark by fluorescence microscopy. With calcein-AM, through a fluorescent filter 
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(fluorescence excitation of 494 and emission of 517 nm), living cells appeared 
bright green. With propidium iodide, through a rhodamine filter (fluorescence 
excitation of 535 nm and emission of 617 nm), dead cells appeared bright red. 
Double staining was obtained in Z-stack mode with a resolution of 17 μm 
between slides. 
 
4.5.2 DAPI-phalloidin 
DAPI and phalloidin dyes were used to perform DAPI-phalloidin assays. DAPI 
stains preferentially double-stranded DNA by delineating cells nuclei in blue. 
Phalloidin is a bicyclic peptide with selectivity to label F-actin, revealing the 
distribution of actin filaments in fixed cells. Prior to staining, at each time 
point, culture medium was removed and 10% formalin was added to each well 
(n = 5 particles or capsules per well, in triplicate). After 1 h at RT, formalin was 
removed and replaced by 0.1% Triton X for 5 min to permeabilize cells. Upon 
PBS washing, 1 mL of PBS containing 1 μL of DAPI and 10 μL of phalloidin 
was added to each well. After 1 h at RT protected from light, samples were 
washed three times with PBS and immediately visualized in the dark by 
fluorescence microscopy. Cell nuclei appeared bright blue and F-actin 
filaments appeared bright red due to DAPI and phalloidin dyes, respectively. 
Double staining was obtained in Z-stack mode with a resolution of 17 μm 
between slides. 
 
4.5.3 Osteopontin-DAPI and osteopontin-CD31-DAPI 
At pre-determined periods, capsules (Chapter VI) were fixed in formalin (10% 
v/v) for 30 min at RT. After fixation, capsules were destroyed and cells were 
permeabilized for 5 min at RT with Triton-X (0.1% v/v). Samples were 
immersed in BSA (3% w/v) for 30 min at RT to block non-specific binding and 
then incubated overnight at 4ºC with the primary antibody rabbit anti-human 
osteopontin (1:100 in 1% BSA). After PBS washing, samples were incubated 
for 1h at RT with the secondary antibody anti-rabbit AlexaFluor 488 (1:500 in 
1% BSA). Samples were immediately visualized in the dark by confocal 
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microscopy. Double staining was obtained in Z-stack mode with a resolution of 
17 μm between slides. Additionally, the same type of capsules (Chapter VI) 
were used for osteopontin-CD31-DAPI staining, however after histological 
procedure (Chapter VI). Samples were fixed in formalin (10% v/v) for 30 min 
at RT, and processed in an automatic spin tissue processor for histological 
analysis. Afterwards, samples were embedded in paraffin and cut into sections 
of 5 μm thickness using a microtome.  After the deparaffinization process, the 
antigen retrieval was performed in a microwave-heated sodium citrate buffer 
(10 mM). Samples were immersed in hydrogen peroxide (3% v/v) at RT for 30 
min. The primary antibody mouse anti-human CD31 (1:100 in 1% BSA) 
conjugated with the osteopontin and the secondary antibody anti-mouse 
AlexaFluor 594 (1:500 in 1% BSA). Ultimately, samples were counterstained 
with DAPI (1 mg.mL-1 diluted 1:1000 in PBS) for 5 min at RT and analyzed by 
microscopy. Triple staining was obtained in Z-stack mode with a resolution of 
10 μm between slides. 
Tissue explants containing the implanted capsules (Chapter VII) were also 
used for osteopontin-DAPI staining after histological procedure. Samples were 
fixed in formalin (10% v/v) for 30 min at RT, and processed in an automatic 
spin tissue processor for histological analysis. Afterwards, samples were 
embedded in paraffin and cut into sections of 5 μm thickness using a 
microtome.  After the deparaffinization process, the antigen retrieval was 
performed in a microwave-heated sodium citrate buffer (10 mM). Non-specific 
binding was blocked by immersion in BSA (3% w/v) for 30 min at RT. Samples 
were then incubated overnight at 4ºC with the primary antibody rabbit anti-
human osteopontin (1:100 in 1% BSA). After a PBS washing, samples were 
incubated for 1 h at RT with the secondary antibody anti-rabbit AlexaFluor 488 
(1:500 in 1% BSA). Samples incubated only with the secondary antibody were 
used as controls. Ultimately, samples were subsequently counterstained with 
DAPI (1 mg.mL-1 diluted 1:1000 in PBS) for 5 min at RT, immediately 
mounted, and analyzed by fluorescence microscopy. Double staining was 
obtained in Z-stack mode with a resolution of 10 μm between slides. 
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4.5.4 TGF-β3 
After surface functionalization of PLLA microparticles with collagen II and TGF-
β3 (Chapter V) as described in 3.2 Plasma treatment combined with collagen 
coating to modify the surface of microparticles, microparticles were immersed in 
PBS at 37ºC for 7 days. Samples were collected by centrifugation and 
subsequently immersed in BSA (3% w/v) for 30 min at RT, and then incubated 
overnight at 4ºC with the primary antibody rabbit anti-human TGF-β3 (5 μg 
mL−1). After PBS washing, samples were incubated for 1 h at RT with the 
secondary antibody anti-rabbit AlexaFluor 488 (1:500, BD Biosciences). 
Samples were visualized by fluorescence microscopy.  
 
4.5.5 Collagen II 
The presence of collagen II in the ECM of encapsulated cells within capsules 
was assessed after histological procedures (Chapter V). At pre-determined 
periods, capsules were collected and processed in an automatic ethanol-xylene 
spin tissue processor for histological analysis. Afterward, samples were 
embedded in paraffin and cut into sections of 5 μm thickness using a 
microtome. Sections were subsequently deparaffinized and rehydrated. The 
antigen retrieval was performed in a heat-mediated sodium citrate buffer 
(10x10−4 M). Nonspecific binding was blocked by immersion in hydrogen 
peroxide (3% v/v) followed by BSA (3% w/v), each for 30 min at RT. Samples 
were then incubated overnight at 4ºC with the primary antibody rabbit anti-
human collagen II (1:200 in 1% w/v BSA). After PBS washing, samples were 
incubated for 1 h at RT with the secondary antibody anti-rabbit AlexaFluor 488 
(1:500 in 1% BSA). Ultimately, samples were subsequently counterstained with 
DAPI (1 mg.mL−1 diluted 1:1000 in PBS) for 5 min at RT, immediately 
mounted, and analyzed in the dark by fluorescence microscopy. 
 
4.5.6 DIL and DIO lipophilic dyes 
Prior to encapsulation, ASCs and ECs (Chapter VI) were incubated with the 
lipophilic dyes 3,3’-dioctadecyloxacarbocyanine perchlorate (DIO) and 1,1’-
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dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DIL), 
respectively. Cells were incubated with each dye (1 mL, 2 μM per 1x106 cells) 
at 37ºC for 10 min. Labeled cells encapsulated in liquified and multilayered 
capsules were visualized by confocal microscopy. 
 
5. Statistical analysis 
Statistical analysis was performed using two-way analysis of variance (ANOVA) 
with Tukey’s post-hoc test (GraphPad Prism 6). A p-value < 0.05 was considered 
statistically significant. All results are presented as mean ± standard deviation 
of at least three independent experiments (n = 3). 
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Chapter III 
Liquified chitosan-alginate multilayer capsules incorporating poly(L-
lactic acid) microparticles as cell carriers 3 
 
Abstract 
We report the development of liquified multilayer hierarchical capsules capable 
to provide cell adhesion sites to the encapsulated cells. The proof of principle is 
demonstrated on the example of a chitosan-alginate shell via layer-by-layer 
assembly, encapsulating cells adhered at the functionalized surface of poly(L-
lactic acid)  microparticles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 Based on the publication: C.R. Correia, P. Sher, R.L. Reis, J.F. Mano, Liquified chitosan-alginate 
multilayer capsules incorporating poly(L-lactic acid) microparticles as cell carriers, Soft Matter, 9 (2013) 
2125-2130. 
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1. Introduction 
Since the pioneering study of Decher [1], the layer-by-layer (LbL) assembly 
technique has been widely used to produce polymeric multilayer capsules 
(PMCs). The fabrication is based on the set-wise assembly of oppositely 
charged polyelectrolytes onto a sacrificial template before the decomposition 
of its core [2, 3] PMCs have attracted immense attention due to their great 
applicability in various scientific fields, such as in medical imaging [4, 5], 
controlled drug delivery systems [6], biosensors [7, 8], synthetic vaccines [9], 
cell encapsulation [10], nanoreactors [11], catalysts [12], and many others. 
Due to the high versatility of the LbL technique, different properties of the 
capsules can be easily tailored, e.g. the permeability of the shell can be 
controlled by varying the number of layers deposited and the surface of the 
capsules can be customized by endowing nanoparticles, lipids, viruses, among 
others [13]. Moreover, LbL can be performed in mild conditions. Drawn by 
these appealing properties, PMCs have found great potential in 
bioencapsulation systems. The LbL shell allows the diffusion of nutrients, 
oxygen, metabolites and waste products, maximized by the liquified core, while 
avoiding the entrance of high molecular weight immune system components, 
such as immunoglobulins and immune cells [14]. However, most cells cannot 
grow in suspension and need to adhere to a solid structure. Encapsulated in 
the liquified environment of capsules and deprived of a physical support, 
anchorage-dependent cells are not able to adhere and proliferate. In fact, 
bioencapsulation is often performed using alginate hydrogel particles since the 
crosslinked core provides physical support for cell adhesion. However, alginate 
requires a covalently modification with peptides and proteins, such as arginine-
glycine-aspartic [15], in order to promote cell attachment. Additionally, the 
diffusion of essential molecules for cell survival in hydrogels is less efficient 
compared to the liquified environments of capsules [16, 17]. Therefore, the 
existing capsules for cell immobilization are more focused in the delivery of 
cells rather than tissue formation [10, 14]. 
Chapter III 
Liquified chitosan-alginate multilayer capsules incorporating poly(L-lactic acid) microparticles as cell 
carriers 
 
	 	 	138 
To achieve an efficient diffusion provided by liquified environments, which 
simultaneously are able to provide cell adhesion sites, we propose the 
development of liquified multilayer capsules containing microparticles as cell 
supports. A schematic representation is given in Scheme III.1.  
 
Scheme III.1 - A schematic representation of the organization of the proposed liquified multilayer 
capsules. (a) Cells are seeded at the surface of microparticles, originating the production of 
microcarriers. (b) After encapsulation of the obtained microcarriers in sacrificial hydrogel particles, 
oppositely charged polymers are deposited at their surface by layer-by-layer technique. (c) Upon core 
dissolution, liquified multilayer capsules are obtained. The permselective ability of the shell of the 
capsules allows the diffusion of nutrients, oxygen, metabolites and waste products, while avoiding the 
entrance of host immune mediators. 
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Here, we report the general idea in which capsules composed by a 
permselective multilayered membrane of chitosan and alginate incorporate 
poly(L-lactic acid) (PLLA) microparticles as cell microcarriers. Due to the 
excellent biocompatibility of chitosan and alginate, these two natural polymers 
are often applied as polycation and polyanion electrolytes, respectively, in 
biomedical applications of drug delivery systems and tissue engineering (TE) 
approaches [18-20]. The successful assembly of chitosan (CHT) and alginate 
(ALG) has already been reported to produce capsules for cell immobilization 
[21], drug delivery systems [22] or scaffolds for TE [23, 24]. 
 
2. Materials and Methods 
 
2.1 Production of poly(L-lactic acid) microparticles 
PLLA microparticles were produced by emulsion solvent evaporation technique 
as elsewhere described with minor modifications [25]. Briefly, 1 g of PLLA 
(Mw~1600-2400, 70% crystallinity, Polysciences, Germany) was dissolved in 
20 mL of methylene chloride (CH2Cl2, Fisher Chemical, UK) to obtain a 5% w/v 
transparent solution of PLLA/CH2Cl2. This solution was added under agitation 
to 100 mL of polyvinyl alcohol 0.5% w/v (PVA, Sigma-Aldrich, USA). The 
resulting solution was left to stir for 2 days at room temperature (RT) in order 
to evaporate the organic solvent. The produced PLLA microparticles were 
collected by filtration and washed several times with distilled water. Ultimately, 
microparticles were subsequently frozen at -80ºC and lyophilized (Cryodos, 
Telstar) for 3 days. PLLA microparticles diameter (n = 185) was measured by 
using Image J software. Prior to usage, microparticles were stored at 4°C. 
PLLA microparticles were then surface modified by plasma treatment 
technique. Microparticles were placed inside the plasma reactor chamber 
(PlasmaPrep5, Gala Instrumente, Germany) fitted with a radio-frequency 
generator. Oxygen was used as the working atmosphere. After the pressure of 
the chamber had stabilized to ~0.2 mbar, a glow discharge plasma was 
created by controlling the electrical power at 30 V of electrical potential 
Chapter III 
Liquified chitosan-alginate multilayer capsules incorporating poly(L-lactic acid) microparticles as cell 
carriers 
 
	 	 	140 
difference. The plasma-treated microparticles were treated for 15 minutes. 450 
mg of PLLA plasma treated microparticles were sterilized by UV radiation for 
30min and then immersed in 30 mL of 0.02 M acetic acid (Carlo Erba, Italy) 
containing 1200 µg collagen I (Rat Tail, Invitrogen) for 4 h at RT. 
Microparticles were collected and washed with sterile phosphate buffer saline 
(PBS, Sigma-Aldrich, USA). 
 
2.2 Production of liquified capsules 
Sodium alginate from brown algae (ALG, Sigma-Aldrich, USA) was dissolved in 
0.15 M sodium chloride (NaCl, Panreac, Spain) at a concentration of 1.5% 
w/v. The pH of alginate solution was adjusted to 7. To produce capsules 
containing microparticles, surface modified PLLA microparticles was added to 
the template solution at a concentration of 4.5% w/v. Under agitation rate by a 
mechanical stirrer, alginate solutions with or without PLLA microparticles were 
dropwise to a 0.1 M calcium chloride solution (Merck, Germany) using an 18 G 
needle. Droplets were immediately transformed into hydrogel particles by 
ionotropic gelation, due to the ionic crosslinking of the alginate matrix. 
Hydrogel particles formed were left to stir for 20 min. Then, hydrogels were 
collected and rinsed in 0.15 M NaCl. Once obtained the alginate particles with 
or without PLLA microparticles, the external membrane was processed by 
layer-by-layer deposition. Hydrogel particles were first immersed in water-
soluble highly purified chitosan (CHT, Protasan UP CL 213, viscosity 107 
mPa.s, molecular weight Mw = 2.7x105 g.mol-1, degree of deacetylation DDA = 
83%, NovaMatrix, Norway) and subsequently in ALG. Polymers were dissolved 
in 0.15 M NaCl at a concentration of 0.5 mg.mL-1. The pH of ALG was set to 7 
and, in the case of chitosan, to 6.4. At these pH values the polyelectrolytes 
maintain their positive or negative required charges and cell viability is not 
affected. Following a 10 min of each polymer adsorption, the excess of 
macromolecules was removed by immersion in 0.15 M NaCl for 5 min. The 
washing step removes the remaining unabsorbed polyelectrolyte and its non-
reactive groups, in order to maximize the polymeric adsorption of the following 
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layer. This process was repeated in order to obtain an 8-bilayered membrane 
on the surface of the hydrogel particles. The core-shell alginate particles 
obtained were immersed in 0.02 M ethylenediaminetetraacetic acid (EDTA, 
Sigma-Aldrich, USA) at pH 7 for 5 min to liquefy the alginate core. 
 
2.3 Quartz-crystal microbalance with dissipation monitoring 
The build-up process of the membrane growth was monitored by quartz-crystal 
microbalance with dissipation monitoring (QCM-D, QSense E4, Sweden) in a 
liquid environment. An equivalent circuit model (IPC High Precision 
Multichannel Dispenser, ISMATEC) was fitted to the impedance curve, and the 
obtained parameters were used to calculate the thickness of the multilayers. 
Briefly, CHT and ALG multilayers were deposited on gold-coated quartz 
crystals. Before adsorption, the quartz crystals were cleaned with 0.15 M 
sodium chloride solution at 25ºC until a baseline was obtained. All conditions, 
such as, polymer cycle, concentration, pH, and time of deposition, as 
previously described to obtain the LbL membrane, were also used in the QCM-
D analysis. Polymeric and washing solutions were alternatively introduced into 
the measuring chamber at a flow rate of 100 µL.min-1. Variations in frequency 
(ΔF) and in dissipation (ΔD) were monitored in real time up to a deposition of 8 
cycles. The frequency of each overtone was normalized to the fundamental 
resonant frequency of the quartz-crystal (ΔFν/ν in which ν stands for the 
overtone). Thickness assessment was estimated using the Voigt viscoelastic 
model implemented in the QTools software from QSense. 
 
2.4 Mechanical resistance evaluation 
The influence of depositing different number of layers on the mechanical 
stability of capsules was evaluated using a rotational stress test. Three types of 
membrane were tested, namely 4, 6 or 8-bilayered capsules (n = 15 in 
triplicates). Capsules were placed in centrifuge tubes containing 5mL of PBS. 
The tubes were rotated at a speed of 200 rpm for 60 min at RT. At every 15 
min of rotation, the number of damage capsules was observed and counted 
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under a light microscope. The intact capsules were placed again inside the 
centrifuge tubes to continue the rotational test. 
 
2.5 Scanning electron microscopy 
The membrane morphology of 4, 6 or 8-bilayered capsules was characterized 
by scanning electron microscopy (SEM). Capsules composed by 4, 6 or 8-
bilayers were dehydrated using sequential ethanol series, namely 45%, 50%, 
60%, 70%, 80%, 90%, 96% and 100% v/v, 10min each. Prior to SEM 
visualization, cross-sections of capsules were gold-coated using a sputter 
coater. Cross-sectional morphologies were visualized using a FEI Nova™ 
NanoSEM 200 operating at 5.0 kV accelerating voltage. 
 
2.6 Ion Coupled Plasma 
Ion Coupled Plasma (ICP) was performed to quantify the release of calcium 
during and after the liquefying process. Capsules with 8-bilayers were placed in 
EDTA solution with different concentrations, namely 0.02 M, 0.05 M or 0.1 M. 
At each 5 min, 3 mL of EDTA solution were withdrawn and replaced by fresh 
solution. The concentration of calcium in solution was measured by ICP (SPS-
1500VR, Seiko Instruments Inc., Japan). Additionally, capsules were placed in 
EDTA solutions for 5 min and then transferred to a 0.15 M sodium chloride 
solution. Similarly, at each 5 min, 3 mL of sodium chloride solution were 
withdrawn and replaced by fresh solution. For both experiments, after 30 min, 
capsules were destroyed ensuring the total release of the remaining calcium. 
Data analysis was performed as a cumulative release assay.  
 
2.7 Live-dead and DAPI-phalloidin fluorescence assays 
Alginate particles (control) and ALG and PLLA capsules were incubated for 1, 
3, and 7 days at 37ºC and in a humidified 5% CO2 atmosphere. Live-dead and 
DAPI-phalloidin fluorescence assays were performed at each time culture 
period. 
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Calcein-AM and propidium iodide dyes (1 mg.mL-1, Molecular Probes, 
Invitrogen, USA) were used to perform the live-dead assay  (n = 5 particles or 
capsules per well, in triplicate). Briefly, at each timepoint, culture medium was 
removed and 1 mL of PBS containing 2 μL of calcein-AM (1 mg.mL-1) and 1 µL 
of propidium iodide (1 mg.mL-1) was added to each well. Samples were then 
incubated at 37ºC for 10 min protected from light. Afterwards, samples were 
washed three times with PBS and immediately visualized in the dark by 
fluorescence microscopy (Axioimage RZ1M, Zeiss, Germany).  
4,6-Diaminidino-2-phenylindole-dilactate (DAPI, 20 mg.mL-1, Sigma-Aldrich, 
USA) and phalloidin tetramethylrhodamine B isothiocyanate dyes (phalloidin, 
10 mg.mL-1, Sigma-Aldrich, USA) were used to perform a DAPI-phalloidin 
assay. Prior to staining, at each timepoint, culture medium was removed and 
10% of formalin was added to each well (n = 5 particles or capsules per well, 
in triplicate). After 1 h at RT, formalin was removed and replaced by 0.1% 
Triton X for 5 min to permeabilize cells. Upon PBS washing, 1 mL of PBS 
containing 1 µL of DAPI and 10 µL of phalloidin was added. After 1 h at RT and 
protected from light, samples were washed three times with PBS and 
immediately visualized in the dark by fluorescence microscopy. Cells nuclei 
appeared bright blue and F-actin filaments appeared bright red due to DAPI 
and phalloidin dyes, respectively. 
In both assays, double staining was obtained in Z-stack mode with a resolution 
of 17 µm between slides by using the AxioVision software. 
 
2.8 MTS viability assay 
Capsules with 8-bilayeres were tested for cytotoxicity and suitability for live cell 
encapsulation using a MTS colorimetric assay (Cell Titer 96® AQueous One 
Solution Cell Proliferation Assay, Promega, USA). Briefly, alginate particles 
(control) and capsules with (PLLA capsules) or without (ALG capsules) 
microparticles encapsulating L929 cells were placed in cell culture plates (n = 
5 per well, in triplicate) and incubated at 37ºC and 5% CO2. Similarly, particles 
and capsules without cells were used as background control. At 1, 3 and 7 
Chapter III 
Liquified chitosan-alginate multilayer capsules incorporating poly(L-lactic acid) microparticles as cell 
carriers 
 
	 	 	144 
days of culture, the MTS assay was performed protected from light. Culture 
medium was removed and 1 mL serum-free DMEM containing MTS solution 
with a dilution ratio of 1:5 was added to each well. Samples were then 
incubated in the dark at 37ºC and 5% CO2. After 3 h, 100 µL of each well (in 
triplicate) were transferred to a 96-well plate. The amount of formazan product 
was measured by absorbance at a wavelength of 490 nm using a multiwall 
spectrophotometer (Synergy HT, Bio-TEK). The background was corrected by 
subtracting the absorbance obtained from particles and capsules without cells 
to those with cells encapsulated. 
 
3. Results and discussion 
Capsules were tested regarding their feasibility, membrane stability and ability 
to support cell survival. The assembly of the two natural polymers used to 
produce the layer-by-layer shell, chitosan and alginate, was monitored by 
quartz-microbalance with dissipation monitoring (QCM-D). Figure III.1a shows 
the normalized frequency (ΔFν/ν) and dissipation (ΔD) variations obtained at 
the third overtone during the construction of 8 layers. The decrease in the 
frequency variation after each successive layer of polyelectrolyte adsorption 
(Figure III.1a arrows) suggests a gradual growth of the polymeric film. 
Dissipation increases with time revealing that the film is not rigid and can 
dissipate energy, evidencing the viscoelastic behavior of macromolecules. The 
QCM results show that a stable multilayer nanostructure was obtained, thus 
membrane production is ensured. Over time, the assembly of chitosan and 
alginate, originating the construction of the polymeric film was verified. 
Alginate, as a polyanion, interacts with the positively charged chitosan amine 
groups. The pH of the chitosan solution used was adjusted to 6.4, bellow its 
pKa value of 6.5 [26], in order to ensure its polycation behavior. Alginate, with 
pKa values of 3.38 and 3.65, for mannuronic (M) and guluronic (G) acids [27], 
respectively, tends to be negatively charged across a wide range of pH values. 
Therefore, the pH of alginate was adjusted to 7 to ensure a more cell friendly 
environment in further biological studies. QCM analysis proved the effective 
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interaction between the two polyelectrolytes at the selected concentration and 
pH values. Additionally, the thickness of the multilayer film was also estimated 
using the Voigt viscoelastic model [20] (Figure III.1b). The assembly of 
chitosan and alginate followed a linear regime growth, resulting in a polymeric 
film with 56 nm of thickness after the construction of 8 layers. Once assessed 
the construction of the shell in a two-dimensional system, the liquefying 
process and the mechanical properties were evaluated in a three-dimensional 
(3D) system, i.e. capsules. 
To produce the capsules, an alginate solution of 1.5% w/v was added dropwise 
to a 0.1 M calcium chloride solution and stirred for 20 min. The template 
particles were collected and sequentially immersed in 0.5 mg.mL-1 solutions of 
chitosan and alginate for 10 min, until achieving the desire number of layers. 
Between each deposition step, particles were washed in a 0.15 M sodium 
chloride solution to remove the remaining unabsorbed polyelectrolyte and its 
non-reactive groups. Liquified capsules were obtained through ionic chelation 
by immersing the coated beads in a 0.02 M ethylenediaminetetraacetic acid 
(EDTA) solution for 5min. EDTA, a divalent ion chelator often used to produce 
capsules [6, 21, 22, 28-30] was used to free the calcium ions crosslinked 
within the core matrix of the alginate hydrogel. 
The mechanical resistance of capsules with 4, 6 or 8-bilayers was tested 
(Figure III.1c) as elsewhere described [31] with minor modifications. Results 
show that as the number of deposition cycles increases, the mechanical 
resistance also increases. Therefore, capsules with 8-bilayers were the most 
resistant to impact. Moreover, the shell of the developed 8-bilayered capsules 
was able to maintain its integrity without releasing the liquified core, even 
when they were not immersed (Video III.1). The liquified core was only 
released upon damage with a needle.  
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Figure III.1 - (a) Build-up assembly assessment of chitosan (CHT) and alginate (ALG) up to 8 deposition 
layers. Results correspond to the quartz-crystal microbalance with dissipation monitoring (QCM-D) of 
normalized frequency (ΔFν/ν) and dissipation (ΔD) variations at the third overtone as a function of time. 
Arrows point to the end of polyelectrolytes adsorption. (b) Cumulative thickness evolution of the 
polymeric film as a function of the number of deposition layers. The thickness of the film was estimated 
using the Voigt viscoelastic model. The line represents a linear trend line with R2=0.991. (c) Mechanical 
resistance of the liquefied capsules (n=15 in triplicate) after a rotational stress of 200 rpm for 60 min. 
Every 15 min, capsules where visualized and the number of intact capsules was assessed. Capsules with 
4, 6 or 8-bilayers were tested. 
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Figure III.2 evidences the stratified structure of the shell composed by 4-, 6- or 
8-bilayered by scanning electron microscopy (SEM). Results show that the 
thickness of the membrane of the capsules increases with the number of 
deposition cycles. The thickness differences found may be correlated to the 
superior mechanical resistance of capsules with higher number of layers. Using 
the Image J software, the thickness of each shell presented in Figure III.2 (a), 
(b) and (c) was measured and divided by the number of layers, namely 8, 12 
and 16 layers, respectively. Results show that each deposition layer measured 
1.22 µm ± 0.01. 
 
 
Figure III.2 - Scanning electron microscopy (SEM) of cross-sections of capsules composed by (a) 4-, (b) 
6- or (c) 8-bilayers. Scale bar represents 20 µm. 
 
Ion Coupled Plasma (ICP) was performed to evaluate the liquefying process of 
the 8-bilayered capsules. The assay was conducted regarding the cumulative 
release of calcium ions as a function of time of immersion in sodium chloride 
solution after 5 min of EDTA treatment (Figure III.3) or directly in EDTA 
solution (Figure III.3 inset). As showed by the inset in Figure III.3, after 
capsules being immersed in EDTA solution with different concentrations, 
namely 0.0 2M, 0.05 M and 0.1 M, the cumulative release of calcium increases 
with time. Different concentrations of EDTA resulted in similar calcium release 
profiles. At 5 min of EDTA immersion, the amount of calcium release was 
around 20% of the total calcium incorporated. Since after 5 min of EDTA the 
core was liquified as shown in Video III.1, we intended to assess if after the 
stipulated time of EDTA treatment the calcium is continually being released in 
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sodium chloride solution. This behavior was confirmed, as showed in Figure 
III.3. 
 
 
 
Figure III.3 - Calcium cumulative release as a function of time measured by Ion Coupled Plasma analysis. 
Capsules with 8-bilayers were placed in sodium chloride solution (NaCl) after being immersed in 5 min of 
EDTA treatment or directly in EDTA solution (inset). Different concentrations of EDTA were used, namely 
0.02 M, 0.05 M and 0.1 M. 
 
The lowest concentration of EDTA, namely 0.02 M, had the slowest release of 
calcium, however after 24 h all the calcium was released as occurred with the 
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other formulations. Therefore, 0.02 M of EDTA for 5 min was efficient in 
liquefying the alginate core. 
The capability of capsules to adapt to different structures, such as syringes, 
was assessed (Video III.2). Capsules were collected, demonstrating a certain 
jamming resistance when passing through thinner regions of a syringe. The 
variable shape ability of capsules is also assured because the size of the solid 
PLLA microparticles is almost two orders of magnitude lower than the size of 
the flexible capsules. This ability is of huge interest for encapsulation systems 
since it offers capsules the ability of being implanted by minimal invasive 
methods in transplantation procedures. Figure III.4 shows capsules and 
microparticles visualized by light microscopy. The average diameter of 
capsules was 1.8 ± 0.08 mm and the diameter of the PLLA microparticles 
covered the range 20-100 µm. Microparticles revealed a smooth surface, which 
could jeopardize cell adhesion. Moreover, PLLA lacks of natural cell recognition 
sites, and its hydrophobicity and low surface energy are known to affect cell 
attachment and proliferation [32]. Therefore, prior to biological assays, PLLA 
microparticles were surface modified to enhance cell adhesion affinity. 
 
 
Figure III.4 – Liquified capsules (a) without (ALG capsules) and (b) with PLLA microparticles (PLLA 
capsules). Scale bar is 250 µm. (c) PLLA microparticles. Scale bar is 100 µm. 
 
The ability of capsules to support cell survival was evaluated by encapsulating 
an immortalized mouse lung fibroblast cell line (L929, European Collection of 
Cell Cultures). PLLA microparticles were produced by solvent-emulsion 
technique and further modified by plasma-technique before collagen I coating. 
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After sterilization with UV-radiation, L929 cells were cultured at the surface of 
the microparticles at a density of 1x106 cells per mL of alginate. Then, 4.5% 
w/v surface functionalized microparticles were added to a 1.5% w/v alginate 
solution. This template solution was used to produce capsules (PLLA capsules) 
as previously described. All solutions were sterilized by filtration using a 0.22 
µm filter. Capsules without PLLA microparticles (ALG capsules) were also 
produced and used as negative controls. Before the production of the layer-by-
layer shell, hydrogel particles were collected and used as a 3D culture system 
control (control). The biocompatibility of the capsules was assessed by live-
dead (Figure III.5a-c) and MTS viability assays (Figure III.5e) up to 7 days of 
culture.  Additionally, to evaluate if cells were adhered to the surface of PLLA 
microparticles, a DAPI-phalloidin fluorescence assay was also performed 
(Figure III.5d). In the live-dead assay, capsules had a good viability with any 
detectable dead cells. On the other hand, control particles revealed cell death 
at the inner areas of the structure with living cells concentrated to the 
peripheral regions. This may be due to the fact that control particles had a 
significant swelling increase at 37ºC, and thus the culture medium may not 
reach those inner areas. Additionally, since the core is crosslinked, the 
diffusion efficiency of nutrients and oxygen might be also compromised. MTS 
results corroborate the observed good viability of capsules. Cells were 
metabolically active and at day 7 the viability of capsules compared to the 
control particles exceeded 100%. DAPI-Phalloidin assay showed that cells 
encapsulated in PLLA capsules adhered with the actin filaments being spread 
across the surface of PLLA microparticles, proving that the surface 
modification was efficient. 
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Figure III.5 - (a) Live-dead assay of control particles and (b) capsules without PLLA microparticles (ALG 
capsules) or (c) capsules with PLLA microparticles (PLLA capsules) at day 7 culture. Living cells were 
stained green by calcein and dead cells red by propidium iodide. Scale bar is 500 µm. (d) DAPI-phalloidin 
fluorescence assay of PLLA capsules at day 7 of culture. Cells adhered at the surface of the PLLA 
microparticles. Cells nuclei were stained blue and F-actin filaments red. Scale bar is 50 µm. (e) MTS 
viability assay at 1, 3 and 7 days of culture. Core-crosslinked alginate particles (control) and ALG and 
PLLA capsules were tested. Absorbance was read at a wavelength of 490 nm. Statistical differences are 
marked with (*), which stands for p<0.001. 
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4. Conclusion 
Liquified capsules encapsulating cells and PLLA microparticles were 
successfully developed. The membrane of the capsules, which was produced 
by layer-by-layer, provided stability to capsules, even when they are not 
immersed in a liquid environment, and allowed the diffusion of essential 
molecules for cell survival. The encapsulation system proposed not only 
alleviates the current bioencapsulation issues but also allows tailoring 
membrane permselective ability, capsule mechanical integrity, as well as, 
optimizing and customizing a cell friendly environment inside the capsule. The 
developed approach can potentially be used to encapsulate anchorage 
dependent cells and control the phenotype of primary cells or stem cells fate. 
Moreover, different microparticles can be encapsulated which may be loaded 
with growth factors and other biomolecules of interest, customized to the type 
of cell encapsulated.  
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Supplementary information 
Videos of the release of the liquified alginate core after damage (Video III.1) 
and capsules ability to adapt to different structures, such as syringes and 
needles (Video III.2) are available at the Soft Matter website: 
http://pubs.rsc.org (DOI: 10.1039/C2SM26784E). 
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Chapter IV 
Multilayered hierarchical capsules providing cell adhesion sites 4 
 
Abstract 
Liquified capsules featuring (i) an external shell by layer-by-layer assembly of 
poly(L-lysine), alginate and chitosan, and encapsulating (ii) surface 
functionalized poly(L-lactic acid) (PLLA) microparticles were developed. We 
hypothesize that, while the liquified environment enhances the diffusion of 
essential molecules for cell survival, microparticles dispersed in the liquified 
core of capsules provide the physical support required for cellular functions of 
anchorage-dependent cells. The influence of the incorporation of PLL on the 
regime growth, thickness and stability was analyzed. Results show a more 
resistant and thicker film with an exponential build-up growth regime. 
Moreover, capsules ability to support cell survival was assessed. Capsules 
containing microparticles revealed an enhanced biological outcome in cell 
metabolic activity and proliferation, suggesting their potential to boost the 
development of innovative biomaterials designs for bioencapsulation systems 
and tissue engineering products. 
 
 
 
 
 
 
 
 
 
 
 
 
4 Based on the publication: C.R. Correia, R.L. Reis, J.F. Mano, Multilayered hierarchical capsules 
providing cell adhesion sites, Biomacromolecules, 14 (2013) 743-751. 
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1. Introduction 
Bioencapsulation represents an evolving branch of tissue engineering and 
regenerative medicine, providing a range of therapeutic treatments, such as for 
diabetes [1, 2], bone [3], and cartilage [4] defects and cancer [5]. The 
hydrophilic nature, which provides a highly hydrated microenvironment similar 
to the extracellular matrix (ECM), made hydrogel particles the most widely 
used system [6]. Particularly, alginate is the most frequently employed 
biomaterial due to its abundance, water solubility, mild gelling properties, high 
biocompatibility and resemblance to the natural ECM [6-8]. 
Based on the early pioneering study of Iler [9], the approach to coat charged 
surfaces was introduced by Decher [10]. This method is based on the layer-by-
layer (LbL) adsorption of oppositely charged macromolecules on the surface of 
particles. The multilayers can be made from a variety of constituents such as 
synthetic and natural polyelectrolytes, nanoparticles, lipids and multivalent 
dyes [11]. The core of the LbL particles can be further dissolved or eliminated 
originating capsules. Capsules has been widely used particularly in cell 
encapsulation systems, but also have found great applicability in drug delivery 
or screening systems, biosensors, catalysis, reactors, immunoisolation and 
medical image due to their versatile wall functions, capability to load active 
substances and unique permeability [2, 12–18]. 
In bioencapsulation systems, the diffusion efficiency is a main issue since it 
influences the viability of the encapsulated cells by controlling the exchange of 
nutrients, oxygen, metabolites and waste products. Former studies compared 
the biological outcome of encapsulated cells in capsules with different core 
permeability. Results showed that as the dissolution of the core increased, 
encapsulated cells presented higher viability and proliferation [19, 20]. 
The main drawback of capsules in cell encapsulation approaches is related 
with the fact that most cells are anchorage-dependent and, thus, cannot grow 
in suspension and need to adhere to a solid substrate [8]. Therefore, 
maximizing the core dissolution or even perform its elimination to achieve an 
excellent diffusion of essential molecules will, on the other hand, compromise 
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cell survival. To overcome this main issue, we hypothesized that capsules 
encapsulating microparticles are a promising attempt. While the liquified 
environment of capsules ensures the required excellent diffusion, cell adhesion 
sites required for cellular functions are provided by the encapsulated 
microparticles. We propose an innovative concept termed here as 
Multifunctional Capsules (MCs). MCs are composed by (i) a permselective 
multilayered membrane and (ii) poly(L-lactic acid) (PLLA) microparticles. A 
schematic representation of MCs is given in Scheme IV.1. To obtain the 
membrane, poly(L-lysine) (PLL), chitosan (CHT) and alginate (ALG) 
polyelectrolytes were combined by LbL assembly. Besides being a versatile and 
low-cost technique, one of the main advantages of LbL for bioencapsulation 
systems is the possibility to be performed in mild conditions. Due to the 
excellent biocompatibility of chitosan and alginate, the two natural polymers 
are often applied as polycation and polyanion electrolytes, respectively, in 
biomedical applications of drug delivery systems and tissue engineering (TE) 
approaches [12, 21, 22]. The successful assembly of CHT and ALG has already 
been reported to produce capsules for cell immobilization [23], drug delivery 
systems [24], or scaffolds for TE [25, 26]. PLL is a synthetic biocompatible 
polycation [27, 28] often applied to improve the mechanical strength of 
alginate capsules, as first reported elsewhere [29]. Although PLL-ALG 
membranes have been shown to support tissue growth, studies demonstrated 
the formation of fibrotic tissue around the membrane surface when 
transplanted in rat models [30]. Therefore, to produce capsules for cell 
encapsulation we intend to take advantage of the high biocompatibility of CHT 
and ALG combined with the mechanical stability provided by PLL. This 
assembly of three-component polyelectrolytes via alternate deposition has 
fuelled much interest recently due to its demonstrated superior tunability and 
versatility to the traditional 2-component method [18, 31]. 
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Scheme IV.1 - A schematic representation of the production of Multifunctional Capsules (MCs). Cells are 
mixed with an alginate solution (Solution A) or with an alginate solution containing poly(L-lactic acid) 
microparticles (PLLA) (Solution B). Both solutions are extruded separately, originating alginate particles 
by ionotropic gelation. Alginate particles obtained with solution A will be used as control. Afterwards, an 
external shell is developed at the surface of the obtained particles by layer-by-layer technique. The 
crosslinked alginate core is further liquified by ethylenediaminetetraacetic acid (EDTA) treatment, 
originating liquified capsules encapsulating cells (ALG capsules) or encapsulating cells and PLLA 
microparticles (PLLA capsules). 
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2. Materials and Methods 
 
2.1 Materials 
Poly(L-lactic acid) (PLLA) with a molar mass Mw~1,600-2,400 and 70% of 
crystallinity was purchased from Polysciences (Germany). Methylene chloride 
(CH2Cl2) was purchased from Fisher Chemical (UK). Polyvinyl alcohol (PVA), 
phosphate buffer saline (PBS), low viscosity sodium alginate from brown algae 
(ALG, ~250cP), poly(L-lysine) (PLL, Mw~30,000-70,000), 
ethylenediaminetetraacetic acid (EDTA), low glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM), sodium bicarbonate, 4,6-Diaminidino-2-phenylindole-
dilactate (DAPI, 20 mg.mL-1) and phalloidin tetramethylrhodamine B 
isothiocyanate (10 mg.mL-1) were purchased from Sigma-Aldrich (USA). Acetic 
acid was purchased from Carlo Erba (Italy). Collagen type I Rat Tail in liquid 
form (5 mg.mL-1), fetal bovine serum (FBS), penicillin-streptomycin and 
trypsin-EDTA solution were purchased from Invitrogen. Sodium chloride (NaCl) 
was purchased from Panreac (Spain). Calcium chloride was purchased from 
Merck (Germany). Water-soluble highly purified chitosan (CHT, Protasan UP CL 
213, viscosity 107 mPa.s, molecular weight Mw= 2.7x105 g.mol-1, 83% degree 
of deacetylation) was purchased from NovaMatrix (Norway). The immortalized 
mouse lung fibroblast cell line (L929) was purchased from the European 
Collection of Cell Cultures. The MTS colorimetric assay (Cell Titer 96® AQueous 
One Solution Cell Proliferation Assay) was purchased from Promega (USA). 
Calcein-AM and propidium iodide (PI) dyes (1 mg.mL-1) and the Quant-iTTM 
PicoGreen® dsDNA Assay Kit were purchased from Molecular Probes-Invitrogen 
(USA). 
 
2.2 PLLA microparticles production 
PLLA microparticles were produced by emulsion solvent evaporation technique 
as elsewhere described [32] with minor modifications. Briefly, 1 g of PLLA was 
dissolved in 20 mL of CH2Cl2 to obtain a 5% w/v transparent solution of 
PLLA/CH2Cl2. This solution was added under agitation to 100 mL of 0.5% w/v 
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PVA. The resulting solution was left to stir for 2 days at room temperature (RT) 
in order to evaporate the organic solvent. The produced PLLA microparticles 
were collected by filtration and washed several times with distilled water. 
Ultimately, microparticles were subsequently frozen at -80ºC and lyophilized 
(Cryodos, Telstar) for 3 days. Prior to usage, microparticles were stored at 4°C. 
 
2.3 PLLA microparticles surface functionalization 
PLLA microparticles were surface modified by plasma treatment technique. 
PLLA microparticles were placed inside the plasma reactor chamber 
(PlasmaPrep5, Gala Instrumente, Germany) fitted with a radio-frequency 
generator. Air was used as the working atmosphere. After the pressure of the 
chamber had stabilized to ~0.2 mbar, a glow discharge plasma was created by 
controlling the electrical power at 30 V of electrical potential difference. The 
plasma-treated microparticles were treated for 5 min. The sample was 
removed from the chamber and a gentle mixing was employed in order to 
maximize the PLLA surface exposition to plasma treatment. This procedure 
was repeated three times in order to apply a total plasma reaction time of 15 
min. 450 mg of PLLA plasma treated microparticles were sterilized by UV 
radiation for 30 min and then immersed in 30 mL of 0.02 M acetic acid 
containing 1200 µg of collagen I for 4 h at RT. A mild shaking was employed 
every hour. Ultimately, microparticles were collected and washed three times 
PBS. 
 
2.4 Preparation of capsules 
1.5% w/v of alginate (pH 7, ALG) was dissolved in 0.15 M NaCl. To produce 
capsules containing microparticles, 4.5% w/v surface modified PLLA 
microparticles was added to the template solution. Under agitation rate by a 
mechanical stirrer, alginate solutions with or without PLLA microparticles were 
dropwise to a 0.1 M calcium chloride solution using an 18 G needle. Droplets 
were immediately transformed into hydrogel particles by ionotropic gelation 
due to the ionic crosslinking of the alginate matrix. The hydrogel particles 
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formed were left to stir for 20 min and then washed with NaCl. Once obtained 
the alginate particles, the external membrane by LbL assembly was processed. 
Hydrogel particles were first immersed in PLL, and subsequently in ALG, CHT 
and in ALG again. Between each polyelectrolyte immersion of 10 min, the 
excess of macromolecules was removed by immersion in NaCl for 5min. This 
process was repeated three times in order to obtain a 12-layered membrane on 
the surface of the hydrogel particles. Core-shell hydrogel particles obtained 
were then immersed in 0.02 M EDTA at pH 7 for 5 min to liquefy the alginate 
core. The polyelectrolyte solutions with a concentration of 0.5 mg.mL-1 were 
dissolved in 0.15 M NaCl. The pH of PLL and ALG was set to 7 and, in the case 
of chitosan, to 6.4. 
 
2.5 Microparticles and capsules morphology 
The surface of PLLA microparticles before and after plasma treatment was 
visualized by scanning electron microscopy (SEM). Microparticles were gold-
coated using a sputter coater and visualized using a Leica Cambridge S-360 
operating at 15 kV accelerating voltage. Additionally, microparticles and 
capsules encapsulating surface modified PLLA microparticles were visualized 
by optical microscopy. Microparticle (n = 185) and capsules (n = 20) 
diameters were measured by using Image J software. 
 
2.6 Quartz-crystal microbalance with dissipation monitoring 
The build-up process of the ability of PLL, CHT and ALG to adsorb in a 
sequential fashion was performed on planar gold surfaces. The process was 
monitored by quartz-crystal microbalance with dissipation monitoring (QCM-D, 
QSense E4, Sweden) in a liquid environment. The instrument measuring 
principle is based on the analysis of the quartz crystal impedance at multiple 
overtones. An equivalent circuit model (IPC High Precision Multichannel 
Dispenser, ISMATEC) was fitted to the impedance curve and the obtained 
parameters were used to calculate the regime growth of the multilayers. 
Briefly, PLL, ALG and CHT multilayers were deposited on gold-coated quartz 
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crystals. Before adsorption, the quartz crystals were cleaned with 0.15 M NaCl 
at 25ºC until a baseline was obtained. Since the quartz crystals surface is 
negatively charged, as well as the surface of the alginate hydrogel particles, it 
was possible to follow the same polymer cycle previously described to produce 
capsules. Moreover, all conditions such as concentration, pH, and time of 
deposition, and washing as previously described to obtain the LbL membrane, 
were also used in the QCM-D analysis. Polymeric and washing solutions were 
alternatively introduced into the measuring chamber at a flow rate of 100 
µL.min-1. Variations in frequency (ΔF) and in dissipation (ΔD) were monitored in 
real time up to a deposition of 12 polymer layers. The frequency of each 
overtone was normalized to the fundamental resonant frequency of the quartz-
crystal (ΔFν.ν -1, in which ν stands for the overtone). Thickness measurements 
were estimated using the Voigt viscoelastic model implemented in the QTools 
software from QSense. 
 
2.7 Capsules membrane stability test 
The influence of the introduction of PLL on the mechanical stability of capsules 
was evaluated using a rotational mechanical test. Since the aim of this test is 
to assess membrane resistance, only capsules without PLLA microparticles 
were used (ALG capsules). Two types of membrane were tested, namely 12-
layered capsules with PLL (PLL-ALG-CHT), and 12-layered capsules without 
PLL (CHT-ALG) (n = 10 in triplicates). The two types of ALG capsules were 
placed in centrifuge tubes containing 5 mL of PBS. The tubes were rotated at a 
speed of 200 rpm for 60 min. At every 15 min of rotation, the number of 
damage capsules was observed and counted under a light microscope. The 
intact capsules were placed again inside the centrifuge tubes to continue the 
rotational test. After the time of experiment an additional rotation at a speed of 
2000 rpm for 15 min was performed. 
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2.8 In vitro cell culture 
Cells were routinely cultured with low glucose DMEM supplemented with 3.7 
g.L-1 sodium bicarbonate, 10% FBS and 1% penicillin-streptomycin at pH 7.4. 
Cells were grown in 75 cm2 tissue culture flasks and incubated at 37ºC in a 
humidified air atmosphere of 5% CO2. Every 3-4 days fresh medium was 
added.  
 
2.9 Cell encapsulation 
At 90% of confluence, L929 cells grown in tissue culture flasks were washed 
with PBS and subsequently detached by a chemical at 37ºC in a humidified air 
atmosphere of 5% CO2. To inactivate the trypsin effect, cell culture medium 
was added. Cells were then centrifuged at 300 g and 25ºC for 5 min and the 
medium was decanted. Afterwards, cells were mixed with 1.5% w/v ALG. Cell 
density was set to 1x106 cells per mL of alginate. This solution was then used 
to produce alginate particles (control) and capsules without PLLA 
microparticles (ALG capsules). To produce capsules with PLLA microparticles 
(PLLA capsules) a concentrated cell suspension with 1x106 cells per mL of 
alginate was first seeded on the surface of PLLA microparticles. PLLA 
microparticles were then incubated at 37ºC and 5% CO2 for 3h. Afterwards, 
1.5% w/v alginate solution was mixed with cells and microparticles. The same 
procedure used to produce capsules previously described was performed to 
produce ALG and PLLA capsules encapsulating cells. Layer-by-layer assembly 
and EDTA treatment were not performed in alginate hydrogel particles, which 
were used as a 3D cell culture control. The entire procedure was performed 
under sterile conditions. All the solutions used at this step were sterilized by 
filtration through a 0.22 µm filter. 
 
2.10 Cell morphology 
The morphology of the encapsulated cells adhered at the surface of the 
modified PLLA microparticles was analyzed by SEM. PLLA capsules 
encapsulating L929 cells were incubated at 37ºC and 5% CO2. At day 1 and 7, 
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culture medium was removed and 10% formalin was added to each well (n = 5 
capsules per well). After 1h at RT, formalin was removed and capsules were 
dehydrated using sequential ethanol series, namely 60%, 70%, 80%, 90%, 
96% and 100%, 10 min each. Prior to SEM visualization, capsules were 
destroyed to release the core contents. Subsequently, the released 
microparticles with cells were gold-coated using a sputter coater and visualized 
using a Leica Cambridge S-360 operating at 15 kV accelerating voltage. 
 
2.11 MTS viability assay 
Capsules were tested for cytotoxicity and suitability for live cell encapsulation 
using a MTS colorimetric assay. This assay is based on the bioreduction ability 
of mitochondrial dehydrogenase enzymes present in viable cells to convert the 
MTS compound into a cell culture soluble brown formazan product. Briefly, 
alginate particles and capsules encapsulating L929 cells were placed in a non-
treated surface 12-well cell culture plate (n = 5 per well, in triplicate) and 
incubated at 37ºC and 5% CO2. Alginate particles and capsules without cells 
were used as a background control. At 1, 3 and 7 days of culture, the MTS 
assay was performed protected from light. Briefly, culture medium was 
removed and 1 mL of serum-free DMEM containing MTS solution with a 
dilution ratio of 1:5 was added to each well. Samples were then incubated in 
the dark at 37ºC and 5% CO2. After 3 h, 100 µL of each well (in triplicate) were 
transferred to a 96-well plate. The amount of formazan product was measured 
by absorbance at a wavelength of 490 nm using a multiwall spectrophotometer 
(Synergy HT, Bio-TEK). The background was corrected by subtracting the 
absorbance obtained from particles and capsules without cells to those with 
cells encapsulated. 
 
2.12 Fluorescence assays 
Alginate particles (control) and capsules (n = 5 samples per well, in triplicate, 
both assays) were incubated for 1, 3, 7, 14, 21 and 28 days at 37ºC and in a 
Chapter IV 
Multilayered hierarchical capsules providing cell adhesion sites 
 
 
	 	 	168 
humidified 5% CO2 atmosphere. Live-dead and DAPI-phalloidin fluorescence 
assays were performed at each time culture period. 
Calcein-AM and propidium iodide dyes were used to perform a live-dead assay. 
Calcein-AM is a membrane-permeant dye, which is hydrolyzed by endogenous 
esterase into the highly negatively charged green fluorescent cell marker 
calcein retained in the cytoplasm. PI is a membrane impermeant and, thus, 
binds to DNA of dead cells. Briefly, at each timepoint, culture medium was 
removed and 1mL of PBS containing 2 µL of calcein-AM and 1 µL of PI was 
added to each well. Samples were then incubated at 37ºC for 10 min protected 
from light. Afterwards, samples were washed three times with PBS and 
immediately visualized in the dark by fluorescence microscopy (Axioimage 
RZ1M, Zeiss, Germany). With calcein-AM, trough a fluorescent filter 
(fluorescence excitation of 494 and emission of 517 nm), living cells appeared 
bright green. With PI, trough a rhodamine filter (fluorescence excitation of 535 
nm and emission of 617 nm), dead cells appeared bright red.  
DAPI and phalloidin dyes were used to perform a DAPI-phalloidin assay. DAPI 
stains preferentially double-stranded DNA by delineating cells nuclei in blue. 
Phalloidin is a bicyclic peptide with selectivity to label F-actin, revealing the 
distribution of actin filaments in fixed cells. Prior to staining, at each 
timepoint, culture medium was removed and 10% formalin was added to each 
well (n = 5 particles or capsules per well, in triplicate). After 1 h at RT, 
formalin was removed and replaced by 0.1% Triton X for 5 min to permeabilize 
cells. Upon PBS washing, 1 mL of PBS containing 1 µL of DAPI and 10 µL of 
phalloidin was added to each well. After 1 h at RT protected from light, 
samples were washed three times with PBS and immediately visualized in the 
dark by fluorescence microscopy. Cells nuclei appeared bright blue and F-actin 
filaments appeared bright red due to DAPI and phalloidin dyes, respectively.  
In both fluorescence assays, double staining was obtained in Z-stack mode 
with a resolution of 17 µm between slides by using the AxioVision software. 
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2.13 DNA quantification assay 
Capsules ability to support encapsulated cells proliferation was tested by DNA 
quantification assay. Alginate particles (control) and capsules (n = 5 samples 
per well, in triplicate) were incubated in 12-well plates with non-treated 
surfaces for 1, 3, 7, 14, 21 and 28 days at 37ºC and humidified 5% CO2 
atmosphere. Similarly, particles and capsules without cells were used as 
background control. At each time culture period, each well was washed with 
PBS and 1 mL of ultra-pure sterile water was added. Upon mixing, contents 
were transferred to eppendorf tubes, which were then placed in a shaking 
water bath at 37ºC for 1 h. Ultimately, the tubes were immediately stored at -
80ºC until use. Quantification of total DNA was determined after cell lysis, 
according to the manufacturer’s description. After transferring each solution to 
a 96-well white opaque plate (in triplicates), the plate was incubated at RT 
protected from light for 10 min. The standard curve for DNA analysis was 
generated with provided DNA from the assay kit. Fluorescence was read at 
excitation of 485/20 nm and emission of 528/20 nm using a multiwall 
spectrophotometer (Synergy HT, BioTek, USA). The background was corrected 
by subtracting results obtained from particles and capsules without cells to 
those with cells encapsulated. 
 
2.14 Statistical analysis 
MTS and DNA data were grouped by timepoint, namely 1, 3 and 7 days or 1, 3, 
7, 14, 21 and 28 days, respectively, in order to analyze significant differences 
between formulations. Additionally, both data were also grouped by 
formulation, namely, control, ALG capsules and PLLA capsules, in order to 
assess time-course significant differences of each formulation. Statistical 
analysis of both data cases was performed using two-way analysis of variance 
(ANOVA) with Bonferroni post-test using GraphPad Prism 5.0 software. A p-
value<0.05 was considered statistically significant. Significant differences in 
grouped by timepoint were marked with an asterisk character (*). In grouped 
by formulation all results were significant different unless otherwise marked 
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with a cardinal character (#). All results are presented as mean ± standard 
deviation. 
 
3. Results 
 
3.1 Morphological analysis of PLLA microparticles and capsules 
Capsules encapsulating microparticles with an average diameter of 1.8 ± 0.06 
mm were visualized by optical microscopy (Figure IV.1a). Microparticles 
(Figure IV.1b) had a diameter range of 45.6 ± 13.5 µm, with 90.0 µm and 15.5 
µm of maximum and minimum diameters, respectively. SEM analysis 
evidenced the smooth surface of the produced microparticles, as shown in 
Figure IV.1c. After plasma treatment, the roughness of the surface of PLLA 
microparticles significantly increased as shown in Figure IV.1d. 
 
Figure IV.1 - Optical microscopy of (a) liquified capsules encapsulating (b) PLLA microparticles. Scale 
bar represents 500 µm and 100 µm for (a) capsules and (b) microparticles images, respectively. 
Scanning electron microscopy of a poly(L-lactic acid) (PLLA) microparticle (c) before and (b) after plasma 
treatment. Scale bar represents 20 µm with 1000x of magnification. 
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3.2 Polyelectrolytes interaction and thickness measurements 
The assembly of PLL, ALG and CHT polyelectrolytes was characterized by 
QCM-D analysis. Figure IV.2a shows the normalized frequency (ΔFν.ν-1) and 
dissipation (ΔD) variations for the third overtone (15 MHz) after the deposition 
of 12 layers. Two different profiles were obtained, namely PLL-ALG-CHT 
(Figure IV.2a, continuous line) or ALG-CHT (Figure IV.2a, dotted line). The 
frequency shift (see vertical arrows in Figure IV.2a) evidences the deposition of 
each successive layer of polyelectrolyte on the surface of the quartz-crystals. 
For PLL-ALG-CHT profile, after the construction of 12 layers, the frequency 
decreased about 255 Hz. For CHT-ALG profile the frequency decreased about 
210 Hz, after the same number of deposition layers. In both profiles the 
dissipation variation increased during the experiment. The QCM-D data was 
further used to estimate the thickness variations of the films with each 
adsorption cycle, as shown in Figure IV.2b and Figure IV.2c. In the PLL-ALG-
CHT profile, the thickness of the film increased exponentially (dotted line in 
Figure IV.2b with R2 = 0.985) with the number of deposition steps. At the end 
of the deposition cycle the estimated thickness of the PLL-ALG-CHT film was 
around 110 nm. On the other hand, the thickness of the CHT-ALG film (Figure 
IV.2c) increased linearly (dotted line in Figure IV.2b with R2 = 0.997) up to a 
final estimated value around 80 nm. 
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Figure IV.2 - Build-up assembly assessment of poly(L-lysine) (PLL), alginate (ALG) and chitosan (CHT) up 
to 12-deposition layers. (a) Quartz-crystal microbalance with dissipation monitoring (QCM-D) of 
normalized frequency (ΔFν/ν) and dissipation (ΔD) variations at the third overtone as a function of time. 
PLL-ALG-CHT and CHT-ALG profiles are represented by the continuous and dotted line, respectively. (b) 
Cumulative thickness evolution for PLL-ALG-CHT polymeric film as a function of the number of deposition 
layers. The dotted line represents an exponential trend line with R2 = 0.985. (c) Cumulative thickness 
evolution for CHT-ALG polymeric film as a function of the number of deposition layers. The dotted line 
represents a linear trend line with R2 = 0.997. Thickness measurements were estimated using the Voigt 
viscoelastic model. 
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3.3 Membrane mechanical stability test 
The assessment of the mechanical properties of capsules is important to 
determine the durability of capsules during production and handling. 
Additionally, mechanical properties of capsules are an indication of the 
membrane integrity. The ability of the membrane to maintain its integrity after 
being subjected to mechanical impact by rotational stress was assessed 
(Figure IV.3). The percentage of rupture capsules with a PLL-ALG-CHT 
membrane increased up to 27% ± 6 after 60 min of rotation at 200 rpm. 
Similarly, after applying a 2000 rpm rotational stress for 15 min, the 
percentage of ruptured capsules slightly increased to 33% ± 6. On the other 
hand, the percentage of rupture capsules with a CHT-ALG membrane rapidly 
increased to 43% ± 6 after the first 15 min of rotation and continued to 
increase with further mechanical stresses.  
Figure IV.3 - The effect of rotational mechanical impact at 200 rpm up to 60 min and for an extra time of 
15 min at 2000 rpm on capsules with 12-deposition layers was assessed. Two different capsules were 
tested, namely a two-component membrane capsule composed by chitosan and alginate (CHT-ALG, ) 
and a three-component membrane capsule composed by poly(L-lysine), alginate and chitosan (PLL-ALG-
CHT, n). 
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3.4 Morphology of encapsulated cells  
Cell-material interactions of the encapsulated cells with microparticles were 
visualized by SEM (Figure IV.4). At day 1, cells were adhered and spread 
across the surface of microparticles (Figure IV.4a). At day 7, large aggregates 
of microparticles and cells could be detected as evidenced by Figure IV.4c. 
The encapsulated cells maintained their elongated fibroblast-like morphology 
as evidenced in higher magnification Figure IV.4b and Figure IV.4d. 
 
 
Figure IV.4 - Scanning electron microscopy of encapsulated PLLA microparticles and cells at (a) day 1 
and (c) day 7 of culture.  Scale bar represents 200 µm with 200x of magnification. Pictures (b) and (d) 
represent higher magnification images of days 1 and 7, respectively. Scale bar is 50 µm with 500x of 
magnification. 
 
3.5 Metabolic activity and cell viability of encapsulated cells 
Cell metabolic activity of encapsulated L929 cells was evaluated by MTS assay 
for 1, 3 and 7 days (Figure IV.5). The formazan absorbance of PLLA capsules 
was significantly higher than ALG capsules and control particles at day 1 and 
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day 3, respectively. At day 7, PLLA capsules absorbance was significantly 
higher compared to control and ALG capsules. 
 
 
Figure IV.5 - MTS viability assay at 1, 3 or 7 days of culture. Alginate particles (control) and capsules 
with (PLLA capsules) or without (ALG capsules) PLLA microparticles were tested. Absorbance was read at 
a wavelength of 490 nm. Statistical differences in grouped by timepoint analysis are marked with (**) and 
(***), which stand for p<0.01 and p<0.001, respectively. Statistical differences in grouped by formulation 
analysis were found for all formulations unless otherwise marked with # character. 	
Moreover, all samples had a significant increase in the time-course 
absorbance. In addition, a fluorescence viability staining was performed to 
assess living and dead cells dispersed in the liquified capsule environment, 
using a live-dead assay (Figure IV.6). Control and ALG capsules exhibited a 
higher number of dead cells compared to PLLA capsules. This difference 
becomes more evident as the time of culture increases, particularly from day 
14. Overall, MTS and live-dead data suggest a good viability for all 
formulations, particularly for PLLA capsules.	
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Figure IV.6 - Live-dead fluorescence assay at 1, 3, 7, 14, 21 or 28 days of culture. Alginate particles 
(control) and liquified capsules with (PLLA capsules) or without (ALG capsules) PLLA microparticles were 
tested. Living cells were stained green by calcein and dead cells red by propidium iodide. Scale bar 
represents 500 µm and 40 µm in overview and higher magnification images, respectively. 
 
3.6 Cell organization and proliferation studies 
The distribution and structural organization of encapsulated cells within the 
crosslinked core of control particles or the liquified environment of capsules 
was assessed by DAPI-phalloidin fluorescence assay (Figure IV.7). 
Cell proliferation was assessed as a function of culture time up to 28 days by 
DNA quantification assay (Figure IV.8). Overall, during the time of the 
experiment, both ALG and PLLA capsules had a significant higher proliferation 
compared with control particles. Particularly, PLLA capsules had the highest 
cell proliferation. ALG capsules had an increase in time-course proliferation up 
to 21 days of culture, and then at day 28 the proliferation decreases to an 
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intermediate value not significant different from days 14 and 21. Cells 
encapsulated in PLLA capsules exhibited a rapid and significant increase of 
proliferation up to 7 days of culture. At day 14 the proliferation profile appears 
to stabilize to an intermediate value no statistical different from days 7 and 21. 
Due to the smooth and continuous increase, at day 21 the DNA content is 
statistical different compared to day 7, followed by a significant increase at 
day 28. In control particles, cell proliferation increased up to 14 days of 
culture, without significant differences compared to day 21. However, at day 
28, a significant decrease was observed. DAPI-phalloidin and DNA data 
suggest an improved value provided by PLLA capsules regarding cell-material 
interactions and cell proliferation. 
 
Figure IV.7 - DAPI-phalloidin fluorescence assay at 1, 3, 7, 14, 21 or 28 days of culture. Alginate 
particles (control) and liquified capsules with (PLLA capsules) or without (ALG capsules) PLLA 
microparticles were tested. Cells nuclei were stained blue by DAPI and F-actin filaments in red by 
phalloidin. Scale bar represents 500 µm and 40 µm in overview and higher magnification images, 
respectively. 
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Figure IV.8 - DNA quantification assay at 1, 3, 7, 14, 21 or 28 days of culture. Alginate particles (control) 
and capsules with (PLLA capsules) or without (ALG capsules) PLLA microparticles were tested. Statistical 
differences in grouped by timepoint analysis are marked with (*), (**) and (***), which stands for p<0.05, 
p<0.01 and p<0.001, respectively. Statistical differences in grouped by formulation analysis were found 
for all formulations unless otherwise marked with # character. 
 
4. Discussion 
Results from the current study investigated the biological outcome when 
anchorage-dependent cells are encapsulated with PLLA microparticles. 
Microparticles and cells were both confined inside liquified capsules built by 
multilayers of PLL, ALG and CHT. The contribution of PLL in the mechanical 
strengthening of the capsules membrane was also evaluated.  
PLLA microparticles featured an appropriate diameter in the micro-scale range 
to be used as cell microcarriers (Figure IV.1b-d). In order to improve cell 
adhesion, the smooth surface of PLLA microparticles (Figure IV.1b) was 
treated by plasma. Plasma technique is a very simple and well-known 
technique applied to modify biomaterials surface, including PLLA [33]. As 
showed in Figure IV.1c, the plasma treatment clearly enhanced the surface 
roughness of microparticles. Moreover, modified microparticles are able to 
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offer the great advantage of providing a large surface area for cellular adhesion 
and growth compared to traditional 2D cell culture systems or empty capsules. 
In order to create a system in which the developed microparticles together with 
cells would be entrapped, a multilayered membrane was developed by LbL 
assembly. The interaction of three different polymers was tested by QCM-D. 
The experimental pH range of 7 for PLL and ALG and 6.4 for CHT 
polyelectrolytes were set. At pH 7 both PLL and the carboxylate groups of 
alginate remain deprotonated due to the dissociation constants (pKa) of ~10 
for PLL and 3.38 for mannuronic (M) and 3.65 for guluronic (G) acid alginate 
monomers [16, 34]. The protonation of amine groups on chitosan glucosamine 
monomers is kept at pH 6.4 since the pKa of chitosan is ~6.5 [35, 36] 
enabling chitosan to interact with the anionic components. Therefore, the 
working pH range allowed the interaction of oppositely charged 
polyelectrolytes, as showed by the continuous frequency decrease in QCM-D 
analysis (Figure IV.2a). Moreover, cell viability is not compromised (Figures 
IV.5 and IV.6) because the working pH range is slightly bellow physiological 
conditions. The swelling is also more controlled at this pH range, not 
compromising the LbL membrane build-up, since capsules containing 
polymers with amino groups swell at alkaline pH [37]. Consequently, up to the 
later culture time of 28 days, the membrane of capsules remained stable in 
culture medium at 37ºC. The incorporation of PLL led to a higher frequency 
decrease compared to the CHT-ALG profile. Additionally, PLL incorporation 
also led to an exponential regime growth and to a thicker film (Figure IV.2b) 
compared to the typical linear regime growth of the two-component CHT-ALG 
LbL system (Figure IV.2c). Therefore, in this particular case, the presence or 
absence of PLL modulated the growth type of build-up process. Accordingly to 
the explanation of exponential growth regimes in literature [38, 39], PLL 
polyelectrolyte diffuses “in” and “out” of the film during build-up. Thus, in the 
presence of the ALG solution, PLL diffuses out of the film to form 
PLL/polyanion complexes at the outer layer. The thickness of the new forming 
layer on the surface of the film is then proportional to the amount of PLL 
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chains that diffuse out of the multilayer to interact with ALG. The film thickness 
obtained after 12 deposition layers is within the typical hundreds of 
nanometers reported for exponential multilayer films growth.38 The exponential 
growth contribution of PLL was already been reported, for example when 
combined with hyaluronic acid [38–40] or poly(L-glutamic acid) [38, 41]. In the 
absence of PLL, a linear growth was observed (Figure IV.2c). CHT and ALG 
polyelectrolytes interaction was restricted to the outer layer of the film, which 
is a characteristic behavior of a linear growth. The increase in dissipation 
variation during both films build-up reveals that the films are viscoelastic and, 
thus, not rigid [22]. This represents a great advantage since viscoelasticity 
gives capsules a certain jamming resistance. Moreover, the liquified core of 
capsules (Video IV.1) also allows capsules to adapt to structures with variable 
shapes, such as syringes (Video IV.2). This ability is of huge interest for 
encapsulation systems since it offers capsules the ability of being implanted by 
minimal invasive methods in transplantation procedures. The injectability of 
the liquified capsules is also assured because the size of the stiff PLLA 
microparticles is almost two orders of magnitude lower than the size of the 
flexible capsules. 
The capsules coated with the three macromolecular components showed an 
improved mechanical stability (Figure IV.3). This result can be correlated to 
the thickness increase in PLL-ALG-CHT film. The strength of the obtained 
capsules permits its manipulation and expected implantation without 
compromising their mechanical integrity.  
The biological performance of the PLL-ALG-CHT membrane capsules was 
evaluated. Here, the contribution of adding surface modified PLLA 
microparticles to the liquified environment of capsules was assessed. Despite 
the advantages of PLLA, such as nontoxicity, easy processing and 
biodegradability, its surface is hydrophobic, has low surface energy and lacks 
of natural recognition sites for cells, thus compromising cell adhesion [42, 43]. 
Therefore, PLLA microparticles were surface modified by combining plasma 
treatment with collagen, which as a natural biomacromolecule possesses 
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domains that are recognized as ligands that can specifically bind to integrin. 
Figure IV.4 evidences the interaction of surface modified microparticles with 
encapsulated cells. Cells adhered and spread across the modified surface of 
microparticles, evidencing their fibroblast-like elongated morphology. 
Up to 7 days of culture, encapsulated cells had a continuous increase in the 
metabolic activity for all formulations (Figure IV.5). Specifically, PLLA capsules 
at day 7 had the highest cell viability, since cells were more metabolically 
active compared to control and ALG capsules. In concordance, despite of all 
formulations presented a good amount of well spread living cells (green spots 
in Figure IV.6), PLLA capsules had much less dead cells (red spots in figure 6) 
compared to control and ALG capsules. Especially from day 14, more dead 
cells were detected in control and ALG capsules. This may be due to the fact 
that L929 cells are anchorage dependent and, thus, the cell adhesion sites 
provided by PLLA microparticles increased the surface area for cell growth. 
Consequently, PLLA capsules presented an enhanced metabolic activity and 
cell viability. Moreover, the good viability of capsules suggested by MTS and 
live-dead data are a indicator factor that the membrane allowed the diffusion of 
nutrients and exchange of waste products for a prolonged time period. 
DAPI-phalloidin assay showed that cells adhered to PLLA microparticles 
surface treated with collagen I. Interestingly, cells started to form large 
aggregates with PLLA microparticles constructing their own 3D cell culture 
assembly system. This cell behavior was already observed in spherical 
particles for injectable systems [44]. Ultimately, cell proliferation was 
improved with the presence of PLLA microparticles (Figure IV.8). PLLA 
capsules had the highest cell proliferation during culture time, which had a 
continuous increase up to 28 days of culture. On the other hand, at 28 days 
ALG capsules proliferation did not increase and a significant decrease in 
control particles was observed. Besides the lack of adhesion sites, these 
results may also corroborate the jeopardized diffusion rate offered by the 
crosslinked core of control particles. 
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5. Conclusion 
Multilayered liquified capsules of poly(L-lysine), alginate and chitosan for cell 
encapsulation were successfully obtained using the layer-by-layer technique. 
The incorporation of PLL led to an exponential regime growth of the polymeric 
film and improved the mechanical stability of capsules. Capsules containing 
PLLA microparticles resulted in the highest cell metabolic activity and 
proliferation. We believe that the knowledge generated by this research will 
have a strong impact and open new prospects in many areas, including cell 
encapsulation. The most characteristic and promising feature of the proposed 
multilayered capsules is the ability to tailor different properties in one 
structure and to create novel multifunctional materials in accordance with the 
target application field. 
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Chapter V 
A closed chondromimetic environment within magnetic-responsive 
liquified capsules encapsulating stem cells and collagen II/TGF-β3 
microparticles5 
 
Abstract 
TGF-β3 is enzymatically immobilized by transglutaminase-2 action to poly(L-lactic 
acid) microparticles coated with collagen II. Microparticles are then encapsulated 
with stem cells inside liquified spherical compartments enfolded with a 
permselective shell through layer-by-layer adsorption. Magnetic-nanoparticles are 
electrostatically bounded to the multilayered shell, conferring magnetic-response 
ability. Our goal is to engineer a closed environment inside which encapsulated 
stem cells would undergo a self-regulated chondrogenesis. To test our hypothesis, 
capsules are cultured in chondrogenic differentiation medium without TGF-β3. 
Their biological outcome is compared with capsules encapsulating microparticles 
without TGF-β3 immobilization and cultured in normal chondrogenic 
differentiation medium containing soluble TGF-β3. Results show that similar 
chondrogenesis levels are achieved, as demonstrated by glycosaminoglycans 
quantification. Moreover, collagen fibrils resembling the native extracellular matrix 
of cartilage can be observed. Importantly, the genetic evaluation of characteristic 
cartilage markers confirms the successful chondrogenesis, while hypertrophic 
markers are downregulated. In summary, the engineered capsules are able to 
provide a suitable and stable chondrogenesis environment for stem cells without 
the need of TGF-β3 supplementation. This kind of self-regulated capsules with 
softness, robustness and magnetic responsive characteristics is expected to 
provide injectability and in situ fixation, which is of great advantage for minimal 
invasive strategies to regenerate cartilage. 
 
 
5 Based on the publication: C.R. Correia, S. Gil, R.L. Reis, J.F. Mano, A Closed chondromimetic 
environment within magnetic-responsive liquified capsules encapsulating stem cells and collagen II/TGF-
β3 microparticles, Adv. Funct. Mater., DOI: 10.1002/adhm.201600034 (2016) (in press) 
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1. Introduction 
A healthy adult cartilage tissue consists of a relatively sparse single population 
of non-proliferating chondrocytes embedded within an extracellular matrix 
(ECM). Because of its hypocellular structure and the lack of neural 
connections, vascularization, and a latent pool of stem cells [1, 2], cartilage 
has a very limited capacity of regeneration through endogenous healing. While 
in current clinical practice different techniques are being used with promising 
outcomes, they are generally not applicable for large cartilage defects or for 
degenerative joint diseases such as osteoarthritis. Meanwhile, numerous 
surgical cases have not yet proven to be successful for long-term applications 
[1]. In this regard, different cartilage tissue engineering (TE) strategies have 
emerged as alternative treatment methods of this uniquely challenging tissue. 
Integral to such approaches is the need for an abundant and easily accessible 
source of cells. The use of adult stem cells presents a viable alternative. 
Amongst the different multipotent sources, adipose stem cells (ASCs) has been 
shown to exhibit the potential for chondrogenesis [3] and they can be easily 
obtained from liposuction waste [4, 5]. Controlling the differentiation fate of 
stem cells represents a challenging task requiring a three-dimensional (3D) 
environment, which is commonly achieved by micromass culture [6, 7] or 
using scaffolds composed by natural and/or synthetic polymers [8-10], 
collagen sponges [11, 12], hydrogels [13-16], fiber meshes [17-20], and 
microparticles [21-23] combined with a finely tuned supply of growth factors 
(GFs). The most commonly used GF able to modulate the chondrocyte 
phenotype contains members of the TGF-β family, including TGF-β3 which has 
the highest and rapid chondrogenic potential among the different isoforms [24-
26]. 
Herein, we propose an injectable cartilage TE strategy composed by different 
components orchestrated in a hierarchical manner to fulfill the different above-
referred requirements. For that, ASCs were encapsulated with surface modified 
poly(L-lactic acid) (PLLA) microparticles within liquified capsules coated with 
magnetic nanoparticles (MNPs). The surface of PLLA microparticles was 
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coated with collagen II that was then enzymatically conjugated with TGF-β3 by 
the action of transglutaminase-2 (TG2). TG2 is a ubiquitously expressed 
member of an enzyme family catalyzing Ca2+ dependent transamidation of 
proteins via ε(γ-glutamyl)lysine bonds, being its ability to crosslink proteins, 
including collagen II, well described in the literature [11, 27, 28]. 
The engineered microparticles have two purposes, namely to provide a 3D 
culture environment to the stem cells, and also to provide immobilized TGF-β3. 
We envisage that the liquified environment of capsules would facilitate not only 
the diffusion of essential molecules for cell survival, but also allow the 
encapsulated cells to freely construct a hierarchical structure by the 
assembling of microparticles. As a proof-of-concept, we also conferred 
magnetic-response ability to the capsules by electrostatically bond to the 
multilayered membrane magnetic nanoparticles (MNPs). 
The suitability for cell encapsulation of the liquified capsules containing solid 
microparticles was already successfully validated in our previous studies [29-
31]. Here, it is the first time that we test its suitability for cartilage 
regeneration by including new features, such as the use of instructive 
microparticles and a magnetic-responsive shell through GFs and MNPs 
immobilization, respectively. Scheme V.1 shows the schematic representation 
of the proposed liquified capsules. 
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Scheme V.1. Representation of the proposed magnetic-responsive liquified capsules. (I) Alginate hydrogel 
particles encapsulating stem cells and surface modified poly(L-lactic acid) (PLLA) microparticles are 
obtained by dropwise into a calcium chloride bath. The surface of the PLLA microparticles is modified 
with collagen II and enzymatically crosslinked by the action of transglutaminase 2 to TGF-β3. (II) Alginate 
hydrogels are used as templates to produce a multilayered shell by sequential adsorption of poly(L-lysine) 
(PLL), alginate (ALG), and chitosan (CHT) (n = 11 layers). In the last layer, surface modified magnetic-
nanoparticles (MNPs) are incorporated in the CHT solution to confer to the capsules magnetic-response 
ability. (III) The multilayered hydrogels are immersed in EDTA solution to liquefy the core, originating 
liquified capsules. 
 
Our hypothesis is that an engineered chondromimetic environment would be 
developed in order to led encapsulated stem cells to differentiate into a stable 
chondrogenic lineage, i.e. avoiding de-differentiation, without requiring 
endogenous TGF-β3 supplementation. To test our hypothesis, two different 
capsules were produced, (i) capsules encapsulating PLLA microparticles 
coated with collagen II and TGF-β3 enzymatically crosslinked by TG2 (Coll-
ll/TGF-β3 capsules), and (ii) capsules encapsulating PLLA microparticles 
coated only with collagen II (Coll-ll capsules). Coll-ll/TGF-β3 capsules were 
cultured in chondrogenic differentiation medium without TGF-β3 
supplementation (CD-TGF-β3), while Coll-ll capsules were cultured in normal 
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chondrogenic differentiation medium (CD+TGF-β3). As control, both capsules 
were cultured in growth medium (GM). 
 
2. Materials and methods 
 
2.1 Synthesis and characterization of magnetic-nanoparticles 
The production of the magnetite nanoparticles was based from our previously 
described protocol [32]. Briefly, Fe3O4 MNPs were synthesized by the co-
precipitation reaction of ferrous (FeCl2.4H2O, Sigma-Aldrich) and ferric 
(FeCl3.6H2O, Sigma-Aldrich) salts in the presence of ammonium hydroxide 
(NH4OH, Sigma-Aldrich) under a nitrogen atmosphere at 60ºC. MNPs were 
washed with deionized water and ethanol for several times, and ultimately 
dried in a VD23 (Binder, Germany) vacuum oven. MNPs had a hydrodynamic 
size of 20.2 nm ± 0.8 and -37.9 mV ± 0.3 measured by zeta potential as 
described in our previous report [33]. 
 
2.2 Microparticles production and diameter measurements 
PLLA microparticles were produced by oil/water (o/w) emulsion technique [29-
31] and surface modified by combining plasma treatment with the coating and 
immobilization materials. Briefly, PLLA (5% w/v, 1.25 g/cm3, 70% 
crystallinity, Polysciences) was dissolved in methylene chloride (CH2Cl2, Fisher 
Chemical) and added under agitation to polyvinyl alcohol (0.5% w/v, PVA, 
Sigma-Aldrich). The microparticles were subsequently collected, washed with 
distilled water, and lyophilized (Cryodos, Telstar).  The microparticles obtained 
have a medium diameter of 45.5 µm ± 0.50 (n = 400 microparticles per batch, 
n = 3 batches) ranging from a maximum diameter of 85.3 µm ± 8.2 to a 
minimum of 15.1 µm ± 1.5. Diameter measurements were obtained using 
ImageJ software (version 1.44o, Wayne Rasband, USA). 
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2.3 Microparticles surface functionalization 
Lyophilized microparticles were placed in a plasma reactor chamber 
(PlasmaPrep5, Gala Instrumente) fitted with a radio frequency generator. Air 
was used as the working atmosphere. A glow discharge plasma (0.2 mbar, 30 
V) was created for 15 min. Microparticles were then sterilized for 2 h in ethanol 
(70% v/v) and immediately immersed in collagen II (170 µg per 50 mg of 
microparticles, rat protein tail, Gibco) overnight at 37ºC under agitation. After 
washing with phosphate-buffered saline (PBS, Sigma-Aldrich), microparticles 
were immersed in a solution containing TGF-β3 (10 ng per 50 mg of 
microparticles, Peprotech) and TG2 (0.01 U per 50 mg of microparticles, 
guinea pig liver, Sigma-Aldrich) overnight at 4ºC. 
 
2.4 Collagen II quantification 
The amount of collagen II coating the PLLA microparticles was quantified by 
Sircol Collagen assay (Biocolor) using manufacturer’s specifications. Briefly, 
50 mg of microparticles coated with collagen II (n = 5) were used. Before 
adding the Alkali reagent, the stained microparticles were visualized by optical 
microscopy. Then, absorbance was read at 555 nm. 
 
2.5 Human TGF-β3 ELISA quantification 
The amount of TGF-β3 in the supernatant coating solution was quantified by a 
commercially available human TGF-β3 ELISA kit (Omnikine, Tebu-Bio). 
Absorbance was read at 450 nm with correction wavelength set to 570 nm in a 
microplate reader (Gen 5 2.01, Synergy HT, Biotek). The amount of TGF-β3 
coating the microparticles was calculated by subtracting the ELISA 
quantification results to the initial amount of the TGF-β3 solution (10 ng). 
Then, the microparticles immobilized with TGF-β3 were immersed in PBS for 7 
days. This solution was also quantified by ELISA to assess the release of TGF-
β3. 
 
 
Chapter V 
A closed chondromimetic environment within magnetic-responsive liquified capsules encapsulating stem 
cells and collagen II/TGF-β3 microparticles 
 
	 	 	196 
2.6 Immunofluorescence of TGF-β3 
After surface functionalization, collagen II-TGF-β3 microparticles were 
immersed in PBS at 37ºC for 7 days. Samples were collected by centrifugation 
and subsequently immersed in bovine serum albumin (BSA, 3% w/v, Sigma-
Aldrich) for 30 min at RT, and then incubated overnight at 4ºC with the primary 
antibody rabbit anti-human TGF-β3 (5 µg.mL-1, Abcam). After PBS washing, 
samples were incubated for 1 h at RT with the secondary antibody anti-rabbit 
AlexaFluor 488 (1:500, BD Biosciences). Samples were visualized by 
fluorescence microscopy (Axio Imager Z1m, Zeiss). 
 
2.7 Isolation of adipose stem cells 
Subcutaneous adipose tissue from liposuction procedures was used to isolate 
human ASCs as previously described [34]. The collected tissues were obtained 
under a cooperation agreement between the 3B’s Research Group and Hospital 
da Prelada (Porto, Portugal), after approval of the respective ethical 
committees. The patient's informed consent and anonymity was assured. 
Samples were transported in PBS supplemented with penicillin-streptomycin 
(10%, pen-strep, Gibco) and kept at 4ºC. The lipoaspirates were washed with 
PBS and incubated with collagenase type II A (0.05% w/v, Sigma-Aldrich) for 
45 min at 37ºC in a shaking water bath. The digested samples were filtered 
and centrifuged at 800 g for 10 min at 4ºC. The obtained stromal vascular 
fraction (SVF) was resuspended in erythrocyte lysis buffer at pH 7.4 containing 
ammonium chloride (155 mM, Merk), potassium bicarbonate (5.7 mM, Riedel-
de-Häen), and ethylenediaminetetraacetic acid (0.1 M, EDTA, Sigma-Aldrich) in 
distilled water. After 10 min of incubation at room temperature (RT), the 
mixture was centrifuged at 300 g for 5 min. To isolate the ASCs the red blood 
cell-free SFV was resuspended in α-MEM medium (Invitrogen) supplemented 
with fetal bovine serum (10%, FBS, Invitrogen) and pen-strep (1:100, Gibco). 
Culture medium was changed 48 h after initial plating and then every 3-4 days 
until confluence. 
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2.8 Bioencapsulation set-up within magnetic-responsive multilayered 
capsules 
At 90% confluence, ASCs (passage 2) grown in T150 tissue culture flasks were 
washed with PBS and subsequently detached using TrypLETM Express solution 
(Life Technologies) at 37ºC for 5 min. PBS was added and the cell suspensions 
were centrifuged for 5 min at 300 g. Low viscosity sodium alginate from brown 
algae (1.5% w/v, ALG, ~250cP, Sigma-Aldrich) was dissolved in sodium 
chloride (0.15 M, NaCl, Enzymatic) containing MES hydrate (25 mM, Sigma-
Aldrich) at pH 7. The solution was sterilized by 0.22 µm filtration. 5x106 ASCs 
(5x106 cells per mL of alginate solution) were added to the surface 
functionalized PLLA microparticles with collagen II or with collagen II- TGF-β3 
(50 mg microparticles per mL of alginate solution). Under agitation, the 
alginate solutions loaded with the microparticles and the stem cells, were 
added drop wise using a 21 G needle to a calcium chloride solution (0.1 M, 
CaCl2, Merck) buffered with MES hydrate (25 mM, Sigma-Aldrich) at pH 7. 
After 20 min at RT, alginate hydrogel particles were collected and rinsed in a 
washing solution of NaCl (0.15 M, Sigma-Aldrich). The external membrane was 
processed by subsequent adsorption of oppositely charged polyelectrolytes by 
layer-by-layer deposition. Alginate hydrogel particles were first immersed in a 
poly(L-lysine) solution (PLL, Mw~30,000-70,000, pH 7, Sigma-Aldrich), and 
subsequently in ALG solution (pH 7), water-soluble highly purified chitosan 
solution (CHT, pH 6, Protasan UP CL 213, viscosity 107 mPa.s, Mw = 2.7x105 
g.mol-1, 83% degree of deacetylation, NovaMatrix) and, ultimately, in ALG 
solution again. The polyelectrolyte solutions (0.5 mg.mL-1) were dissolved in 
NaCl (0.15 M, Sigma-Aldrich) containing MES hydrate (25 mM, Sigma-Aldrich). 
Following an adsorption of 10 min for each polyelectrolyte, the excess of 
macromolecules was removed by immersion in NaCl (0.15 M, Sigma-Aldrich) 
for 5 min. This process was repeated until an 11-layered membrane was built. 
In the last adsorption of chitosan, the solution was loaded with the MNPs (1 
mg.mL-1). The coated hydrogels were immersed in EDTA (20 mM, Sigma-
Aldrich) at pH 7 for 5 min to liquefy the alginate core. Capsules with a 
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diameter of 1.5 mm ± 0.3 were obtained (measured by ImageJ software). The 
two formulations of liquified capsules obtained, namely Coll-ll/TGF-β3 and 
Coll-ll capsules were cultured in chondrogenic differentiation medium without 
(CD-TGF-β3) or with (CD+TGF-β3) TGF-β3 supplementation, respectively. The 
chondrogenic differentiation medium was prepared according to previously 
established culture conditions for ASCs chondrogenesis [3], namely DMEM-
High glucose (Life Technologies), FBS (10% v/v, Invitrogen), pen/step (1:100, 
Gibco), ITS+premix (1:100, Life Sciences), MEM sodium pyruvate (1:100, Life 
Technologies), proline (0.4 mM, Sigma-Aldrich), dexamethasone (100 nM, 
Sigma-Aldrich), and TGF-β3 (10 ng.mL-1, Peprotech). Additionally, capsules 
were also cultured in growth factor medium containing only DMEM-High 
glucose (Life Technologies), FBS (10% v/v, Invitrogen), and pen/step (1:100, 
Gibco). Capsules were transferred to non-adhesive 24-well plates and 
incubated at 37ºC in a humidified 5% CO2 air atmosphere. 
 
2.9 MTS quantification 
The viability of the encapsulated cells was assessed by mitochondrial 
metabolic activity quantification using a MTS colorimetric assay (CellTiter96® 
AQueous one solution cell proliferation assay, Promega) according to 
manufacture’s specifications. Capsules (n = 4 per well in triplicate) were 
incubated with the reagent kit (1 mL per well) at 37ºC protected from light. 
After 3 h, absorbance was read at 490 nm using a microplate reader (Gen 5 
2.01, Synergy HT, Biotek). 
 
2.10 DNA quantification 
Total DNA quantification was performed after cell lysis (Quant-iTTM PicoGreen® 
dsDNA assay kit, Life Technologies). Samples (n = 4 per well in triplicate) were 
suspended in ultra-pure sterile water (1 mL per well). After 1 h in a 37ºC 
shaking water bath, samples were frozen at -80ºC overnight. Samples were 
defrosted and used according to the specifications of the kit. A standard curve 
for DNA analysis was generated with the provided dsDNA solution. After 10 
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min of incubation at RT, fluorescence was read at an excitation wavelength of 
485/20 nm and 528/20 nm of emission using a microplate reader (Gen 5 
2.01, Synergy HT, Biotek). 
 
2.11 Glycosaminoglycans quantification 
The quantification of sulfated glycosaminoglycans (GAGs) was performed by 
the dimethylmethylene blue (DMB) assay [3]. Briefly, a digestion buffer at pH 
6.8 composed by phosphate buffer (200 nM, Na2PO4 and NaH2PO4, Sigma-
Aldrich) and EDTA (1 mM, Sigma-Aldrich) was prepared. To the digestion 
buffer (50 mL), papain (25 mg, papaya latex solution, Sigma-Aldrich) and L-
cysteine hydrochloride anhydrous (48 mg, Sigma-Aldrich) were added. The 
prepared papain solution was added to each well containing the capsules (1 
mL, n = 4 capsules, in triplicate). Samples were incubated at 65ºC for 18 h. To 
perform the DMB assay, a standard curve with chondroitin 4-sulfate 
(chondroitin sulfate A sodium salt from bovine trachea, Sigma-Aldrich) was 
prepared. Additionally, the DMB dye (16 mg, Sigma-Aldrich) was dissolved in 
absolute ethanol (5 mL), and then NaCl (2.37 g, Sigma-Aldrich) and glycine 
(3.04 g, Sigma-Aldrich) dissolved in distilled water (900 mL) were added. The 
pH was set to 3 and distilled water was added to make up 1 L. Samples or 
chondroitin sulfate standards (20 µL) were mixed with the prepared DMB dye 
(250 µL, Sigma-Aldrich) in a transparent 96-well plate. Absorbance was read at 
595 nm using a microplate reader (Gen 5 2.01, Synergy HT, Biotek). Total DNA 
quantification was used to normalize the DMB content. 
 
2.12 Histological analysis 
Capsules were collected and processed in an automatic ethanol-xylene spin 
tissue processor (STP120-2, Microm) for histological analysis. Afterwards, 
samples were embedded in paraffin and cut into sections of 5 µm thickness 
using a microtome (HM355S, Microm). Sections were subsequently 
deparaffinized, rehydrated, and automatically stained (HMS740, Microm) for 
safranin-O (0.1%, Sigma-Aldrich) and alcian blue (1%, Sigma-Aldrich) 
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stainings. Samples were then dehydrated and immersed in xylene, before 
being mounted (Entellan, Millipore). The stained sections were analyzed by 
inverted microscopy (Axio Imager Z1m, Zeiss). The presence of collagen II I the 
histological analysis was also assessed by an immunofluorescence assay. The 
antigen retrieval was performed in a heat-mediated sodium citrate buffer (10 
mM, Sigma-Aldrich). Non-specific binding was blocked by immersion in 
hydrogen peroxide (3% v/v) followed by BSA (3% w/v), each for 30 min at RT. 
Samples were then incubated overnight at 4ºC with the primary antibody rabbit 
anti-human collagen II (1:200 in 1% BSA, abcam). After PBS washing, samples 
were incubated for 1 h at RT with the secondary antibody anti-rabbit AlexaFluor 
488 (1:500 in 1% BSA, Molecular Probes). Ultimately, samples were 
subsequently counterstained with DAPI (1 mg.mL-1 diluted 1:1000 in PBS, 
Sigma-Aldrich) for 5 min at RT, immediately mounted (Permafluor, 
ThermoFisher Scientific), and analyzed in the dark by fluorescence microscopy 
(Axio Imager Z1m, Zeiss). 
 
2.13 Scanning electron microscopy (SEM) with energy dispersive X-ray 
spectroscopy (EDS) 
Capsules were washed with PBS and fixed at RT in formalin (10% v/v). After 1 
h, samples were dehydrated in an increasing gradient series of ethanol for 10 
min each.  EDPS mapping (15kV, JSM-6010LV, Jeol) of iron was performed at 
the surface of the capsules to visualize the surface adhesion of the MNPs. 
Afterwards, the membrane of the capsules was destroyed to expose the core 
contents. Samples were gold sputtering and subsequently visualized by SEM 
(15 kV, JSM-6010LV, Jeol). 
 
2.14 RNA extraction and cDNA production 
Capsules (n = 5 per well, in triplicate) stored in TRIzol (800 µL, Sigma-Aldrich) 
at -80ºC were slowly defrosted on ice and chloroform (160 µL, Fisher Chemical) 
was added. After 15 min at 4ºC, samples were centrifuged at 13000 rpm 
(Bioline, MCF-2360) for 15 min. The aqueous part of each sample was 
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collected and isopropanol (400 µL, BDH Prolabo) was added. Following an 
overnight incubation at -20ºC, samples were centrifuged at 13000 rpm for 10 
min at 4ºC. The resulting pellets were washed with ethanol (70% v/v) in 
RNase/DNase free distilled water (Lonza) and let to partially dry on air. 
Subsequently, the pellets were dissolved in RNase/DNase free distilled water 
(10 µL). RNA quantity and purity was determined in nanodrop 
spectrophotometer (NanoDrop ND-1000, ThermoScientific). Samples with a 
260/280 purity ratio higher than ~1.8 were used for cDNA synthesis. The 
cDNA synthesis was performed using a qScript cDNA SuperMix kit (Quanta 
Biosciences) and the MiniOpticon Real-time PCR Detection System (MJ Mini, 
BioRad). All samples were normalized (1 µg of RNA in 20 µL of RNase/DNase 
free distilled water). 
 
2.15 Quantitative real-time polymerase chain reaction 
The expression of the target genes were quantified in the cDNA samples using 
a real-time polymerase chain reaction (PCR) reaction. The target genes were 
normalized with 18S rRNA as the housekeeping. Th e primers (200nM) were 
designed to span exon-exon junctions using the primer-BLAST tool. The real-
time PCR reaction was performed using the PerfeCTa SYBR Green FastMix 
Reaction Mixes (Quanta Biosciences), according to manufacturer’s 
specifications. The reactions were monitored in a Mastercycler (Realplex4, 
Eppendorf) using the software realplex version 2.2 (Eppendorf). The 2-ΔΔCT 
method (Perkin-Elmer) was used to convert the normalized gene expression 
levels to fold differences. Results are expressed relatively to gene expression 
levels of Coll-II-PLLA capsules in chondrogenic medium at day 1. The primer 
sequences used in this analysis were: 18S: 5’-GAAACCTTCCGACCCCTCTC-3’, 
5’-TACGAGGTCGATTTGGCGAG-3’; COLLAGEN II: 5’-
CGGTGAGAAGGGAGAAGTTG-3’, 5’-GACCGGTCACTCCAGTAGGA-3’; AGGRECAN: 
5’-TGAGTCCTCAAGCCTCCTGT-3’, 5’-TGGTCTGCAGCAGTTGATTC-3’; SOX9: 5’-
TTCATGAAGATGACCGACGC-3’, 5’-GTCCAGTCGTAGCCCTTGAG-3’; COLLAGEN I: 
5’-AAGAACCCCAAGGACAAGAG-3’, 5’-GTAGGTGATGTTCTGGGAGG-3’; 
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COLLAGEN X: 5’-CAGGCATAAAAGGCCCACTA-3’, 5’-
AGGACTTCCGTAGCCTGGTT-3’. 
 
2.16 Statistical analysis 
Statistical analysis was performed using two-way analysis of variance (ANOVA) 
with Tukey’s post-hoc test (GraphPad Prism 6.0) and multiple comparisons. A 
p-value <0.05 was considered statistically significant. All results are presented 
as mean ± standard deviation. 
 
3. Results and discussion  
 
3.1. Functionalization features of the liquified magnetic-responsive capsules 
An overview of the proposed magnetic-responsive capsules is shown in Figure 
V.1A by light microscopy. The immobilization of the MNPs at the surface of the 
multilayered shell is evidenced in the histological cut of Figure V.1B. This 
allowed conferring magnetic-response properties to the capsules. By applying 
an external magnetic field, the movement of the capsules could be easily 
manipulated (Figure V.1B.1). Additionally, the movement of the capsules could 
be controlled to achieve aggregation or fixation at specific sites, as evidenced 
in Video V.S1. The membrane of the capsules was also analyzed by SEM 
(Figure V.1B.2), which revealed the morphology of MNPs. Due to the magnetite 
composition of the MNPs, their spatial dispersion could be also assessed by 
iron detection through EDS analysis (red dots in Figure V.1B.3). The presence 
of MNPs at the surface of the multilayered membrane indicates that they did 
not diffuse out, even after core liquefaction. This behavior is due to the 
electrostatic attraction between the negatively charged nanoparticles, and the 
positively charged chitosan polyelectrolyte solution used to construct the 
multilayered shell. The electrostatic attraction between chitosan and MNPs 
was studied by Wei et al. [35] by the production of microcapsules composed by 
crosslinked chitosan with embedded MNPs. Due to electrostatic attraction, it 
was observed that the MNPs could be kept stably inside the membrane even 
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after swelling in acidic conditions. By employing magnetic manipulation we 
envisage that capsules can aggregate and form moldable and complex 
macrostructures, in which each liquified capsules could work as 
compartmentalized building blocks. Capsules can be fixated in situ, and their 
motion can be controlled and guided into a specific spot. These features might 
be useful for the handling of the capsules during in vitro studies but also to 
guide and fixate the injectable capsules into a lesion site during implantation 
procedures. Additionally, due to the spherical shape of the capsules, and the 
flexibility of the shell combined with the liquified environment, we envisage that 
they can be implanted by injection. Importantly, besides movement control, 
the high surface area to volume ratio of MNPs provides abundant chemically 
active sites for functionalization and biomolecule conjugation, which may allow 
the implementation of other features. For example, it might allow incorporating 
anti-inflammatory drugs that might be useful during the healing process. In 
particular, Fe3O4 nanoparticles have received enormous interests and attracted 
the most attention due to its unique magnetic properties and biocompatibility. 
Therefore, capsules and MNPs have been combined in several biomedical 
applications, including targeted drug delivery, tissue engineering, magnetic 
thermotherapy (hyperthermia), magnetic resonance imaging, among others 
[36-38]. Previously, we immobilized rhodamine after a modification with a 
silane (APTES) at the surface of the proposed MNPs to monitor the cellular 
uptake and then further assemble cells in a sheet-like 3D structure [33].  
Moreover, due to the multilayered shell, the encapsulated material is physically 
isolated from the surrounding environment. This can represent a great 
advantage for cartilage regeneration strategies since it can prevent not only the 
invasion of cells from the immune system, but also to customize the ability of 
the membrane to avoid the ingrowth of the vascular system, thus 
recapitulating the avascular environment of natural cartilage. 
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Figure V.1 - (A) Macroscopic visualization of magnetic-responsive liquified capsules encapsulating PLLA 
microparticles coated with collagen II and immobilized TGF-β3. (B) Membrane visualization with surface 
modified MNPs at the surface after histological cut of a liquified capsule. (B1) The magnetic-response 
ability of capsules is showed by manipulation of its movement in different directions (arrows) with the aid 
of an external magnet from t0-t3 (t stands for time). The presented images are print screens from Video 
V.S1. (B2) SEM visualization of MNPs and (B3) its dispersion by EDS iron mapping (red) at the surface of 
the multilayered membrane of capsules. (C) Quantification of collagen II (µg) by Sircol Collagen assay and 
TGF-β3 (ng) by ELISA assay of 50 mg of microparticles (n = 5). (C1) Collagen staining (red) at the surface 
of microparticles before Sircol quantification. (C2) Immunofluorescence of TGF-β3 (green) at the surface 
of microparticles after 7 days of immersion in PBS. 
 
The functionalization of the encapsulated PLLA microparticles was performed 
by collagen II coating, a main component of cartilage, and TGF-β3 
immobilization, a well-known chondrogenic differentiation factor. Combing 
plasma treatment with collagen coating allow to improve cell adhesion 
properties of the surface of PLLA microparticles, either by improving its 
roughness and by creating cell-material binding domains, as previously showed 
in our report with collagen I and L929 cells [30]. The amount of collagen II and 
TGF-β3 on the surface of 50 mg of microparticles was quantified by Sircol 
Collagen and ELISA assays, respectively (Figure V.1C). For a quantification of 
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79.63 µg ± 9.71 of collagen II, the amount calculated per area is 1.5 µg/cm2 ± 
0.2, using the PLLA density (1.25 g/cm3) and the area and volume equations 
of spheres with the medium diameter of 45.5 µm. As showed in Figure V.1C.1 
the collagen II coating stained in red was uniformly distributed at the surface 
of microparticles. The amount of TGF-β3 in the surface of microparticles was 
calculated after ELISA quantification of the supernatant solution. Similarly, for 
a quantification of 9.81 ng ± 0.01 the amount calculated per area is 0.2 
ng/cm2. Only a small amount remained in the supernatant solution, indicating 
that a large amount of the TGF-β3 present in the coating solution was used to 
coat the surface of the PLLA microparticles. Additionally, after 7 days of PBS 
immersion, the presence of TGF-β3 at the surface of the microparticles could 
be detected by green fluorescence (Figure V.1C.2), while no traces of TGF-β3 
release in the PBS solution could be detected by ELISA assay (data not shown). 
This can be explained by the sustained release of TGF-β3, and thus the amount 
of protein released could be bellow the detection level of ELISA assay, or by an 
irreversibly crosslinking to the surface of the PLLA microparticles that avoids 
the protein release. Nevertheless, either sustained or avoided, it revealed a 
strong binding of TGF-β3 to the surface of microparticles that might be 
explained by the efficient enzymatic crosslinking reaction with TG2. In vitro 
studies demonstrated that a wide range of natural and synthetic biomaterials 
crosslinked by TG2 have improved stability by increasing strength and 
resistance to proteolytic digestion [39, 40]. Overall, TG2 contributes 
significantly to the organization of ECM by mediating cell-matrix interactions 
that affect cell spreading and migration [41, 42], and also has an interesting 
role in the activation of the latent form TGF-β in the ECM [43]. Some of the 
tasks of TG2 are accomplished through its unique ability to bind fibronectin, as 
firstly reported by Lorand et al. [44] and further generate ternary complexes 
with collagen [45], and integrins (β1 and β3) [46]. In articular cartilage, TG2 
contributes to the control of cell differentiation and it is involved in the 
crosslinking of a number of cartilage components, such as fibronectin, collagen 
II, and osteopontin [27]. In vitro studies already showed that the TG2 
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crosslinking of collagen matrices with TGF-β3 promoted the chondrogenic 
differentiation of human bone marrow-derived mesenchymal stem cells [47]. 
Although providing soluble TGF-β3 in the culture medium has been widely used 
for stem cells chondrogenesis in vitro [3], this strategy is difficult to apply in 
vivo because of complexities involved in spatially controlling dosing locale, 
maintaining constant concentration over time and mitigating cost. Therefore, 
those systems require previous in vitro differentiation of stem cells before 
implantation. However, readily to use devices are much more attractive in TE 
applications. Therefore, we envisage that the immobilization of TGF-β3 in the 
microparticles surface will provide an appropriate 3D platform for 
chondrogenic differentiation, which could be proposed as a readily 
implantation device for cartilage regeneration.  
 
3.2. Cell viability, proliferation and morphology, and glycosaminoglycans 
production 
The viability of the encapsulated cells and their ability to proliferate and 
produce glycosaminoglycans within the liquified compartments were assessed 
up to 28 days post-encapsulation (Figure V.2A). Overall, MTS and DNA results 
increased with time, demonstrating that the process of generating capsules did 
not jeopardize the viability and proliferation of the encapsulated cells. Cells 
encapsulated in capsules cultured in chondrogenic differentiation medium 
have a significantly increase viability against growth medium. Of note, Coll-
ll/TGF-β3 capsules cultured in CD-TGF-β3 reached a maximum value at 21 days, 
while Coll-ll capsules cultured in CD+TGF-β3 at 14 days. This difference can be 
explained by the different proliferation profiles as showed after DNA 
quantification. DNA quantification results demonstrate that the encapsulated 
cells were able to proliferate in both capsules. Analyzing the two proliferation 
profiles, it seemed that the proliferation ability of the Coll-ll capsules cultured 
in CD+TGF-β3 evolved in a more restrained fashion since the beginning of the 
experiment, with no significant differences between 14 and 21 days. On the 
other hand, this occurred later for the Coll-ll/TGF-β3 capsules cultured in CD-
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TGF-β3 in which no significant differences were found between 21 and 28 days. 
The two different proliferation profiles might be indicative of two different cell 
differentiation profiles, in which an earlier differentiation might be occurring in 
the Coll-ll capsules. On the other hand, as observed in the viability results, 
capsules cultured in growth medium have a significant lower proliferation 
against chondrogenic medium.  
To test the hypothesis of having two different cell differentiation profiles when 
providing TGF-β3 by two different pathways, glycosaminoglycans (GAGs) 
production, a key component of cartilage-specific matrix, was quantified. The 
results found for GAGs production corroborate the hypothesis formulated when 
analyzing the proliferation ability, namely the existence of two different cell 
differentiation profiles. While Coll-ll/TGF-β3 capsules cultured in CD-TGF-β3 show 
a more discreet increase in the GAGs production, in Coll-ll capsules cultured in 
CD+TGF-β3 a rapid increase in the beginning of the experiment was observed. 
Nevertheless, after 28 days of culture both formulations of capsules produced 
similar amounts of GAGs. Therefore, an important finding to highlight is that 
not only the immobilization of TGF-β3 was sufficient to stimulate the 
encapsulated stem cells to differentiate into the chondrogenic lineage in 
chondrogenic medium without TGF-β3 supplementation, but also that it lead to 
similar levels of GAGs production compared to the Coll-ll capsules with 
exogenous TGF-β3 supplementation. Importantly, Coll-ll/TGF-β3 capsules 
cultured in GM revealed production levels of GAGs significantly higher at day 
28 compared to Coll-ll capsules in the same medium. Therefore, although 
significantly lower compared to capsules in chondrogenic medium, the 
immobilization of TGF-β3 when using GM contributed to a higher GAGs 
production compared to Coll-ll capsules cultured in the same medium. 
Importantly, this demonstrates that the immobilized TGF-β3 on the surface of 
microparticles is influencing the production of GAGs, thus demonstrating its 
bioactivity. The significantly lower GAGs production in Coll-ll/TGF-β3 cultured 
in GM compared to the same capsules cultured in CD+TGF-β3 or to Coll-ll 
capsules in CD-TGF-β3 might be increased with increasing the immobilization of 
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TGF-β3. As quantified by ELISA (Figure V.1C), since almost all of TGF-β3 was 
used to coat the microparticles, with increasing concentrations of TGF solution 
a higher amount of protein might be immobilized. In future developments, we 
intend to test different concentrations of TGF-β3 to immobilize at the surface 
of microparticles and study its influence on chondrogenesis of stem cells. 
The ECM deposited by the encapsulated cells inside Coll-ll/TGF-β3 capsules 
cultured in CD-TGF-β3 or Coll-ll capsules in CD+TGF-β3 was analyzed by SEM 
(Figure V.2B). At day 7 of post-encapsulation, collagen fibrils characteristic 
from a cartilage-like ECM could be seen in the core of both capsules. In natural 
cartilage, the collagen fibrils are located throughout the matrix and are 
intertwined with highly concentrated negatively charged proteoglycan matrix 
[3]. Moreover, several aggregates could be found inside liquified capsules, as 
showed in the 150x magnification images at day 28. Besides the influence of 
growth factors, the three-dimensional (3D) environment is also an essential 
component in the chondrogenesis ability [48]. The use of a pellet culture 
mimics the development of cartilage during limb formation and is therefore 
often used as a method for understanding how the interaction of cells, growth 
factors and environmental factors promotes a chondrogenic phenotype [49]. 
The co-encapsulation of stem cells with microparticles within a liquified 
environment allowed cells to differentiate and freely construct their own 3D 
physical support, giving rise to micro aggregates. In capsules cultured in GM, 
the formation of collagen fibrils could not be visualized (Figure V.SI) neither 
the formation of large aggregates. However, in Coll-ll capsules a dense ECM 
deposition covering the microparticles could be visualized, with encapsulated 
cells presenting a highly stretched morphology. If chondrogenesis might be 
occurring on those capsules, this could be indicative of a more hypertrophic 
chondrogenic differentiation pathway. 
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Figure V.2 – (A) MTS, DNA and GAGs quantification of Coll-II/TGF-β3 capsules cultured in chondrogenic 
differentiation medium without TGF-β3 supplementation (CD-TGF-β3) and Coll-II capsules cultured in 
chondrogenic differentiation medium with TGF-β3 supplementation (CD+TGF-β3) up to 28 days. Coll-II/TGF-
β3 and Coll-ll capsules cultured in growth medium (GM) were also analyzed. GAGs results were 
normalized by total DNA. Significant differences were marked with *(p < 0.05), **(p < 0.01), ***(p < 
0.001) and ****(p < 0.0001) (n = 3 with 4 capsules per well). (B) SEM images of the core of Coll-II/TGF-
β3 and Coll-ll capsules cultured in CD-TGF-β3 or CD CD+TGF-β3, respectively, revealing the presence of 
collagen fibrils in the extracellular matrix. Magnifications of 3000x and 1000x are showed. Magnifications 
of 150x show an overview of the aggregates formed inside liquified capsules. 
 
3.3 Histological analysis of the cartilage-like extracellular matrix 
The histological evaluation, presented in Figure V.3, corroborated the findings 
of a cartilage-like ECM found inside Coll-ll/TGF-β3 cultured in CD-TGF-β3 and 
Coll-ll capsules in CD+TGF-β3. With increasing cell culture time, the staining of 
glycosaminoglycans (in red by safranin-O staining) and proteoglycans (in blue 
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by alcian blue staining) become more intense. At day 28, an ECM fully rich in 
glycosaminoglycans and proteoglycans was found. As already observed by SEM 
(Figure V.2B), in which micro aggregates composed by cells and 
microparticles were visualized, in the rich ECM of the aggregates the blank 
dots correspond to the space previously occupied by the microparticles. 
Moreover, the ECM of the capsules was positive for the chondrogenic marker 
collagen II (in green by immunofluorescence staining). On the other hand, as 
expected by the above-discussed results, capsules in GM had a lower staining 
intensity of GAGs (Figure V.SI). However, in Coll-ll/TGF-β3 in GM higher GAGs 
content could be visualized compared to Coll-ll capsules in the same medium.  
 
 
 
Figure V.3 - Histology analysis of Coll-II/TGF-β3 and Coll-ll capsules cultured in chondrogenic differentiation medium 
without (CD-TGF-β3) or with (CD+TGF-β3) TGF-β3 supplementation, respectively. The presence of sulfated 
glycosaminoglycans is evidenced in red and blue by safranin-O and alcian blue stainings, respectively. At day 28, the 
presence of collagen II (green) in extracellular matrix is visualized counterstained with DAPI (blue) by 
immunocytochemistry. 
 
3.4 Genetic quantification of chondrogenic markers 
Gene expression levels of selected chondrogenic and hypertrophic markers 
after 28 days of culture are shown in Figure V.4. Results show that the 
expressions of COLLAGEN II, AGGRECAN, and SOX9 in the Coll-ll/TGF-β3 
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capsules were similar to Coll-ll capsules when comparing both formulations 
within each medium, namely chondrogenic differentiation (-TGF-β3 or +TGF-
β3) or growth media. Therefore, the immobilization of TGF-β3 in the 
microparticles was efficient in upregulating the chondrogenic markers to 
similar levels compared to the standard condition, i.e. the supplementation of 
TGF-β3 in the culture medium. Knowing that in the native ECM of cartilage, 
collagen II is the primary protein and aggrecan the main proteoglycan found, 
and that SOX9 encodes a potent chondrogenic transcription factor closely 
correlated with collagen II transcription [50], it can be stated that a successful 
chondrogenic differentiation within Coll-ll/TGF-β3 capsules in the absent of 
exogenous TGF-β3 was achieved. TGF-β3 has been proposed as the initial 
differentiation stimulus of stem cells towards the chondrogenic lineage [51]. 
After achieving the chondrogenic differentiation inside the Coll-ll/TGF-β3 
capsules, our main concern was the maintenance of the phenotype to avoid the 
characteristic drawback of dedifferentiation. In fact, the most challenging 
achievement when aiming chondrogenesis is not the differentiation pathway 
but rather the maintenance of the phenotype. Commonly, these cells shift the 
synthesis of collagen II to I, a characteristic marker of a fibroblastic cartilage 
[4]. In an attempt to avoid hypertrophic differentiation along the 
chondrogenesis of stem cells different strategies have been successfully 
proposed. Kim et al. [52] showed that a brief exposure of only 1 week of MSC 
cultures to high levels (100 ng.mL-1) of TGF-β3 was capable of inducing and 
maintaining stem cells chondrogenesis. Dahlin et al. [17] co-cultured stem cells 
and chondrocytes in chondrogenic differentiation medium for two weeks, and 
showed their phenotype stability after the removal of TGF-β3 for an additional 
culture time of two weeks. Others suggested that hypoxia, like growth factors 
or hormones, may be a potential tool to control the hypertrophic differentiation 
of stem cells [53]. 
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Figure V.4 – Gene expression in fold changes, first internally normalized to 18S and then normalized to 
the expression of Coll-ll capsules in normal chondrogenic medium at day 1, which was normalized to 1 
(dotted line at y = 1). Chondrogenic (COLLAGEN II, AGGRECAN, and SOX9) and hypertrophic (COLLAGEN X 
and COLLAGEN I) markers are tested after 28 days post-encapsulation. Coll-II/TGF-β3 capsules cultured 
in chondrogenic differentiation medium without TGF-β3 supplementation (CD-TGF-β3) or in growth medium 
(GM), and Coll-II capsules cultured in chondrogenic differentiation medium with TGF-β3 supplementation 
(CD+TGF-β3) or in growth medium (GM) are analyzed. Significant differences were marked with *(p < 0.05), 
**(p < 0.01), ***(p < 0.001) and ****(p < 0.0001) (n = 3 with 4 capsules per well). 
 
In our work, although at lower levels, the chondrogenic genes were also 
upregulated in the capsules cultured in growth medium. Knowing that ASCs 
highly express collagen I [3], it is relevant to monitor its expression. The 
collagen I transcripts reveal the degree to which fibrous tissue may develop. 
Additionally, collagen X, the hallmark of hypertrophic cartilage [54], is found in 
the transition from articular cartilage to bone. Analyzing the expression of 
COLLAGEN I and X in the capsules cultured in growth medium, they were 
upregulated in Coll-ll capsules, while in Coll-ll/TGF-β3 capsules only 
COLLAGEN X was upregulated. Considering the high expression level of 
COLLAGEN X in Coll-ll/TGF-β3 capsules cultured in GM, we consider that the 
tissue formed within those capsules was toward an ossification pathway, 
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corroborating the SEM observations. Despite the upregulation of COLLAGEN X, 
the positive effect on ASCs chondrogenesis after the immobilization of TGF-β3 
is again demonstrated when comparing the genetic profiles of both capsules in 
growth medium. Therefore, this particular result highlights not only the 
positive influence resulted from the immobilization of TGF-β3 in the surface of 
microparticles, by limiting to a certain extend the hypertrophic differentiation 
of chondrogenically-induced stem cells; but it also highlights the bioactivity of 
the immobilized TGF-β3. On the other hand, in Coll-ll/TGF-β3 capsules 
cultured in chondrogenic medium without TGF-β3, both hypertrophic genes 
were downregulated. The same behavior was found for Coll-ll capsules cultured 
in normal chondrogenic medium. Notably, the genetic profile analysis shows 
that the immobilization of TGF-β3 was not only able to differentiate the 
encapsulated stem cells but to maintain their chondrogenic phenotype of a 
hyaline cartilage. The in vivo delivery of effective concentrations of growth 
factors can be challenging as the in vivo environment can lead to rapid removal 
of the proteins from the lesion site, loss of bioactivity, or low availability as a 
result of the slow tissue diffusion of large proteins [55]. Hence, we believe that 
the results obtained in this work are of great importance for cartilage 
regeneration strategies. We trust that the proposed capsules with immobilized 
TGF-β3 might potentially allow for better success in regenerating the cartilage 
tissue. 
 
4. Conclusion 
The suitability for chondrogenic differentiation within magnetic-responsive 
liquified capsules co-encapsulating stem cells and surface modified PLLA 
microparticles was assessed. The results showed that, in the absence of TGF-
β3 supplementation, the immobilization of TGF-β3 crosslinked by TG2 to 
collagen II was able to induce the chondrogenic differentiation and, 
importantly, the phenotype maintenance of the encapsulated stem cells. 
Notably, the chondrogenesis observed occurred in similar levels of those found 
for capsules cultured in normal chondrogenic differentiation medium, which 
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used higher amounts of TGF-β3. We demonstrated the feasibility of an 
engineered self-regulated chondromimetic device that represents an efficient 
easy-to-handle and injectable tool aiming cartilage regeneration. The use of 
such capsules can be further envisaged as a one-step clinically translatable 
protocol for cartilage repair, presenting many advantages over current 
treatments. In future works, we envisage to test different amounts of protein 
immobilization and assess its influence on achieving different chondrogenesis 
levels. We also propose to add more features to the chondromimetic device to 
fulfill all the required and challenging conditions for a successful total cartilage 
repair, as well as to assess the outcome of this promising encapsulation 
strategy in vivo. 
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Figure V.SI - SEM images and histology analysis by safranin-O and alcian blue stainings of the core of 
Coll-II/TGF-β3 and Coll-ll capsules cultured in growth medium (GM) for 28 days. 
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Chapter VI 
Semipermeable capsules wrapping a multifunctional and self-regulated co-
culture microenvironment for osteogenic differentiation 6 
 
Abstract 
A new concept of semipermeable reservoirs containing co-cultures of cells and 
supporting microparticles is presented, inspired by the multi-phenotypic 
cellular environment of bone. Based on the deconstruction of the “stem cell 
niche”, the developed capsules are designed to drive a self-regulated 
osteogenesis. PLLA microparticles functionalized with collagen I, and a co-
culture of adipose stem (ASCs) and endothelial (ECs) cells are immobilized in 
spherical liquified capsules. The capsules are coated with multilayers of poly(L-
lysine), alginate, and chitosan nano-assembled through layer-by-layer. 
Capsules encapsulating ASCs alone or in a co-culture with ECs are cultured in 
endothelial medium with or without osteogenic differentiation factors. Results 
show that osteogenesis is enhanced by the co-encapsulation, which occurs 
even in the absence of differentiation factors. These findings are supported by 
an increased ALP activity and matrix mineralization, osteopontin detection, 
and the up regulation of BMP-2, RUNX2 and BSP. The liquified co-capsules also 
act as a VEGF and BMP-2 cytokines release system. The proposed liquified 
capsules might be a valuable injectable self-regulated system for bone 
regeneration employing highly translational cell sources. 
 
 
 
 
 
6 Based on the publication: C.R. Correia, R.P. Pirraco, M.T. Cerqueira, A.P. Marques, R.L. Reis, J.F. Mano, 
Semipermeable capsules wrapping a multifunctional and self-regulated co-culture microenvironment for 
osteogenic differentiation, Sci. Rep., 6 (2016) 21883. 
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1. Introduction 
The successful regeneration of bone remains a significant challenge in 
orthopedic research. Strong affords have been made as a potential alternative 
to the conventional use of bone grafts due to their limitless supply and no 
disease transmission. In particular, vascularization remains an obstacle to 
engineer large volume bone tissues. In order to face such challenges, new 
generations of devices for tissue engineering (TE) should improve the physical 
and biochemical cues operating in tandem during native regeneration, in 
particular at the scale/organizational-level of the stem cell niche. The 
understanding and the deconstruction of these factors (e.g. multiple cell types 
exchanging both paracrine and direct signals, structural and chemical 
arrangement of the extracellular matrix, mechanical signals) should be then 
incorporated into the design of advanced and clinically relevant biomimetic 
biomaterials [1]. Moreover, biomimetic biomaterials have been increasingly 
combined with multi-phenotypic cells to produce new advanced systems that 
better model the complex cellular environment of natural tissues. Particularly, 
considering the highly vascularized network of bone, osteoprogenitor cells 
inevitably interact with endothelial cells (ECs) in a synergetic fashion [2, 3]. 
The cellular interactions facilitate viability and proliferation as well as 
generation of growth factors and proteins that promote osteogenic and 
angiogenic differentiation, while enabling other key biological tasks during 
bone development [4, 5]. Different fundamental studies have established that a 
reciprocal interaction, both physical and biochemical, between osteoblasts, 
stem cells and endothelial cells occurs during osteogenesis, as well as the 2D 
interaction between endothelial and stem cells towards osteogenic 
differentiation was already demonstrated in vitro and in vivo [6-13]. While 
endothelial cells secrete numerous regulatory molecules that influence the 
differentiation and activity of bone forming cells [14-17], 
osteoblasts/osteoprogenitor cells release diverse pro-angiogenic growth factors 
[7, 18-20]. However, the commonly used co-culture systems involve the 
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challenge of generating stable in vitro pre-vasculature in the constructs with 
typically a slow rate of anastomosis efficacy. Moreover, conventional porous 
hybrid scaffolds have typically a fixed geometry and need to be implanted 
under open surgery. Alternatives to transport biomaterials and cells are 
injectable systems that could carry all the necessary cargo able to stimulate 
upon implantation the formation of new bone vascularized tissue using 
minimally invasive procedures [21]. To achieve such concept, one could 
envisage the development of an injectable device, pre-cultured with cells that 
could have all the necessary instructive signals to upon implantation generate 
new bone tissues and an initial support for angiogenesis that is expected to 
integrate with time with the surrounding vasculature. Considering the referred 
requirements, we propose a rather unique combination of functional 
biomaterials and cells for the groundbreaking advances of engineering self-
regulated 3D compartmentalized devices. We aim to transfigure the concept of 
conventional 3D scaffolds for TE, typically associated on the use of porous 
structures or hydrogels to support cells, by using an alternative hierarchical 
methodology in which solid microparticles and cells are wrapped by 
semipermeable capsules. Our previous studies demonstrated already the 
suitability of the liquified capsules as successful bioencapsulation devices [22, 
23]. In this work, inspired by the native co-existence of multiple cell types and 
from the concept of deconstructing the “stem cell niche” [1], we propose for 
the first time to use liquified capsules as self-regulated co-encapsulation 
reservoirs of stem and endothelial cells. Owing to a number of appealing 
features, such as being available in large quantities with diminutive donor site 
morbidity or patient discomfort, adipose tissue was the source used to isolate 
both cell types. Scheme VI.1 represents the methodology of the production of 
the capsules. Capsules are composed by three essential components: (i) a 
permselective membrane barrier that wraps the liquefied core of the capsule, 
ensuring permeability to essential molecules for cell survival, flexibility to the 
capsule, and enhancing direct contact between the encapsulated materials; (ii) 
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surface functionalized collagen I poly(L-lactic acid) (PLLA) microparticles as 
cell adhesion sites; and (iii) a co-culture of adipose stem (ASCs) and 
endothelial (ECs) cells. 
 
Scheme VI.1 - Production of the proposed liquified multilayered capsules encapsulating poly(L-lactic 
acid) microparticles coated with collagen I, and adipose stem (orange, ASCs) and endothelial cells (red). 
The loaded hydrogel particles are obtained after the ionotropic gelation of alginate in a calcium chloride 
(CaCl2) bath. Then, layer-by-layer is performed with the polyelectrolytes, namely poly(L-lysine), alginate, 
and chitosan, in order to produce the multilayered membrane. Ultimately, the liquified core is obtained 
by chelation with EDTA. As the time of culture increases, the encapsulated cells subsequently adhere to 
the surface of microparticles, proliferate, and create cell aggregates. The ASCs start to differentiate into 
the osteogenic lineage (color change from orange to yellow) and ultimately a mineralized osteogenic 
matrix is obtained inside the liquified environment of capsules. The multilayered membrane allows the 
exchange of essential molecules for cell survival. 
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The membrane of the capsules is produced using the layer-by-layer assembly. 
Although many interactions may be employed for the build-up of the 
multilayers [24], we employed simple electrostatic forces for assembling 
oppositely charged polyelectrolytes. Our main hypothesis is that ECs would 
provide a more physiologically relevant microenvironment, while regulating the 
structure and function of ASCs towards the osteogenic lineage (ASCs have 
been shown in numerous studies to exhibit the potential to contribute to 
chondrogenesis, osteogenesis, adipogenesis, myogenesis as well as some 
aspects of neurogenesis [25-28]). Therefore, we expect that ECs would led 
ASCs to differentiate without requiring the supplementation of two main 
osteogenic differentiation factors, namely dexamethasone and ascorbic acid. 
Moreover, we expect that the liquefied environment of the capsules will assure 
the excellent diffusion of nutrients to the encapsulated cells, even those at the 
inner region of the capsule, and spatial freedom for cell communication and 
self-organization. The biodegradable nature of the capsules, combined with 
their intrinsic osteo- and angiogenic natures, could engender a novel 
generation of injectable biomimetic systems with clinically viability to be used 
in orthopedic applications. To test our hypothesis, the multifunctional liquified 
capsules encapsulating only ASCs (MONO capsules) or a co-culture with ECs 
(CO capsules) were cultured in endothelial medium with (EDAG medium) or 
without (EG medium) osteogenic differentiation factors. 
 
2. Materials and methods 
 
2.1 Cells isolation from adipose tissue 
Subcutaneous adipose tissue from liposuction procedures was used to isolate 
both human adipose stem cells (ASCs) [29] and human adipose microvascular 
endothelial cells (ECs) [30]. The collected tissues were obtained under a 
cooperation agreement between the 3B’s Research Group and Hospital da 
Prelada (Porto, Portugal), after approval of the Competent Ethics Committee 
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(CEC). The human tissues received were handled in accordance with the 
guidelines approved by the CEC. Informed consent was obtained from all 
subjects. Briefly, samples were transported in phosphate-buffered saline (PBS, 
Sigma-Aldrich) supplemented with penicillin-streptomycin (10%, pen-strep, 
Gibco) and kept at 4ºC. The lipoaspirates were washed with PBS and incubated 
with collagenase type II A (0.05% w/v, Sigma-Aldrich) for 45 min at 37ºC in a 
shaking water bath. The digested samples were filtered (200 µm) and 
centrifuged at 800 g for 10 min at 4ºC. The obtained stromal vascular fraction 
(SVF) was resuspended in erythrocyte lysis buffer at pH 7.4 containing 
ammonium chloride (155 mM, Merk), potassium bicarbonate (5.7 mM, Riedel-
de-Häen), and ethylenediaminetetraacetic acid (0.1 M, EDTA, Sigma-Aldrich) in 
distilled water. After 10 min of incubation at room temperature (RT), the 
mixture was centrifuged at 300 g for 5 min. To isolate the ASCs the red blood 
cell-free SFV was resuspended in α-MEM medium (Invitrogen) supplemented 
with fetal bovine serum (10%, FBS, Invitrogen) and pen-strep (1% v/v). To 
isolate the ECs the red blood cell-free SFV was resuspended in EndoGroTM-MV-
VEGF complete media kit (Millipore Iberica). The ECs were plated in cell 
culture flasks, previously coated with gelatin (0.7% w/v, porcine skin type A, 
Sigma-Aldrich) for 30 min at 37ºC. Culture medium was changed 48 h after 
initial plating and then every 3-4 days for both cell phenotypes.  
 
2.2 Microparticles production and surface functionalization 
PLLA microparticles were produced by oil/water (o/w) emulsion technique and 
surface modified by combining plasma treatment with collagen I as similarly 
described in our previous reports [22, 23]. PLLA (5% w/v, Mw~1,600-2,400, 
70% crystallinity, Polysciences) was dissolved in methylene chloride (CH2Cl2, 
Fisher Chemical). Under agitation, this solution was added to polyvinyl alcohol 
(0.5%, PVA, Sigma-Aldrich). After 2 days at RT, the produced microparticles 
were subsequently collected, washed with distilled water, and lyophilized 
(Cryodos, Telstar). Microparticles were then placed in a plasma reactor 
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chamber (PlasmaPrep5, Gala Instrumente) fitted with a radio frequency 
generator. Air was used as the working atmosphere. A glow discharge plasma 
(0.2 mbar, 30 V) was created for 15 min. Subsequently, microparticles (500 
mg) were immersed in collagen I (1200 µg, rat protein tail, Gibco) diluted in 
acetic acid (0.02 M) for 4 h at RT. 
 
2.3 Mono- and co-cultures set up 
At 90% confluence, ASCs (passage 2) and ECs (passage 4-6) grown in T150 
tissue culture flasks were washed with PBS and subsequently detached using 
TrypLETM Express solution (Life Technologies) at 37ºC for 5 min. PBS was 
added and the cell suspensions were centrifuged for 5 min at 300 g. Low 
viscosity sodium alginate from brown algae (1.5% w/v, ALG, ~250 cP, Sigma-
Aldrich) was dissolved in sodium chloride (0.15 M, NaCl, Enzymatic) 
containing MES hydrate (25 mM, Sigma-Aldrich) at pH 7. The solution was 
sterilized by 0.22 µm filtration. 5x106 ASCs (5x106 cells per mL-1 of alginate) 
alone or mixed with ECs (5x106.mL-1 of alginate, co-culture ratio 1:1) were 
added to the microparticles (50mg.mL-1 of alginate). The alginate solutions 
were then used to produce liquified capsules encapsulating ASCs alone (MONO 
capsules) or in co-culture with ECs (CO capsules). 
 
2.4 Liquified multilayered capsules production 
All the conditions used to produce the liquified capsules (the combination of 
the polyelectrolytes, concentration, pH, number of layers, and time of 
adsorption and liquefaction) were optimized in our previous studies [22, 23]. 
The alginate solutions containing cells and microparticles were added drop 
wise using a 21 G needle to calcium chloride (0.1 M, CaCl2, VWR) buffered with 
MES hydrate (25 mM, Sigma-Aldrich) at pH 7. After 20 min at RT, alginate 
hydrogels were collected and rinsed in a washing solution of NaCl (0.15 M). 
The external membrane was processed by subsequent adsorption of oppositely 
charged polyelectrolytes by layer-by-layer deposition. Alginate hydrogel 
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particles were first immersed in a poly(L-lysine) (PLL, Mw~30,000-70,000, pH 
7, Sigma-Aldrich), and subsequently in ALG solution (pH 7), water-soluble 
highly purified chitosan (CHT, pH 6, Protasan UP CL 213, viscosity 107 mPa.s, 
Mw=2.7x105 g.mol-1, 83% degree of deacetylation, NovaMatrix), and, 
ultimately, in ALG solution again. The polyelectrolyte solutions (0.5 mg.mL-1) 
were dissolved in NaCl (0.15 M) containing MES hydrate (25 mM). Following a 
10 min period for each polymer adsorption, the excess of macromolecules was 
removed by immersion in NaCl (0.15 M) for 5 min. This process was repeated 
three times in order to obtain a 12-layered membrane. The coated hydrogels 
were immersed in EDTA (20 mM) at pH 7 for 5 min to liquefy the alginate core. 
The two formulations of liquified capsules obtained were cultured in 
EndoGroTM-MV-VEGF complete kit media without ascorbic acid (E). To the E 
medium, β-glycerophosphate (10 mM, G, Sigma-Aldrich) were added, here 
termed as EG medium. Additionally, capsules were also cultured in E medium 
containing all the osteogenic differentiation factors, namely, dexamethasone 
(10 nM, D, Sigma-Aldrich), ascorbic acid (50 µg.mL-1, A), and β-
glycerophosphate (10 mM, G, Sigma-Aldrich), here termed as EDAG medium. 
Capsules were transferred to non-adhesive 24-well plates and incubated at 
37ºC in a humidified 5% CO2 air atmosphere. The entire procedure was 
performed under sterile conditions. All the solutions used at this step were 
sterilized by filtration through a 0.22 µm filter. 
 
2.5 Flow cytometry analysis 
The phenotypic profile of ASCs and ECs was assessed regarding mesenchymal 
(CD105-FITC, Arium; CD90-APC, and CD73-PE, BD Biosciences) and 
endothelial (CD31-APC, Citomed) markers before and after encapsulation 
within MONO and CO capsules. Isolated and encapsulated cells were harvested 
by TrypLETM Express solution (Life Technologies) at 37ºC for 5 min, and 
centrifuged. Samples were resuspended in PBS solution containing bovine 
serum albumin (3% w/v, BSA, Sigma-Aldrich) and the specified antibodies at 
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the dilutions defined by the manufacture’s specifications. After 20 min at RT, 
samples were subsequently washed with PBS, centrifuged, fixed in PBS with 
formaldehyde (1% v/v, Sigma-Aldrich), and analyzed in a flow cytometer (BD 
FACSCalibur, CellQuest v3.3 software, BD Biosciences). 
 
2.6 Lipophilic fluorescent labeling 
Prior to encapsulation, ASCs and ECs were incubated with the lipophilic dyes 
3,3’-dioctadecyloxacarbocyanine perchlorate (DIO, green) and 1,1’-dioctadecyl-
3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DIL, orange), respectively. 
Cells were incubated with each dye (1 mL, 2 µM per 1x106 cells) at 37ºC for 10 
min. Labeled cells in the MONO and CO capsules were visualized by confocal 
microscopy (TCS SP8, Leica). 
 
2.7 Mitochondrial metabolic activity quantification 
Mitochondrial metabolic activity quantification was performed using a MTS 
colorimetric assay (CellTiter96® AQueous one solution cell proliferation assay, 
Promega) according to manufacture’s specifications. Capsules (n = 4 per well 
in triplicate) were incubated with the reagent kit (1 mL per well) at 37ºC 
protected from light. After 3 h, absorbance was read at 490 nm using a 
microplate reader (Gen 5 2.01, Synergy HT, Biotek). 
 
2.8 Cell proliferation quantification 
Total DNA quantification was performed after cell lysis (Quant-iTTM PicoGreen® 
dsDNA assay kit, Life Technologies). Samples (n = 4 per well in triplicate) were 
suspended in ultra-pure sterile water (1 mL per well). After 1 h in a 37ºC 
shaking water bath, samples were frozen at -80ºC overnight. Samples were 
defrosted and used according to the specifications of the kit. A standard curve 
for DNA analysis was generated with the provided dsDNA solution. After 10 
min of incubation at RT, fluorescence was read at an excitation wavelength of 
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485/20 nm and 528/20 nm of emission using a microplate reader (Gen 5 
2.01, Synergy HT, Biotek). 
 
2.9 Imaging cell morphology by scanning electron microscopy (SEM) 
Samples (n = 4 per well in triplicate) were washed with PBS and fixed at RT in 
formalin (10% v/v). After 1 h, samples were dehydrated in an increasing 
gradient series of ethanol for 10 min each. The membrane of capsules was 
destroyed to expose the core contents. After gold sputtering, samples were 
visualized by SEM (15kV, JSM-6010LV, Jeol). 
 
2.10 Alkaline phosphatase activity quantification 
The activity of alkaline phosphatase was determined by the amount of p-
nitrophenol. A substrate solution (pH 9.8) was prepared by dissolving 4-
nitrophenylphosphate disodium salt hexahydrate (0.2% w/v, Sigma-Aldrich) in 
diethanolamine (1 M, Sigma-Aldrich). Each sample (20 µL, in triplicate) was 
mixed with the prepared substrate solution (60 µL). After 45 min at 37ºC 
protected from light, the reaction was stopped (80 µL) with NaOH (2 M) and 
EDTA (0.2 mM). A standard curve with a range of concentrations was prepared 
by diluting 4-nitrophenol solution (10 mM, Sigma-Aldrich) in the stop solution. 
Absorbance was read at 405 nm in a microplate reader (Gen 5 2.01, Synergy 
HT, Biotek). Results were normalized with dsDNA quantification data. 
 
2.11 Calcium quantification 
Samples were washed with PBS and resuspended in 100 µL of HCl (6 M). A 
standard curve was prepared with a CaCl2 solution (5 mM). 10 µL of each 
sample and standard (in triplicate) were transferred to a 96-well plate. Upon 
mixing the calcium kit components according to manufacture’s specifications 
(Roche), absorbance was read at 570 nm in a microplate reader (Gen 5 2.01, 
Synergy HT, Biotek). 
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2.12 Histological mineralization analysis 
MONO and CO capsules cultured in EG or EDAG media were collected after 21 
days, washed in PBS, and processed in an automatic spin tissue processor 
(STP120-2, Microm) for histological analysis. Afterwards, samples were 
embedded in paraffin and cut into sections of 5 µm thickness using a 
microtome (HM355S, Microm). To visualize calcium-rich deposits, sections 
were deparaffinized and subsequently immersed in alizarin red staining 
solution for 5 min at RT. Samples were then mounted and analyzed (Axio 
Imager Z1m, Zeiss).  
 
2.13 Immunofluorescence staining on 3D structures and histological sections 
Samples were fixed in formalin (10% v/v, BD Biosciences) for 30 min at RT. 
After fixation, capsules were destroyed and cells were permeabilized for 5 min 
at RT with Triton-X (0.1% v/v, Sigma-Aldrich). Samples were immersed in BSA 
(3% w/v) for 30 min at RT to block non-specific binding and then incubated 
overnight at 4ºC with the primary antibody rabbit anti-human osteopontin 
(Promega, 1:100 in 1% BSA). After PBS washing, samples were incubated for 
1 h at RT with the secondary antibody anti-rabbit AlexaFluor 488 (BD 
Biosciences, 1:500 in 1% BSA). The immunofluorescence staining in the 
histological sections was performed in CO capsules cultured in EG or EDAG 
media for 21 days. Samples were washed in PBS and processed in an 
automatic spin tissue processor (STP120-2, Microm) for histological analysis. 
Afterwards, samples were embedded in paraffin and cut into sections of 5 µm 
thickness using a microtome (HM355S, Microm). After the deparaffinization 
process, the antigen retrieval was performed in a microwave-heated sodium 
citrate buffer (10 mM, Sigma-Aldrich). Samples were immersed in hydrogen 
peroxide (3% v/v, VWR) at RT for 30 min. The same immunofluorescence 
staining protocol used for the 3D structures was repeated with the adding of 
the primary antibody mouse anti-human CD31 (Sigma-Aldrich, 1:100 in 1% 
BSA) conjugated with the osteopontin and the secondary antibody anti-mouse 
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AlexaFluor 594 (BD Biosciences, 1:500 in 1% BSA). Ultimately, 3D and 2D 
structures were counterstained with DAPI (Sigma-Aldrich, 1 mg.mL-1 diluted 
1:1000 in PBS) for 5 min at RT and analyzed by confocal microscopy (TCS 
SP8, Leica). 
 
2.14 Quantification of cytokines 
The supernatants (500 µL) were stored at -80ºC with a diluted protease 
inhibitor cocktail (1:100, Sigma-Aldrich) until analysis. Commercially available 
human BMP-2 and VEGF ELISA development kits (Peprotech) were used 
according to manufacture’s specifications. Absorbance was read at 405-650 
nm in a microplate reader (Gen 5 2.01, Synergy HT, Biotek). 
 
2.15 RNA extraction and cDNA production 
The extraction of mRNA was performed using TRIzol reagent (Sigma-Aldrich). 
Capsules (n = 5 per well in triplicate) were stored in TRIzol (800 µL) at -80ºC 
until analysis. Samples were slowly defrosted on ice and chloroform (160 µL, 
Sigma-Aldrich) was added. After 15 min at 4ºC, samples were centrifuged at 
13,000 rpm (Bioline, MCF-2360) for 15 min. The aqueous part of each sample 
was collected and isopropanol (400 µL, Sigma-Aldrich) was added. Following 
an overnight incubation at -20ºC, samples were centrifuged at 13,000 rpm for 
10 min at 4ºC. The supernatant was discarded and the resulting pellets were 
washed with ethanol (70% v/v) in RNase/DNase free distilled water (VWR). The 
pellets were let to partially dry on air, and dissolved in RNase/DNase free 
distilled water (10 µL). RNA quantity and purity was determined in nanodrop 
spectrophotometer (NanoDrop ND-1000, ThermoScientific). Samples with a 
260/280 purity ratio higher than ~1.8 were used for cDNA synthesis. The 
cDNA synthesis was performed using a qScript cDNA SuperMix kit (VWR) and 
the MiniOpticon Real-time PCR Detection System (MJ Mini, BioRad). All 
samples were normalized (1 µg of RNA in 20 µL of RNase/DNase free distilled 
water). 
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2.16 Quantitative real-time polymerase chain reaction 
The expression of the osteogenic genes bone morphogenic protein-2 (BMP-2), 
transcription factor RUNX2, and bone sialoprotein (BSP), and of the angiogenic 
genes von Willebrand factor (vWF), CD31, and vascular endothelial growth 
factor A (VEGF) were quantified in the cDNA samples using a real-time PCR 
reaction. The target genes were normalized with 18S rRNA as the 
housekeeping. The primers (200 nM) were designed to span exon-exon 
junctions using the primer-BLAST tool (sequences in Table VI.SI). The real-
time PCR reaction was done using the PerfeCTa SYBR Green FastMix Reaction 
Mixes (Quanta Biosciences), according to manufacturer’s specifications. The 
reactions were monitored in a Mastercycler (Realplex4, Eppendorf) using the 
software realplex version 2.2 (Eppendorf). The relative quantification of the 
osteogenic and angiogenic markers expression was performed using the 2-ΔΔCT 
method (Perkin-Elmer). Results are expressed relatively to gene expression 
levels of day 3. 
 
2.17 Statistical analysis 
Statistical analysis was performed using two-way analysis of variance (ANOVA) 
with Tukey’s post-hoc test (GraphPad Prism 6.0). A p-value < 0.05 was 
considered statistically significant. Only non-significant differences (ns) were 
marked to facilitate the interpretation of the data. All results are presented as 
mean ± standard deviation. 
 
3. Results and discussion 
 
3.1 Encapsulation of cells within multilayered liquified capsules 
The successful isolation of ASCs and ECs from adipose tissue was determined 
by flow cytometry (Figure VI.1A). More than 90% of the ASCs were found to be 
positive for the mesenchymal stem cell markers CD105, CD90, and CD73, 
whilst all cells lacked the expression of the endothelial marker CD31. On the 
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other hand, the endothelial phenotype of ECs was confirmed by the CD31 
expression. The maintenance of the mesenchymal and endothelial phenotypes 
after cell encapsulation in MONO and CO capsules also confirmed that the 
encapsulation process did not affect the cells. Moreover, the expression of 
CD31 by 47.14% ± 3.31 of the cells in the CO capsules confirmed the 1:1 ratio 
of the co-cultures as well as the inertness of the method. The random 
distribution of both cell types within the capsules was confirmed upon 
microscopic analysis. In the MONO capsules only green fluorescence 
corresponding to ASCs could be detected, while in the CO capsules both green 
and orange fluorescence identifying respectively ASCs and ECs could be 
visualized (Figure VI.1B). 
 
3.2 Metabolic activity, proliferation, and morphology of the encapsulated 
cells 
MONO capsules in EDAG medium showed an increasing metabolic activity 
(Figure VI.2A) and DNA content (Figure VI.2B) up to 14 days of culture. 
However, at day 21, no significant differences were found in comparison to day 
14 for both parameters. On the other hand, cells in MONO capsules cultured in 
EG medium kept proliferating up to the end timepoint, which was also 
traduced in significantly higher metabolic activity. The same trend found in 
MONO capsules cultured in EDAG medium was observed for the CO capsules 
cultured in both media. The stagnation in the metabolic activity and in the DNA 
content between 14 and 21 days of culture in MONO capsules cultured in 
EDAG medium, and in CO capsules cultured in both media might be an 
indication that cell differentiation is occurring. The cells interacting with the 
microparticles in the core of both MONO and CO capsules was visualized by 
SEM after 21 days of culture (Figure VI.2C). In order to visualize the core 
contents by SEM, the layer-by-layer membrane of the capsules, which 
remained stable up to the 21 days of in vitro culture, was disrupted. In all 
conditions cells adhered to the surface of the microparticles, proliferated, and 
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deposited matrix in such a way that the particles were assembled in large 3D 
constructs. 
 
 
 
Figure VI.1 - (A) Flow cytometry analysis of human adipose stem cells (ASCs) and human microvascular 
endothelial cells (ECs) after isolation and encapsulation at day 0 within MONO and CO capsules. (B) 
Confocal images of MONO and CO capsules encapsulating cells at day 0 previously labeled with DIO 
(green, ASCs) and DIL (orange, ECs) lipophilic fluorescent dyes. Scale bar is 200 µm. 
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Figure VI.2 - (A) Cell metabolic activity determined by MTS colorimetric assay and (B) cell proliferation 
by DNA quantification. All results were significantly different unless marked with ns (p>0.05). (C) SEM 
images of the encapsulated microparticles and cells inside MONO and CO capsules after 21 days 
(magnification: 500x, scale bar: 50µm). The symbols * and # mark the microparticles and the 
extracellular matrix deposition of the encapsulated cells, respectively. 
Chapter VI 
Semipermeable capsules wrapping a multifunctional and self-regulated co-culture microenvironment for 
osteogenic differentiation 	
	 	 	240 
3.3 In vitro assessment of the osteogenic potential of liquified multilayered 
capsules 
 
3.3.1 Quantification of ALP activity and mineralization evaluation 
Knowing that increased levels of ALP activity are correlated with enhanced 
osteogenic differentiation [31], it can be stated that cell differentiation 
occurred earlier in MONO and CO capsules cultured in EDAG medium (Figure 
VI.3A). However, as the time of culture increased, ALP activity in CO capsules 
cultured in EG also increased. At day 14 both CO capsules showed the highest 
levels of ALP activity. Therefore, co-cultures in the liquefied capsules led to an 
enhanced cell differentiation, although delayed when co-cultured in EG 
medium. MONO capsules cultured in EG medium presented the lowest ALP 
activity levels during the entire experiment. ALP is secreted by active 
osteoblasts and is responsible for the cleavage of pyrophosphate ions, which 
are inhibitors of the formation of hydroxyapatite crystals. The hydrolysis 
reaction results in the saturation of the extracellular fluid with orthophosphates 
that induce mineralization [32, 33]. Hence, ALP activity results were 
corroborated with calcium quantification (Figure VI.3B). Similarly, calcium 
deposits were hardly detected in MONO capsules cultured in EG medium whilst 
earlier detected in the capsules cultured in EDAG compared to CO capsules 
cultured in EG medium. In the end, co-cultures resulted in an enhanced newly 
deposited mineralized ECM, even in EG medium. Mineralization was 
qualitatively assessed by alizarin red staining at day 21 (Figure VI.3C), 
confirming the deposition of calcium. 
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Figure VI.3 - (A) Alkaline phosphatase (ALP) activity normalized by DNA content and (B) quantification of 
calcium. All results were significantly different unless marked with ns (p > 0.05). (C) Alizarin red staining 
on histological sections of MONO and CO capsules cultured in EG or EDAG media after 21 days. Calcium 
deposits were stained in red. Scale bar is 50 µm. 
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3.3.2 Osteopontin and CD31 immunofluorescence detection 
The secretion of the late osteogenic marker osteopontin in MONO and CO 
capsules after 21 days of culture in EG and EDAG media was confirmed (Figure 
VI.4A). On the other hand, cells in the MONO capsules cultured in EG medium 
did not secrete osteopontin. The presence of the ECs in the CO capsules 
cultured in both media was assessed by the expression of CD31. The 
immunofluorescence could only be detected after histological cuts. This 
indicates that ECs were located in the inner regions of cell aggregates enfolded 
by ASCs, probably due to the higher proliferative rate of the latter. Altogether, 
these results indicate not only that cells were able to spread throughout the 
inner areas of capsules, but also that the diffusion of essential and signaling 
molecules for cell survival, proliferation, and differentiation was allowed. The 
diffusion of molecules in 3D systems is a major concern in tissue engineering 
strategies, since it dictates the success or failure of the regeneration process 
[34]. Its inefficiency can lead to tissue repair only at the circular periphery of 
3D constructs, while cell death occurs in the inner areas. The liquified 
environment of capsules led to an excellent diffusion of molecules as already 
demonstrated in our previous studies [22, 23]. The layer-by-layer methodology, 
that has been proposed in a variety of biomedical applications [35], was 
effectively useful to produce a flexible permselective shell that sustained the 
viability of compartmentalized cells, while maintaining the mechanical integrity 
of the liquified capsules.  The properties of the multilayers can be tuned to 
control the transfer properties of essential molecules [36]. However, the 
conception of a liquified environment required the introduction of solid 
microparticles to provide cell adhesion sites, since the encapsulated cells were 
anchorage dependent. 
 
3.3.3 BMP-2 and VEGF cytokines release 
The profile of BMP-2 and VEGF release into the supernatants of MONO and CO 
capsules cultured in EG or EDAG media is shown in Figure VI.4B. The release 
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of BMP-2 was similar for both MONO and CO capsules cultured in EDAG, which 
remained constant up to 14 days, and increase after 21 days. The highest 
amounts were detected for the CO capsules. On the other hand, for the CO 
capsules cultured in EG, BMP-2 was increasingly secreted along the entire 
experiment, reaching at day 14 the value detected for the CO capsules cultured 
in EDAG. Residual amounts of BMP-2 were detected for the MONO capsules 
cultured in EG during the entire experiment. The profile release of VEGF was 
similar for all conditions. The highest levels of VEGF were observed for MONO 
capsules cultured in EG, and then for CO capsules cultured in the same 
medium. However, as the culture time increased, the VEGF detected for CO 
capsules cultured in EG decreased to values similar to those observed for 
MONO and CO capsules cultured EDAG medium. Different studies [37-39] have 
already been show that ASCs stimulate blood vessel growth due to the 
secretion of many angiogenic and anti-apoptotic growth factors, such as VEGF, 
which is widely known to enhance the biological performance of endothelial 
cells [7, 19, 20]. Furthermore, a positive effect on the differentiation of 
osteoprogenitor cells when co-cultured with endothelial cells was already 
documented in different studies [6-8, 10-17, 19, 40-44]. As observed by ALP 
activity and calcium content results, a delayed osteogenic differentiation was 
observed in the CO capsules cultured in EG medium in comparison to capsules 
cultured in EDAG. Correlating the delay of the osteogenic differentiation in CO 
capsules cultured in EG medium with their initial release of higher levels of 
VEGF, and the absence of osteogenic differentiation in MONO capsules 
cultured in EG medium with their highest release of VEGF, it seems that the 
release of VEGF and the osteogenic stage of differentiation of the ASCs are 
intrinsically correlated. As time increased, while osteogenesis occurred in CO 
capsules cultured in EDAG the amount of VEGF decreased to similar values 
observed for capsules cultured in EDAG medium. These interesting findings 
might indicate that osteogenic differentiated ASCs have a decreased ability to 
enhance angiogenesis by diminishing VEGF release. A similar behavior was 
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already reported [45] for mesenchymal stem cells (MSCs). It was observed that 
MSCs cultured in a 2D cell culture system secreted the highest concentration 
of VEGF compared to MSCs cultured in osteogenic media, which down 
regulated the gene expression of pro-angiogenic factors. Therefore, although 
the ultimate goal of the proposed bioencapsulation system is to promote the 
osteogenic differentiation, the delayed osteogenesis observed in CO capsules in 
EG medium could represent an advantage - the higher amounts of VEGF 
released by those capsules in the initial times of culture can lead to an 
enhanced angiogenesis and, consequently, to a vascularized osteogenic tissue. 
Importantly, besides inducing angiogenesis, VEGF is also known to increase 
the osteogenic healing capacity of ASCs [46]. Likewise, Boletreau et al. [47] 
showed that microvascular endothelial cells were able to release BMP-2 by the 
action of VEGF treatment. Although MONO capsules cultured in EDAG medium 
also released BMP-2 during the entire experiment, this was enhanced by co-
encapsulation. Interestingly, when the release of VEGF started to decrease in 
both CO capsules, the release of BMP-2 increased exponentially. In this case, 
the synergistic effect of the co-cultures and the presence of osteogenic 
differentiation factors in the culture medium resulted in the highest BMP-2 
release by CO capsules cultured in EDAG medium. However, in later timepoints 
the co-culture was sufficient to stimulate BMP-2 release since the amount 
released by CO capsules cultured in EG was similar to the one observed for the 
EDAG. Since VEGF and BMP-2 were detected and measured in the culture 
medium surrounding the capsules, this indicates that the membrane is 
permeable to small molecules while remaining stable up to 21 days of in vitro 
culture. We envisage that after implantation, the developed capsules can 
positively influence the neighboring cells by paracrine signaling in the highly 
vascularized environment of bone. 
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3.3.4 Genetic profile quantification of osteogenic and angiogenic markers 
The quantification of the transcripts for the osteogenic and angiogenic genes of 
interest was performed at the different timepoints (Figure VI.4C). The 
expression of the osteogenic genes BMP-2, BSP, and RUNX2, was up regulated 
in all capsules and at all the timepoints, excepting for MONO capsules cultured 
in EG media. While for BMP-2 and BSP markers, the expression level increased 
with culture time, for RUNX2 no significant differences were found over time, 
although a slight peak could be observed at day 14. Again, no significant and 
distinct results were found between CO capsules cultured in EG and EDAG 
media, indicating that the crosstalk between the two cell types was sufficient to 
induce the osteogenic differentiation. In all CO capsules the endothelial 
markers vWF, CD31, and VEGF were up regulated up to 21 days although its 
expression decreased with culture time, as similarly observed in co-culture 
systems [8]. This decrease might be explained by the fact that total RNA was 
used to normalize the genetic profile results, thus including RNA also from 
ASCs and not only from ECs. Significant differences were found for the 
expression of VEGF marker at days 7 and 14, and for vWF and CD31 markers 
at day 7, at which CO capsules cultured in EG medium presented the highest 
expression.  
Altogether these results showed that the crosstalk between ASCs and ECs 
played a significant role in osteogenic differentiation. More importantly, the co-
encapsulation of ASCs and ECs suppressed the need of dexamethasone and 
ascorbic acid to osteoblastic differentiation occurs. Considering the reported 
findings, we believe that the proposed CO capsules will find great applicability 
in bone regeneration, while bringing new insights to bioencapsulation 
strategies. Additionally, in the present study a new 3D biomimetic platform to 
assess the interaction of stem and endothelial cells was developed. 
Importantly, the biological outcome demonstrated was achieved by using cells 
isolated from a waste and abundant tissue, which is highly desirable for tissue 
engineering applications considering the high number of cells required in 3D 
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systems. Since it was demonstrated that the capsules also release important 
cytokines for bone healing, namely VEGF and BMP-2, we thus believe to be 
close to a completely self-regulated confined system that could stimulate 
autonomous production mineralized bone tissue, with clear therapeutic 
advantages. The liquified environment of capsules is a key point in the novelty 
and success of the proposed system, since it allows the encapsulated cells to 
freely move and proliferate – as they can easily occupy the liquid space of the 
capsules environment – and self-organize a 3D culture composed by 
microparticles. Consequently, we envisage that in a dynamic culture the results 
obtained in the present study could be boosted by enhancing the diffusion of 
molecules across the liquified environment, such as essential molecules for 
cells survival or even signaling biomolecules either circulating outside the 
capsules environment or released by the encapsulated cells. Additionally, we 
trust that minimal invasive procedures could be adopted due to their 
injectability provided by the liquified environment. Moreover, having a single 
structure encapsulating all the different components might facilitate the 
implantation process, while avoiding their dispersion to other regions of the 
body. This study focused its applicability in the bone regeneration field, but we 
believe that such kind of complex hierarchical systems able to encapsulate 
multi-phenotypic cells could find important applications in other TE strategies, 
such as closed devices to be used in drug screening or disease models. 
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Figure VI.4 - (A) Immunofluorescence of osteopontin (green) in MONO and CO capsules cultured in EG 
and EDAG media after 21 days of culture. Cells nuclei were counterstained with DAPI (blue). To visualize 
the encapsulated ECs, CD31 (red) was identified by immunofluorescence staining in histological sections 
of CO capsules cultured for 21 days. Scale bar is 50 µm. (B) Quantification of BMP-2 and VEGF release 
by ELISA. (C) Relative expression of osteogenic (BMP-2, RUNX2, and BSP) and angiogenic (VEGF, CD31, 
and vWF) markers up to 21 days. All results were significantly different unless marked with ns (p > 0.05). 
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4. Conclusion 
Inspired by the local interactions at the molecular level from the co-existence 
of stem and vascular cells in the native environment of bone, we developed a 
stem-cell based bioencapsulation strategy. The co-encapsulation of stem and 
endothelial cells, both derived from adipose tissue, within a single hierarchical 
structure proved to be an effective strategy for the in vitro osteogenic 
differentiation. Overall, the co-encapsulation of ECs lead ASCs to differentiate 
into the osteogenic lineage inside the liquified and multilayered capsules with 
microparticles, even in the absence of two major osteogenic differentiation 
factors, namely dexamethasone and ascorbic acid. Additionally, CO capsules 
released BMP-2 and VEGF, which evidences the potential of the capsules as a 
cytokine delivery system. We believe that the developed co-encapsulation 
strategy represents a ground-breaking advance in the engineering of 3D 
compartmentalized devices that aim to control the cascade of biological 
processes and lead to faster high-quality new tissue formation with minimum 
cell manipulation. 
 
Acknowledgements 
The authors acknowledge the financial support by the Portuguese Foundation 
for Science and Technology (FCT) through the Ph.D. (SFRH/BD/69529/2010-
Clara R. Correia). This work was also supported by European Research Council 
grant agreement ERC-2014-ADG-669858 for project ATLAS. 
 
 
 
 
 
 
 
 
Chapter VI 
Semipermeable capsules wrapping a multifunctional and self-regulated co-culture microenvironment for 
osteogenic differentiation 	
	 249 
Supplementary information 
 
Table VI.SI – Primer sequences used for real-time polymerase chain reaction. 
Type Name Forward/reverse sequence 
Housekeeping 18S 5’-GAAACCTTCCGACCCCTCTC-3’ 
5’-TACGAGGTCGATTTGGCGAG-3’ 
O
st
eo
ge
n
ic
 
m
ar
ke
rs
 
BMP-2 5’-TGAATCAGAATGCAAGCAGG-3’ 
5’-TCTTTTGTGGAGAGGATGCC-3’ 
RUNX2 5’-TTCCAGACCAGCAGCACTC-3’ 
5’-CAGCGTCAACACCATCATTC-3’ 
BSP 5’- ACTGAGCCTGTGTCTTGAAA-3’ 
5’-CTTCCAACAGCCAATCACTG-3’ 
A
n
gi
og
en
ic
 
m
ar
ke
rs
 
vWF 5’-CCCTGGGTACAAGGAAGAAAAT-3’ 
5’-AGTGTCATGATCTGTCTCCTCTTAG-3’ 
CD31 5’-AAGGCCAGATGCACATCC-3’ 
5’-TTCTACCCAACATTAACTTAGCAGG-3’ 
VEGF-A 5’- GATCCGCAGACGTGTAAATG-3’ 
5’-TACGAGGTCGATTTGGCGAG-3’ 
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Abstract 
The regeneration of tissues through ready-to-use tissue engineering strategies 
requiring minimum in vitro manipulation is highly desirable. Here we show that by 
using a hierarchically engineered bioencapsulation system, self-regulated mineralized 
tissue could be generated in vivo. Capsules coated with nanostratified multilayered 
polyelectrolytes compose the proposed system, encapsulating adipose stem (ASCs) 
and endothelial cells (ECs) and surface modified microparticles. Microparticles and 
cells are freely dispersed in a liquified core, responsible to maximize the diffusion of 
essential molecules and allowing the geometrical freedom for the autonomous three-
dimensional (3D) organization of cells. While the membrane wraps all the instructive 
cargo elements within a single structure, the microparticles provide a solid 3D 
substrate for the encapsulated cells. Our hypothesis is that inside this isolated 
biomimetic 3D environment, ECs would lead ASCs to differentiate into the osteogenic 
lineage to ultimately generate a mineralized tissue in vivo. To test our system, 
capsules encapsulating only ASCs (MONO capsules) or ASCs and ECs (CO capsules) 
were subcutaneously implanted in nude mice up to 6 weeks. Two implantation 
strategies were tested, namely capsules implanted immediately after production or 
after 21 days of in vitro osteogenic stimulation. Results show that all the implanted 
capsules were biotolerable, and no signs of necrosis or a severe infiltration of 
inflammatory cells were detectable. Of note, the most valuable outcome of the present 
study is the mineralized tissue in CO capsules without in vitro pre-differentiation, 
which occurred at similar levels compared to the pre-differentiated capsules in vitro. 
We believe that the proposed bioencapsulation strategy is a potent self-regulated 
system, which might find great applicability in bone tissue engineering. 
7 Based on the publication: C.R. Correia, T.C. Santos, R.P. Pirraco, M.T. Cerqueira, A.P. Marques, R.L. 
Reis, J.F. Mano, In vivo osteogenic differentiation of stem cells inside compartmentalized capsules loaded 
with co-cultured endothelial cells and microparticles (submitted). 
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1. Introduction 
The regeneration of large bone defects remains a major concern in the 
orthopedic field. To avoid the potential disadvantages of autografts and 
allografts, namely their limited supply and disease transmission potential [1], 
engineered bone constructs have been proposed as promising alternatives in 
clinical applications. Donor-site morbidity associated to cell isolation (both 
osteoblasts or bone marrow-derived mesenchymal stem cells) and limited 
proliferative capacity of primary osteoblasts are major challenges in providing 
adequate numbers for transplantation [2, 3]. In addition to bone marrow, 
adipose tissue has been identified as a source of multipotent cells that due to 
the capacity to differentiate into adipogenic, chondrogenic, myogenic, and 
osteogenic lineages are seen as promising for tissue regeneration [4, 5]. 
Moreover, adipose tissue is often available in an abundant quantity after a 
relatively easy harvesting. However, controlling mesenchymal differentiation 
and engineering bone in vivo are challenging accomplishments, as it often leads 
to heterotypic and inferior osseous tissues. Additionally, when osteogenesis is 
aimed at, angiogenesis must be considered since it plays an important role 
during the development and maturation of bone [6, 7]. The induction of 
orchestrated osteo- and angiogenesis by biochemical stimulation [8, 9] or by 
co-culturing osteoprogenitor and endothelial cells [10-13] has been shown to 
better induce bone tissue formation, as well as to improve survival of the 
engineered tissues. Particularly, considering native bone vascular network, 
osteoprogenitor cells inevitably interact with endothelial cells (ECs) in a 
synergetic fashion [14, 15]. While endothelial cells secrete numerous 
regulatory molecules that influence the differentiation and activity of bone 
forming cells [16-19], osteoprogenitor cells release diverse pro-angiogenic 
growth factors [11, 13, 20, 21]. To mimic such concept, one could envisage 
the in vitro development of a single reservoir that contain instructive signals to, 
upon implantation, generate bone-like tissues. In this context, we propose a 
novel bioencapsulation strategy whose in vivo performance is assessed for the 
first time. With this work we expect to highlight the potential of liquified and 
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multilayered capsules as an alternative methodology to the commonly used 3D 
porous structures/hydrogels for TE. For that, mesenchymal stem and 
endothelial cells were both isolated from the adipose tissue and co-cultured 
within liquified and multilayered capsules. Following multi-scale assembling 
strategies [22], the capsules are composed by three essential components: (i) 
a permselective nanostructured membrane that wraps the liquefied core of the 
capsule ensuring permeability to essential molecules for cell survival, and the 
creation of a single reservoir to facilitate the implantation procedure of 
multiple components; (ii) poly(L-lactic acid) (PLLA) microparticles surface 
functionalized with plasma treatment and collagen I that create a 3D 
microenvironment for the encapsulated cell and act as cell adhesion sites; and 
(iii) adipose stem (ASCs) and endothelial (ECs) cells. The membrane was 
produced by layer-by-layer (LbL) technique, which is a versatile, low-cost 
technique, and more importantly for bioencapsulation systems, can be 
performed under mild conditions [23, 24]. We hypothesized that within the 
controlled environment of capsules, endothelial cells would promote the 
osteogenic differentiation of ASCs due to their specific crosstalk, leading to the 
formation of a mineralized tissue in vivo. The design of the experiment is 
represented in Scheme VII.1. Capsules containing only ASCs (MONO capsules) 
or ASCs and ECs (CO capsules) were produced 21 days before the implantation 
(day -21), and subsequently cultured in osteogenic differentiation medium to 
stimulate in vitro the differentiation of the ASCs. At the day of implantation (day 
0), the production of MONO and CO capsules was repeated. Additionally, 
capsules without encapsulated cells (MATERIAL) were also produced. All the 
produced capsules, i.e. after 21 days of in vitro osteogenic stimulation or 
freshly prepared, were subcutaneously implanted in nude mice up to 6 weeks. 
Three capsules of the same formulation were implanted at each pocket 
(Scheme VII.1A). At predetermined intervals, the implants, which could be 
macroscopically identified (Scheme VII.1B), were retrieved for histological 
analysis. 
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Scheme VII.1. Schematic representation of the experimental design. Capsules encapsulating only adipose 
stem cells (MONO capsules) or adipose stem cells and endothelial cells (CO capsules) were produced 
(day -21) and cultured in vitro in osteogenic differentiation medium for 21 days. At the day of 
implantation (day 0), MONO, CO and capsules without cells (MATERIAL) were freshly prepared. Capsules 
were implanted in nude mice up to 6 weeks. (A) Three capsules of the same formulation were implanted 
at each pocket.  Scale bar is 1 cm. (B) After 1, 3, and 6 weeks, implants were retrieved. The localization 
of the implanted capsules could be macroscopically visualized. Scale bar is 1 cm. 
 
2. Materials and methods 
 
2.1 Cells isolation 
Subcutaneous adipose tissue from liposuction procedures was used to isolate 
both human ASCs [25] and human ECs [26]. The collected tissues were 
obtained under a cooperation agreement between the 3B’s Research Group 
and Hospital da Prelada (Porto, Portugal), after approval of the respective 
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ethical committees. Patient's informed consent and anonymity were assured. 
Samples were transported in phosphate-buffered saline (PBS, Sigma-Aldrich) 
supplemented with penicillin-streptomycin (10%, pen-strep, Gibco) and kept at 
4ºC for a maximum of 24 h. Lipoaspirates were washed with PBS and 
incubated with collagenase type II A (0.05% w/v, Sigma-Aldrich) for 45 
minutes at 37ºC in a shaking water bath. The digested samples were filtered 
(200 µm) and centrifuged at 800 g for 10 min at 4ºC. The obtained stromal 
vascular fraction (SVF) was resuspended in erythrocyte lysis buffer at pH 7.4 
containing ammonium chloride (155 mM, Merk), potassium bicarbonate (5.7 
mM, Riedel-de-Häen), and ethylenediaminetetraacetic acid (0.1 M, EDTA, 
Sigma-Aldrich) in distilled water. After 10 min of incubation at room 
temperature (RT), the mixture was centrifuged at 300 g for 5 minutes. To 
obtain the ASCs cultures, the red blood cell-free SVF was resuspended in α-
MEM medium (Invitrogen) supplemented with fetal bovine serum (10%, FBS, 
Invitrogen) and pen-strep (1% v/v). The ECs cultures were obtained from the 
red blood cell-free SVF that was resuspended in EndoGroTM-MV-VEGF complete 
media kit (Millipore Iberica). ECs were plated in cell culture flasks, previously 
coated with gelatin (0.7% w/v, porcine skin type A, Sigma-Aldrich) for 30 min 
at 37ºC. Culture medium was changed 48 h after initial plating and then every 
3-4 days for both cell phenotypes. 
 
2.2 Microparticles production and surface functionalization 
Poly(L-lactic acid) microparticles (µPLLAs) were produced by an oil/water 
(o/w) emulsion technique and surface modified with collagen I after plasma 
treatment as similarly in our previous reports [27, 28]. Briefly, PLLA (5% w/v, 
Mw~1,600-2,400, 70% crystallinity, Polysciences) was dissolved in methylene 
chloride (CH2Cl2, Fisher Chemical). Under agitation, this solution was added to 
polyvinyl alcohol (0.5%, PVA, Sigma-Aldrich). After 2 days at RT, the produced 
µPLLAs were subsequently collected, washed with distilled water, and 
lyophilized (Cryodos, Telstar) for 3 days. Microparticles were then placed in a 
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plasma reactor chamber (PlasmaPrep5, Gala Instrumente) fitted with a radio 
frequency generator. Air was used as the working atmosphere. A glow 
discharge plasma (0.2 mbar, 30 V) was created for 15 min. Subsequently, 
microparticles (500 mg) were immersed for 4 h at RT in collagen I solution 
(1200 µg, rat protein tail, Gibco). 
 
2.3 Mono- and co-cultures set up 
Sodium alginate (1.5% w/v, ALG, ~250 cP, low viscosity from brown algae, 
Sigma-Aldrich) was dissolved in sodium chloride (0.15 M, NaCl, Enzymatic) 
buffered at pH 7 with MES hydrate (25 mM, Sigma-Aldrich). The solution was 
sterilized by 0.22 µm filtration prior mixing with the cells. At 90% confluence, 
ASCs (passage 2) and ECs (passage 4-6) were detached using TrypLETM 
Express solution (Life Technologies) at 37ºC for 5 min. PBS was added and the 
cell suspensions were centrifuged for 5 min at 300 g.  Cells (ASCs alone or 
mixed with ECs, 1:1 ratio) resuspended in the alginate solution (5x106 cells per 
mL of alginate) were added to the microparticles (50 mg.mL-1 of alginate) and 
then used to produce liquified capsules containing ASCs alone (MONO 
capsules) or in co-culture with ECs (CO capsules). 
 
2.4 Liquified multilayered capsules production 
All the conditions used to produce liquified capsules (the combination of the 
polyelectrolytes, concentration, pH, number of layers, and time of adsorption 
and liquefaction) were optimized in our previous studies [27, 28]. Briefly, 
alginate solutions containing cells were added drop wise using a 21 G needle 
to a calcium chloride solution (0.1 M, CaCl2, VWR) buffered at pH 7 with MES 
hydrate (25 mM, Sigma-Aldrich). After 20 min at RT, alginate hydrogel 
particles were collected and rinsed in a washing solution of NaCl (0.15 M). The 
external membrane was processed by layer-by-layer adsorption. Hydrogel 
particles were subsequently immersed in poly-L-lysine (PLL, Mw ~ 30,000-
70,000, pH 7, Sigma-Aldrich), ALG solution (pH 7), chitosan (CHT, pH 6, 
water-soluble highly purified, viscosity 107 mPa.s, Mw = 2.7x105 g.mol-1, 83% 
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degree of deacetylation, Protasan UP CL 213, NovaMatrix), and, ultimately, in 
ALG solution again. All the polyelectrolyte solutions (0.5 mg.mL-1) were 
prepared in NaCl (0.15 M) containing MES hydrate (25 mM). Following a 10 
min adsorption period for each polymer, the excess of macromolecules was 
removed by immersion in NaCl (0.15 M) for 5 min. This process was repeated 
three times in order to obtain a 12-layered membrane. Coated hydrogel 
particles were immersed in EDTA (20 mM) at pH 7 for 5 min to liquefy the 
alginate core. To induce osteogenic differentiation in vitro, MONO and CO 
capsules were cultured for 21 days in supplemented medium composed by 
complete EndoGroTM-MV-VEGF medium supplemented with β-glycerophosphate 
(10 mM, Sigma-Aldrich), ascorbic acid (50 µg.mL-1), and dexamethasone (10 
nM, Sigma-Aldrich). 
 
2.5 In vitro analysis 
 
2.5.1 Lipophilic fluorescent labeling 
Prior encapsulation, ASCs and ECs were incubated with lipophilic dyes, namely 
3,3′ -dioctadecyloxacarbocyanine perchlorate (DIO, green) and 1,1′-
dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DIL, red), 
respectively. Cells were incubated with each dye (1 mL, 2 µM per 1x106 cells) 
at 37 °C for 10 min. Then, MONO and CO capsules were produced as 
previously described encapsulating fluorescently labeled cells. Capsules were 
visualized by fluorescence microscopy (Axio Imager Z1m, Zeiss). 
 
2.5.2 DNA and alkaline phosphatase (ALP) activity quantification 
MONO and CO capsules cultured in osteogenic differentiation medium for 21 
days were analyzed after cell lysis for DNA amount and ALP activity. Four 
capsules per well were suspended in 1 mL of ultra-pure water. After 1 h in a 
37ºC shaking water bath, the solutions were frozen at -80ºC overnight. 
Samples were defrosted and used according to the specifications of the kit 
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(Quant-iTTM PicoGreen® dsDNA assay kit, Life Technologies). A standard curve 
was generated with the provided dsDNA solution. After 10 min of incubation at 
RT, fluorescence was read at an excitation wavelength of 485/20 nm and 
528/20 nm of emission using a microplate reader (Gen 5 2.01, Synergy HT, 
Biotek). Then, the activity of ALP in the remaining solutions was quantified. 
Briefly, a substrate solution (pH 9.8) was prepared by dissolving 4-
nitrophenylphosphate disodium salt hexahydrate (0.2% w/v, Sigma-Aldrich) in 
diethanolamine (1 M, Sigma-Aldrich). Each sample (20 µL) was mixed with the 
prepared substrate solution (60 µL). After 45 min at 37ºC protected from light, 
the reaction was stopped with 80 µL of a NaOH (2 M) and EDTA (0.2 mM) 
solution. A standard curve was prepared with diluted series of 4-nitrophenol 
solution (10 mM, Sigma-Aldrich). Absorbance was read at 405 nm in a 
microplate reader (Gen 5 2.01, Synergy HT, Biotek). ALP activity results were 
normalized with dsDNA quantification data of MONO capsules. 
 
2.5.3 Mineralization analysis 
MONO and CO capsules cultured in osteogenic differentiation medium for 21 
days were washed in PBS, and processed in an automatic spin tissue 
processor (STP120-2, Microm) for histological analysis. Samples were 
embedded in paraffin and cut into sections of 5 µm thickness using a 
microtome (HM355S, Microm). To visualize calcium-rich deposits, sections 
were deparaffinized and subsequently immersed in alizarin red staining 
solution for 5 min at RT. Samples were then mounted and analyzed by 
microscopy (Axio Imager Z1m, Zeiss). 
 
2.6 Animals surgery, euthanasia, and implants retrieval 
The animal experimentation project was approved by the institutional Animal 
Welfare Body (SECVS 032/2015) and the National Authority Direção Geral de 
Alimentação e Veterinária. Five week-old male nude mice (average weight of 25 
g) were used to subcutaneously implant MONO and CO capsules, either freshly 
prepared or after 21 days in vitro in osteogenic differentiation medium, and 
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capsules without encapsulated cells (MATERIAL). Four mice were used for each 
formulation and at each timepoint (1, 3, and 6 weeks). Under surgical sterile 
conditions, animals were anaesthetized with an intraperitoneal injection of a 
mixture of ketamine (75 mg.kg-1, Imalgene®, Merial) and metedomidine (1 
mg.kg-1, Domitor®, Orion). One medial incision of approximately 0.7 cm was 
performed in the dorsum of the mice and two craniolateral-oriented pockets 
were subcutaneously created by blunt dissection. Three capsules were inserted 
into each pocket. Pockets without capsules were also used as control (EMPTY). 
Subsequently, the panniculus carnosus and the skin were carefully sutured with 
non-resorbable 4/0 sutures. After the surgical procedure, the animals were 
induced to recover from anaesthesia with an intraperitoneal injection of 
Atipazemol (1 mg.kg-1, Antisedan, Orion). The animals were kept housed 
together (different conditions in each cage) with standard diet and water ad 
libitum during all the time of the experiment. After 1, 3, and 6 weeks of 
implantation, the animals were sacrificed by carbon dioxide inhalation. The 
implanted capsules and the respective surrounding tissue were explanted from 
each animal. The collected explants were subjected to macroscopic 
observation and fixed in 10% formalin for 24 h at RT. Samples were then 
processed for standard histological evaluation. 
 
2.7 In vivo histological analysis 
The explants were processed in an automatic ethanol-xylene spin tissue 
processor (STP120-2, Microm) and then embedded in paraffin. Histological 
sections (5 µm) were obtained using a microtome (HM355S, Microm, 
ThermoFisher Scientific). Before each histological staining, the sections were 
automatically deparaffinized and rehydrated (HMS740, Microm, ThermoFisher 
Scientific). After each staining protocol, unless otherwise specified, the 
sections were immediately dehydrated and immersed in xylene, before being 
mounted (Entellan, Millipore). Ultimately, the stained sections were visualized 
with Axio Imager Z1m (Zeiss). 
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2.7.1 Hematoxylin and eosin (H&E) staining 
The samples for H&E staining protocol were automatically processed 
(HMS740, Microm, ThermoFisher Scientific). Briefly, histological sections were 
subsequently immersed in hematoxylin (BioOptica) and after bluing in an 
ammonia solution (1% v/v), in eosin y (BioOptica).  
 
2.7.2 CD31 immunohistochemistry 
Antigen retrieval was performed in heat-mediated (95-100ºC) sodium citrate 
buffer (10 mM, Sigma-Aldrich) for 20 min. After cool down for 20 min, 
endogenous peroxidases were inactivated with hydrogen peroxide (3% v/v, 
AnalaR Normapur) and non-specific binding blocked with horse serum 
incubation (2.5% NHS, Vectastain Universal Quick Kit, Vector Laboratories) for 
30 min at RT. The sections were incubated with the primary antibody rabbit 
polyclonal anti-human to CD31 (1:50 diluted in PBS with NHS, abcam) in a 
humidified chamber at 4ºC overnight. The second antibody (Vectastain 
Universal Quick Kit, Vector Laboratories) was added for 1 h at RT, and the 
stained revealed with a DAB solution prepared according to manufacturer’s 
specifications (Vectastain Universal Quick Kit, Vector Laboratories). Sections 
were counterstained with hematoxylin (BioOptica) before microscopic analysis. 
 
2.7.3 Masson’s trichrome staining 
Sections were stained for 5 min in a solution containing azure B (0.5 g, Sigma-
Aldrich), ammonium iron (5 g, ammonium iron sulfate (III) dodecahydrate, 
Millipore) and distilled water (100 mL). Sections were then subsequently 
stained with hematoxylin (BioOptica) and picric ethanol (1% w/v, Sigma-
Aldrich) for 5 min each. After 10 min washing in running tap water, sections 
were stained with the solutions from the Trichrome Stain Masson kit (Sigma-
Aldrich) according to the manufacturer’s specifications. 
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2.7.4 Osteopontin immunofluorescence 
The antigen retrieval was performed in a heat-mediated sodium citrate buffer 
(10 mM, Sigma-Aldrich). Non-specific binding was blocked by immersion in 
BSA (3% w/v) for 30 min at RT. Samples were then incubated overnight at 4ºC 
with the primary antibody rabbit anti-human osteopontin (1:100 in 1% BSA, 
abcam). After a PBS washing, samples were incubated for 1 h at RT with the 
secondary antibody anti-rabbit AlexaFluor 488 (1:500 in 1% BSA, Molecular 
Probes). Samples incubated only with the secondary antibody were used as 
controls. Ultimately, samples were subsequently counterstained with DAPI (1 
mg.mL-1 diluted 1:1000 in PBS, Sigma-Aldrich) for 5 min at RT, immediately 
mounted (Permafluor, ThermoFisher Scientific), and analyzed by fluorescence 
microscopy (Axio Imager Z1m, Zeiss). 
 
2.7.5 Alizarin red staining 
To assess the presence of calcium-rich deposits (red), the sections were 
immersed in alizarin red solution (2% w/v, Sigma-Aldrich) for 5 min at RT. 
 
2.8 Statistical analysis 
All the results were expressed as mean ± standard deviation. Significant 
differences between the different groups were identified by one-way ANOVA 
using the post-hoc Tukey’s with multiple comparison tests. 
 
3. Results 
 
3.1 In vitro evaluation of the capsules 
Prior implantation, ASCs and ECs were fluorescently marked with lipophilic 
dyes. Cells were then encapsulated in MONO (Figure VII.1A) and CO (Figure 
VII.1B) capsules and visualized by microscopy. In the MONO capsules only 
green fluorescence corresponding to ASCs could be detected, while in the CO 
capsules both green and red fluorescence were detected, identifying 
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respectively ASCs and ECs. After 21 days of culture in osteogenic 
differentiation medium, the secretion of the late osteogenic marker osteopontin 
was confirmed in MONO (Figure VII.1C) and CO capsules  (Figure VII.1D). 
Additionally, mineralization was qualitatively assessed by alizarin red staining 
(Figure VII.1E and VII.F), confirming the deposition of calcium. Ultimately, 
capsules were tested for DNA quantification (Figure VII.1G) and ALP activity 
(Figure VII.1H). As expected, day 0 capsules have the lowest DNA amount 
compared to day 21 capsules. This indicates that the encapsulated cells in day 
21 capsules have proliferated during the in vitro culture. Moreover, the efficient 
encapsulation of the cells was proven by the double amount of DNA detected in 
the CO capsules that corresponds to the additional and equal amount of 
endothelial cells used. CO capsules after 21 days of culture continued to 
present the highest DNA amount, which seems to indicate the absence of 
deleterious effects of the system. Figure VII.1H illustrates the ALP activity 
normalized per µg DNA of the MONO capsules at day 0 and after 21 days of in 
vitro culture. Again, day 0 capsules have a significant lower ALP activity 
compared to day 21 capsules since the latter were cultured in vitro in 
supplemented medium to stimulate the osteogenic differentiation of the ASCs. 
Importantly, CO capsules cultured for 21 days presented the highest ALP 
activity compared to MONO capsules. 
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Figure VII.1.  (A) MONO and (B) CO capsules encapsulating cells at day 0 previously labeled with DIO 
(green, ASCs) and DIL (red, ECs) lipophilic dyes. Scale bar is 200µm. (C) Osteopontin 
immunofluorescence (green) in MONO and (D) CO capsules cultured in osteogenic medium for 21 days. 
Cells nuclei were counterstained with DAPI (blue). Scale bar is 200µm. (E) Alizarin red staining on 
histological sections of MONO and (F) CO capsules cultured in osteogenic differentiation medium for 21 
days. Calcium deposits were stained in red. Scale bar is 40µm. (G) DNA quantification and (H) ALP 
activity of MONO and CO capsules freshly prepared at the day of implantation (0 days of in vitro culture) 
or after 21 days in osteogenic differentiation medium (21 days of in vitro culture). 
 
3.2 In vivo histological assessment 
 
3.2.1 Morphological analysis 
Histological analysis of explanted samples stained with H&E (Figure VII.2) 
showed good integration of all types of capsules within the surrounding host 
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tissue. At the first week of implantation, the fragmentation of the layer-by-layer 
membrane of the capsules and the dispersion of the µPLLAs within the tissue 
was visible. It seems that the disruption of the membrane occurred gradually 
since the encapsulation contents, composed by encapsulated cells and 
microparticles, remained grouped at the site of the implantation. Few 
inflammatory cells were found in the condition without cells (MATERIAL) up to 
6 weeks of implantation, which also showed that the capsules did not elicit a 
severe infiltration of inflammatory cells. In addition, the histological evaluation 
with H&E staining also revealed the presence of various blood vessels in MONO 
and CO capsules against the few vessels that could be observed in MATERIAL 
capsules. In the empty control (Figure VII.SI), the presence of blood vessels 
could not be detected. After 6 weeks of implantation, immunostaining of CD31 
(Figure VII.3) was performed in MONO and CO capsule. As evidenced, the 
capsules were permeated to blood vessels with intraluminal red blood cells. 
However, the CD31 was not specific for the endothelium, and particularly in the 
CO capsules, the expression was detected along the sections. This could be 
attributed to the fact that the co-encapsulated endothelial cells are also 
expressing CD31. The presence of collagen was then assessed by Masson’s 
Trichrome staining. As evidenced in Figure VII.4, the presence of collagen 
(blue staining) could be visualized mostly in MONO and CO capsules with 21 
days of previous in vitro culture. Notably, although in less quantify, the 
presence of collagen in the newly deposited ECM could also be detected in CO 
capsules without in vitro stimulation. Additionally, the Masson’s Trichrome 
staining also allowed to visualize the presence of blood vessels inside the 
capsules environment. Importantly, the presence of a dense layer of fibrotic 
connective tissue surrounding the capsules could not be visualized, which 
highlights the biotolerability of the capsules. 
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Figure VII.2 – H&E staining of representative sections from MONO and CO capsules (implantation at day 
0 and day 21) and from capsules without cells (Material). Explants were retrieved after 1, 3, and 6 weeks 
of implantation (scale bar: 50µm). Abbreviations and signs used: microparticles (>), residual material of 
the liquified environment of capsules ($), layer-by-layer membrane (+), blood vessels (*) and regions of 
adipose tissue (AT) are marked. 
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Figure VII.3 – CD31 immunohistochemistry of representative sections from MONO and CO capsules 
(implantation at day 0 and after 21 days of in vitro culture). The presence of blood vessels is evidenced 
with squares. Explants were analyzed after 6 weeks of implantation. Scale bar is 40 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure VII.4 – Masson’s trichrome staining of representative sections from MONO and CO capsules 
(implantation at day 0 and after 21 days of in vitro culture). Explants were analyzed after 6 weeks of 
implantation. Collagen is stained in blue. Scale bar is 40 µm. 
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3.2.2 Osteogenesis evaluation 
The osteogenic marker OP was qualitatively detected by fluorescence 
microscopy (Figure VII.5). As expected, OP was expressed within in vitro pre-
differentiated MONO and CO capsules (day 21 capsules). At the first week of 
implantation, OP could be earlier detected in pre-differentiated CO capsules. 
Latter, with increasing implantation time, the expression of OP could also be 
detectable in CO capsules without in vitro osteogenesis stimulation (day 0 
capsules). The detection of OP with increased implantation time indicates the 
commitment of the encapsulated stem cells towards the osteogenic lineage. 
Only scarce fluorescence could be found in the material capsules as well as in 
day 0 MONO capsules formulations, indicating that osteogenic differentiation 
did not occur. Corroborating the OP results, mineralization (Figure VII.6) 
occurred in the pre-differentiated MONO and CO capsules, as well as in CO 
capsules without in vitro osteogenesis (day 0 capsules). Mineralization 
increased with the implantation time, and after 6 weeks of implantation 
calcium-rich deposits (stained in red) covered the entire region of the capsules. 
In the MONO capsules without pre-differentiation only a few mineralization 
spots were detected, while it was absence in the material capsules. 
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Figure VII.5 – Osteopontin (green) immunohistochemistry counterstained with DAPI (blue) of 
representative sections from MONO can CO capsules (implantation at day 0 and day 21) and, as control, 
from capsules without encapsulated cells (Material). Explants were analyzed after 1, 3, and 6 weeks of 
implantation. Scale bar is 50 µm. 
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Figure VII.6 – Alizarin red staining of representative sections from MONO and CO capsules of 
representative sections from MONO can CO capsules (implantation at day 0 and day 21) and, as control, 
from capsules without encapsulated cells (Material). Explants were analyzed after 1, 3, and 6 weeks of 
implantation. Mineralization spots are stained in red. Scale bar is 20 µm. 
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4. Discussion 
In the current study, we demonstrate for the first time the in vivo osteogenic 
differentiation of stem cells driven by co-culture with endothelial cells within 
liquified and multilayered capsules containing solid microparticles. 
Among the different bioencapsulation systems proposed [29-33], the central 
issue is related with the diffusion of nutrients to prevent necrosis at the bulk of 
implanted materials. In fact, the consensus in all tissue engineering fields is 
that improved vascularization is the crux of all future scaffold designs [6, 7, 
34]. Particularly in bone tissue engineering, engineered scaffolds transplanted 
to patients to restore or improve the functions of damaged tissue have often 
failed to produce the desired results due to a deficient oxygen and nutrient 
diffusion. In order to address this issue, we developed a bioencapsulation 
system, in which the core is in a liquid state, hence maximizing mass 
transportation within all the regions of the construct. However, the majority of 
cells used in tissue engineering are anchorage dependent, and consequently a 
physical support to process different cellular metabolisms is required. 
Therefore, along with the encapsulated cells, solid microparticles were 
incorporated inside the liquified environment of the capsules, which act as cell 
adhesion sites. Additionally, microparticles also allowed creating a biomimetic 
3D environment inside the capsules. Surrounding the liquified core loaded with 
the encapsulated cells and microparticles is the layer-by-layer membrane. As 
shown, the thin multilayer remained stable during 21 days of in vitro culture, 
and allowed the required diffusion of essential molecules for cell survival. The 
membrane also allowed the diffusion of osteogenic differentiation factors 
added to the culture medium that led to in vitro pre-osteogenic stimulation of 
MONO and CO capsules. The presence of the membrane was also essential to 
assemble all the encapsulated components into a single reservoir. Having a 
single structure encapsulating all the different components facilitated the 
implantation process, while avoiding their dispersion to other regions of the 
body. However, notwithstanding the stability shown in vitro, after the first week 
of implantation the histological analysis of the capsules revealed that the 
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membrane was disrupted. Nevertheless, since the disruption of the membrane 
occurred only at some areas, the core contents of the capsules remained 
mobilized and aggregated at the site of implantation. The partial disruption 
could be explained by the fact that the capsules were implanted 
subcutaneously into created pockets, so they were under a squeeze effect 
between the host tissues. Additionally, as time increases, the presence of 
blood vessels could have also contributed to the disruption of the flexible 
membrane that together with the liquified core of capsules could not offer a 
rigid surface. However, the disruption of the membrane proved to be a great 
outcome since the blood vessels transport oxygen and nutrients necessary to 
the transplanted cells and to the tissue surrounding the implanted capsules. 
Our main hypothesis was that the co-encapsulation of endothelial cells with 
stem cells within the capsules environment would lead stem cells to 
differentiate into the osteogenic lineage and, ultimately, led to the formation of 
a mineralized tissue. Different fundamental studies [35-37] have been show 
that ASCs stimulate blood vessel growth due to the secretion of many pro-
angiogenic factors, such as VEGF [11, 13, 21]. This explains the abundant 
presence of blood vessels in all capsules. Furthermore, endothelial cells also 
secrete numerous regulatory molecules for the differentiation and activity of 
bone forming cells [16-19]. However, in vivo this interaction is poorly 
characterized mainly because to the absence of appropriate engineered 
systems. Facca et al. [38] reported that although in vitro no substrate was 
required, the osteogenic differentiation of embryonic stem cells after in vivo 
implantation with microparticles incorporating BMP-2 and VEGF only occurred 
after incorporation of the contents in an alginate gel as a substrate. This was 
mainly attributed to the fact that the alginate matrix improved contact between 
the cells and the microparticles releasing system. In our strategy, the 
encapsulated stem and endothelial cells remained grouped due to the capsules 
structure. We believe that this has directly influenced the reported in vivo 
outcome by promoting a higher exposure to proangiogenic and osteogenic 
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factors released by stem and endothelial cells, respectively. This interaction 
explains the significant advance of this work, namely the in vivo osteogenesis 
with a mineralized and vascularized matrix observed in the CO capsules 
implanted immediately after production. This is a great achievement, 
indicating that CO capsules might be readily implanted into a bone defect, and 
osteogenesis can occur in vivo. The co-culture contribution is supported by the 
absence of mineralized tissue for the MONO capsules also implanted 
immediately after production. The pre-differentiation strategy of MONO and CO 
capsules during 21 days in vitro in culture medium containing osteogenic 
differentiation factors also demonstrated that the osteogenic differentiation 
pattern was maintained in vivo. However, the pre-differentiation of CO capsules, 
since endothelial cells are co-encapsulated, might result in a prevascularization 
in vitro. In bone TE, however, the in vivo success of in vitro prevascularization 
has so far been limited. Rouwkema et al. [39] have shown that vascular 
structures obtained from co-cultures of human umbilical vein endothelial cells 
(HUVECs) and human mesenchymal stem cells (hMSCs) were stable and 
organized into a more mature vascularization network after implantation. 
However, anastomosis of the invading vessels to the in vitro created vasculature 
was limited. Therefore, a vascularized osteogenic system that does not require 
in vitro culture before implantation is of great importance in TE strategies. 
Considering the reported findings, we believe that the proposed CO capsules 
might find great applicability in bone regeneration. 
 
5. Conclusion 
In this study, MONO and CO capsules with or without in vitro osteogenic pre-
differentiation were subcutaneously implanted in nude mice up to 6 weeks. The 
in vivo implantation of capsules did not elicit a severe infiltration of 
inflammatory cells, demonstrating the biotolerability of the liquified capsules. 
Sign of necrosis, either in the host tissue surrounding the implanted capsules 
or in the newly formed tissue inside the capsules, could not be detected, which 
is a major concern when implanting 3D systems. The significant advance of 
Chapter VII 
In vivo osteogenic differentiation of stem cells inside compartmentalized capsules loaded with co-cultured 
endothelial cells and microparticles 	
	 	 	278 
this work is that the co-encapsulation of endothelial cells with stem cells led to 
the formation of a mineralized tissue in vivo. This work is also a unique 
demonstration of the in vivo performance of a liquified and multilayered 
capsule containing microparticles and a co-culture of endothelial and stem 
cells. Considering the reported findings, we suggest the use of CO capsules as 
self-regulated reservoirs that after production can be readily implanted. By 
using this formulation we can incorporate different kinds of active molecules 
aimed at different applications, such as gene therapy, drug delivery, or tissue 
engineering. We believe that the developed capsules will find great applicability 
in bone regeneration, but also in other tissue engineering domains of complex 
tissue restoration. 
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Figure VII.SI - H&E staining of representative sections from empty pockets. Explants were analyzed after 
1, 3, and 6 weeks of implantation. Scale bar is 50 µm. Regions of skin and adipose tissue (AT) are 
marked. 
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Abstract 
In the present chapter are discussed the main conclusions of the work 
developed in this thesis. Additionally, recent progress on cell encapsulation 
field for tissue regeneration and future research directions are also deliberated. 
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1. General conclusion 
A wide range of polymers have been studied for cell encapsulation, in order to 
overcome numerous drawbacks, such as a lack of sufficient biotolerability in 
the host, undesired loss of the enveloped cells, an inability to achieve 
appropriate mechanical stability in vivo, and too low permeability that 
interferes with cell survival. Many of them never made it to the application 
phase since they did not meet one or more basic requirements for their use. 
In parallel with the discovery of new polymers and biomaterials, cell 
encapsulation strategies became more complex, and its use was extrapolated 
to respond to requirements of complex fields, such as Tissue Engineering and 
Regenerative Medicine (TERM). In TERM field, the concept of encapsulating 
cells is different from the immunoprotection required to treat endocrine 
diseases. In TERM applications, it is often desirable that the encapsulation 
matrix degrades while the encapsulated cells proliferate and create their own 
extracellular matrix. Additionally, different pro-healing components, such as 
growth factors and cytokines can be co-encapsulated with cells, while being 
released in a sustained fashion through the encapsulation matrix. 
In an attempt to create such challenging bioencapsulation system, liquified 
and multilayered capsules were developed, as discussed in the present thesis. 
The main goal was to create a sophisticated system with multiple 
functionalities to successfully stimulate the regeneration of damaged tissues. 
In Chapter III, the application of liquified and multilayered capsules 
encapsulating cells and microparticles as a bioencapsulation system for tissue 
engineering was first successfully achieved. The different parameters to 
develop such system were optimized, and results showed that the multilayered 
chitosan-alginate membrane produced by layer-by-layer was able to provided 
stability to capsules up to 7 days of in vitro culture, while allowing the diffusion 
of essential molecules for cell survival. In Chapter IV, the optimized 
parameters to produce multilayered and liquified capsules were applied, 
however, in order to increase the mechanical stability of capsules to allow 
longer periods of cell encapsulation, poly(L-lysine) (PLL) was introduced into 
the multilayered membrane. The incorporation of PLL led to an exponential 
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regime growth of the polymeric film, against the linear growth with only 
chitosan and alginate polyelectrolytes. Therefore, the mechanical stability of 
capsules was improved and capsules were able to support living cell 
encapsulation up to 28 days. Additionally, the metabolic activity and 
proliferation of the encapsulated cells within the liquified capsules were 
superior compared to non-liquified systems or liquified capsules without 
poly(L-lactic acid) (PLLA) microparticles. With the successful of the developed 
bioencapsulation system, capsules were then applied in specific tissue 
engineering fields. In Chapter V, the suitability for chondrogenic differentiation 
within magnetic-responsive liquified capsules co-encapsulating stem cells and 
surface modified PLLA microparticles was assessed. The results showed that in 
the absence of supplementation with TGF-β3, the immobilization of TGF-β3 to 
microparticles coated with collagen II was able to induce the chondrogenic 
differentiation. Notably, the chondrogenesis observed occurred in similar levels 
of those found for capsules cultured in normal chondrogenic differentiation 
medium, which used higher amounts of TGF-β3. Therefore, it was 
demonstrated the feasibility of capsules as an engineered self-regulated 
chondromimetic device. In Chapter VI, inspired by the local interactions at the 
molecular level from the co-existence of stem and vascular cells in the native 
environment of bone, stem (ASCs) and endothelial (ECs) cells both derived 
from adipose tissue were co-encapsulated. Results showed that the co-
encapsulation of ECs lead ASCs to differentiate into the osteogenic lineage 
inside the liquified and multilayered capsules with microparticles, even in the 
absence of two major osteogenic differentiation factors, namely 
dexamethasone and ascorbic acid. Additionally, capsules encapsulating both 
cells released BMP-2 and VEGF, which evidences the potential of the 
bioencapsulation system as a cytokine delivery system. Ultimately, in Chapter 
VII, capsules were tested in vivo after subcutaneous implantation in nude mice. 
This work was a unique demonstration of the in vivo performance of the 
liquified and multilayered capsules. Results confirmed in vivo the biotolerability 
of the bioencapsulation system, since signs of necrosis, either in the host 
tissue surrounding the implanted capsules or in the newly formed tissue inside 
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the capsules, could not be detected. This represents a great outcome in three-
dimensional systems. Additionally, the co-encapsulation of endothelial cells 
with stem cells led to the formation of a mineralized tissue in vivo, thus 
validating the results obtained in vitro in Chapter VI. 
 
2. Scientific progress and future research directions 
In recent years there have been some interesting research developments in cell 
encapsulation. To face the demanding requirement of cell encapsulation 
systems for TERM, new methodologies are being recently applied to develop 
the next generation of cell encapsulation systems. By applying principles of 
layer-by-layer technology new sophisticated membranes are being proposed, 
composed by a wide variety of constituents. The only requirement is that 
multipoint interactions exist between each of them, such as electrostatic 
contacts, van der Walls forces, and hydrogen bonding. Additionally, ultimate 
microfluidics systems and three-dimensional bioprinting devices are being 
projected, which are the main responsible for the high level of complexity and 
hierarchical organization of the new generation of cell encapsulation systems. 
Cell encapsulation is a technology with enormous clinical potential. Yet many 
difficulties remain, some of which will certainly challenge our scientific 
ingenuity. The stepwise analysis of the essential obstacles, coupled with 
increased international collaboration, should move the technology forward in a 
careful and controlled way and bring it much closer to clinical reality. This 
ambitious goal requires the interdisciplinary and integrated effort of scientists 
with different areas of expertise such as genetics, materials science, 
physicochemistry and chemical engineering, pharmaceutical technology, 
biology and medicine. Issues on long term viability, risk of immune response, 
together with the development of high biocompatible materials, with sufficient 
durability and appropriate permeability, should be addressed to further explore 
their possible clinical applications. Particularly, regarding the bioencapsulation 
system here proposed, although the developed capsules were tested for 
cartilage and bone regeneration, their application range is diverse due to the 
different components of the capsules that can be easily changed or combined 
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with new features, in accordance with the target tissue aimed to restore. 
Therefore, the developed capsules and can found application in other fields, 
such as biochemical and biological reactors, platforms for model diseases, 
drug analysis screening, and so on. With the knowledge generated by this 
work, it is expected that the proposed capsules will have a strong impact and 
open new prospects in the tissue regeneration field. The most characteristic 
and promising feature of the proposed multilayered and liquified system is the 
ability to tailor different properties in one single device. It is thus expected that 
the multilayered and liquified capsules encapsulating solid microparticles will 
find great applicability in tissue engineering domains of complex tissue 
restoration. 
